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ABSTRACT 
Identification and Biosensing Application of Molecular Recognition Elements 
Ka Lok Hong 
 Molecular recognition elements (MREs) are biomolecules such as single-stranded DNA 
(ssDNA), RNA, small peptides and antibody fragments that can bind to user defined targets with 
high affinities and specificities. This binding property allows MREs to have a wide range of 
applications, including therapeutic, diagnostic, and biosensor applications. The identification of 
MREs can be achieved by using the process called Systematic Evolution of Ligands by 
Exponential Enrichment (SELEX). This process begins with a large library of 109 to 1015 
different random molecules, molecules that bind to the user defined target or positive target are 
enriched in the process. Subsequently, this process can be modified and tailored to direct the 
enriched library away from binding to related targets or negative targets, and thus increasing the 
specificity. Single-stranded DNA (ssDNA) MREs are particularly favorable for biosening 
applications due to their relative stability, reusability and low cost in production. This work 
investigated the identification and application of ssDNA MREs to detect different bacterial 
toxins and pesticide.  
In Chapter 1, it begins by reviewing recent discovery and advancement in the SELEX 
technique for the identification and biosensing application of ssDNA MREs specific for bacteria, 
viruses, their related biomolecules, and selected environmental toxins. It is then followed by a 
brief discussion on major biosensing principles based upon ssDNA MREs. In Chapter 2, the pilot 
project of this work, ssDNA MRE specific for Pseudomonas aeruginosa exotoxin A was 
identified. In this chapter, a novel variation of SELEX called Decoy-SELEX, previously 
developed by our laboratory is described in greater detail. Additionally, the development of a 
ssDNA MRE modified enzyme-linked immunosorbent assay (ELISA) for the exotoxin A 
detection is also discussed. In Chapter 3, similar methodology was applied to identify a ssDNA 
MRE specific for the second target, Clostridium difficile toxin B. Subsequently, similar ssDNA 
MRE modified ELISA was developed for target detection in clinically relevant samples. In 
Chapter 4, ssDNA MRE specific for alpha toxin of Staphylococcus aureus was identified, and it 
was applied for sensitive detection of the target in clinically relevant samples.  In Chapter 5, the 
overall conclusion and potential future studies as a result from this work is discussed. Lastly, in 
Appendix, the project of identifying and potential future application of ssDNA MREs specific 
for a pesticide, Fipronil is described. 
Overall, this work has shown the proof-of-principle of using ssDNA MREs in biosensing 
application for target detections in clinically relevant samples. The work will be useful in the 
development of potential point-of-care diagnostic tools for rapid diagnosis of bacterial infections.  
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Chapter 1 
Literature review: Recent Advancement in the Biosensing of 
Pathogens and Toxins Based on Single-Stranded DNA 
Molecular Recognition Elements 
This chapter is adapted from the work that is currently under review for publication in BioMed 
Research International. 
Citation: Hong KL and Sooter LJ. 2015. “Single-stranded DNA Aptamers against Pathogens and 
Toxins: Identification and Biosensing Applications” Under review, BioMed Research 
International  
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1.1 Introduction 
 Target detection in diagnostics and sensors relies on successful molecular recognitions. 
Traditionally, antibodies have been used in biosening applications due to their target specificities 
and affinities. However, the inherent properties of proteins give rise to many shortcomings of 
antibodies. In 1990, the Gold Laboratory first described a process, termed Systematic Evolution 
of Ligands by Exponential Enrichment (SELEX) [1], which identifies one or few molecular 
recognition elements (MREs) with high affinity and specificity toward their intended targets. 
MREs can be short sequences of single-stranded DNA, RNA, small peptides or antibody 
fragments. All types of MREs are capable of binding to user-defined targets with high affinity 
and specificity, and these targets include proteins, small molecules, viruses, whole bacteria cells 
and mammalian cells [2].  
In order to identify nucleic acid MREs, the SELEX process generally begins from a very 
large random library consisting of 1013 to 1015 different molecules. An individual nucleic acid 
MRE is composed of two constant regions for primer attachment during polymerase chain 
reaction (PCR) amplification flanked by a 20-80 bases random region [3]. The target of interest 
is first incubated with the library under specific ionic and temperature conditions. Library 
molecules that bind to the target are retained and amplified by PCR, while non-binding library 
molecules are discarded. Negative or counter selections are often performed to increase the 
specificity of the library or direct the enrichment process away from binding to negative targets. 
Negative targets are often chosen for their structural similarities or the likelihood to coexist in 
the native environment with the target of interest. In this case, library molecules that bind to 
negative targets are discarded and those that do not bind are retained and amplified, and thus 
completing one round of in vitro selection (Figure 1.1). It is expected that after approximately 12 
3 
 
rounds of SELEX, one or few nucleic acid MREs with high specificity and affinity toward their 
targets can be identified.  
 
Figure 1.1: Illustration of the SELEX process. A random library consisting of up to 1015 
single-stranded nucleic acids molecules are incubated with the target of interest. Those that 
bound to the target are retrieved and amplified by polymerase case reaction. It is then followed 
by incubation with negative targets. Those that do not bind to negative targets are retained, 
amplified and subjected to further rounds of in vitro selection. 
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Both DNA and RNA MREs can conform into three dimensional structures, which include  
stem-loop, bulges and/or hairpin regions, give rise to binding pockets for their respective targets 
[4]. There are reports suggesting RNA MREs generally have a higher affinity for their target than 
their DNA counterparts [5]. However, unmodified RNA molecules are more susceptible to 
nuclease degradations than DNA. Modification on the 2’ hydroxyl of RNA molecules can 
increase their stabilities but may have negative impact on their binding affinities [6, 7]. It is also 
more difficult to amplify RNA MREs during selection, as reverse transcription to DNA must be 
performed prior to PCR. For these given reasons, there is a bigger hurdle to successfully identify 
and apply RNA MREs in molecular detection, and thus this review has chosen to focus on the 
discussion of ssDNA MREs in biosening applications. 
Single-stranded DNA MREs have high affinity and specificity toward their targets that is 
comparable to antibodies. In addition, ssDNA MREs have several advantages over antibodies. 
Firstly, ssDNA MREs are more thermostable and can be reversibly denatured. This reusability is 
particularly desired for molecular sensing applications. Secondly, ssDNA MREs can be 
identified for targets that are non-immunogenic or toxic to cells, as the SELEX process can be 
performed completely in vitro and independent of living systems. Lastly, identified ssDNA 
MREs with known sequences can be chemically synthesized at low cost and without batch to 
batch variations [8]. Different modifications such as thiol or amino functional groups can also be 
easily incorporated onto the 3’ and/or 5’ ends of oligonucleotides during synthesis and utilized 
for immobilization on solid platforms. Similarly, labeling molecules such as biotin or FITC can 
also be covalently attached and serve as reporters in sensing applications. The attractive features 
of ssDNA MREs allow researchers to investigate the translational application of biosensors. This 
review focuses on the recent advancements in the identification and biosensing application of 
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ssDNA MREs specific for bacteria, viruses, their associated biomolecules, virulence factors, and 
selected biological and chemical toxins. Detection of these targets has been shown to be 
important in medical diagnosis, food safety and environmental monitoring. Additionally, major 
principles in MRE based biosensors are briefly discussed. 
1.2 In vitro Selection of ssDNA Molecular Recognition Elements 
1.2.1 General Methodology of SELEX 
The general process of in vitro selection of ssDNA MREs starts from design and 
chemical synthesis of a ssDNA library. A ssDNA library consists of two pre-determined constant 
regions for primer attachment during PCR amplification flanking a random region. This random 
region gives rise to the diversity of the library, which can be designated by 4n, where n is the 
number of bases in the random region. Longer random regions result in increased library 
diversity, but also may risk inhibition of PCR amplification due to secondary structure formation. 
Therefore, the overall library lengths are usually designed to be less than 150 bases, including a 
random region of 20 to 80 bases, and are chemically synthesized using phosphoramidite 
chemistry [3].  
The SELEX process begins by incubating up to 1015 different ssDNA molecules with the 
target of interest. One of the key steps in the SELEX process is the separation of bound MREs 
from unbound MREs. The separation process is often achieved by target immobilization. 
Immobolization options include nitrocellulose membranes that can be used to adsorb protein 
targets [9], and histidine tags on recombinant proteins that can be with a metal affinity 
chromatography column [10]. However, ssDNA molecules may non-specifically adsorb to 
immobilizing substrates. A round of negative selection is typically performed prior to the start of 
the first round of positive selection to reduce the non-specific adsorption between the library and 
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immobilizing substrates. Magnetic beads have also been used to immobilize a wide range of 
targets [11-14]. The terminal primary amine or a surface lysine on a protein can be used to 
conjugate onto carboxylic acid coated magnetic beads via EDC/NHS reactions. Small molecule 
targets or target analogs with available functional groups can also be biotinylated and 
immobilized on streptavidin coated magnetic beads based on the strong affinity between biotin 
and streptavidin [14, 15]. Magnets can then be used for the separation of bound and unbound 
molecules. However, this technique runs the risk of selecting MREs bound to magnetic beads 
and/or streptavidin. Sooter and co-workers successfully showed that competitive elution with 
free target can effectively isolate ssDNA MREs specific for the target of interest and not to the 
immobilizing substrates or analog molecules [14-16]. 
Amplification of the ssDNA library is also crucial to the success of the in vitro selection 
process. PCR conditions have to be determined and optimized before the selection process. After 
the retrieval of target bound ssDNA molecules for each round of selection, a small-scale PCR 
can be carried out to determine the cycles of PCR needed to successfully amplify the library. 
Large-scale PCR can subsequently be performed based on the determined number of reaction, 
and thus decreasing the chance of over amplification and the generation of undesired PCR 
amplicons. 
It is necessary to obtain ssDNA from double-stranded PCR product prior to the 
subsequent rounds of selection. Several techniques have been shown to effectively isolate the 
single-stranded binding element from double-stranded DNA, such as asymmetric PCR, biotin-
streptavidin separation, lambda exonuclease digestions and size separation on denaturing urea 
polyacrylamide gel electrophoresis. Asymmetric PCR uses a different ratio of forward and 
reverse primer in the reaction mixture to generate both dsDNA and ssDNA allowing the two 
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types of DNA molecules to be visualized and separated using agarose gel electrophoresis. The 
ssDNA is then excised and purified [17]. Biotin-streptavidin separation uses a biotin tagged 
primer in the PCR amplification process to generate biotinylated dsDNA. The dsDNA can then 
be captured by streptavidin coated beads. The unbound strand of DNA can be retrieved using 
sodium hydroxide [18]. Lambda exonuclease can selectively digest a phophorylated strand of the 
dsDNA in 5’ to 3’ direction. PCR reactions carried out with a phosphorylated reverse primer can 
be selectively digested by lambda exonuclease, leaving only the forward strand [19]. Modified 
primers can be used to create size differences between the forward and reverse strand and be 
detected by using urea denaturing polyacrylamide gel electrophoresis (PAGE), and subsequently 
ssDNA can be excised and purified [20].  
1.2.2 Examples of Modified SELEX 
The general process of SELEX has been modified over the past two decades. These 
modifications mostly focus on increasing the efficiency in separating bound and unbound MREs, 
increasing specificity of the selected MREs, eliminating the need for immobilizing target 
molecules, selecting against live whole cells, and decreasing the overall labor intensiveness of 
the SELEX process. Selected modified SELEX methods pertinent to this review are briefly 
discussed.    
Negative or counter selection is incorporated into the normal SELEX process by 
introducing negative targets that have structural similarity to the target of interest or are likely to 
coexist in the target’s environment. This modification is to increase the overall specificity of the 
library during selection, and thus identify MREs that are highly specific to the target. Sooter and 
co-workers identified a ssDNA MRE target for a herbicide, atrazine, with 2.1–fold higher 
binding affinity to atrazine than to  a closely related herbicide, simazine, by introducing multiple 
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negative selection rounds and increasing stringency during the selection [14]. This stringent 
negative selection scheme was utilized to obtain two other ssDNA MREs that bind to their 
respective targets with high affinity and specificity [15, 16]. 
Capillary electrophoresis can separate molecules based upon their charges. Target bound 
and unbound DNA molecules migrate at different rates due to differences in their overall charges, 
and therefore different species can be separated and collected at different time points. Mendonsa 
and Bowser were the first to demonstrate using capillary electrophoresis to identify a ssDNA 
MRE specific for human IgE. Due to its high efficiency in separating different molecules, MREs 
can generally be identified in 4 to 6 rounds of capillary electrophoresis based SELEX (CE-
SELEX) [21]. CE-SELEX can also select MREs bound to free targets in solution, and without 
the need of immobilization. A variant of CE-SELEX utilizes non-equilibrium capillary 
electrophoresis of equilibrium mixtures (NECEEM) to achieve separation (Non-SELEX) has 
also been developed. In Non-SELEX, repetitive rounds of selection are performed without PCR 
amplification. Berezovski and co-workers were the first to use Non-SELEX to identify a high 
affinity MRE (Kd: 0.3 nM) specific for hRas protein [22]. 
Gu and co-workers developed an immobilization-free SELEX method based upon π-π 
stacking interaction between DNA and graphene oxide (GO-SELEX). In GO-SELEX, ssDNA 
library is adsorbed on graphene oxide and then incubated with the target. In the presence of the 
target, a portion of the ssDNA library is released from graphene oxide and bind preferentially to 
the target, while unbound ssDNA remain adsorbed, and can be separated by centrifugation [23]. 
This method was used to isolate ssDNA MREs specific for bovine viral diarrhea virus type 1 
[24]. A high-throughput modification of GO-SELEX was also developed by Gu and co-workers 
to identify flexible ssDNA MREs that are specific for multiple pesticides with affinities in the 
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nanomolar range [25]. Li and co-workers developed a different target immobilization-free 
SELEX method using a ssDNA library containing a 15-base constant region, sandwiched by two 
random regions and finally encompassed by two constant primer hybridization regions at both 3’ 
and 5’ end [26]. The 15-base constant region can hybridize with biotinylated complementary 
strand and be captured by streptavidin coated beads. Binding of the ssDNA library to target 
molecules induces conformational changes and thus releasing the binding-strand from the 
complementary strand. This method has been adapted to screen for ssDNA MREs specific for 
multiple pesticides [27, 28].  
FluMag-SELEX was developed by Stoltenburg and co-workers by immobilizing targets 
on magnetic beads, and using fluorescently labeled forward primer during PCR amplification 
[29]. Magnetic separation of bound and unbound MREs are performed similarly to traditional 
magnetic bead based SELEX. However, the overall binding capacity of the library can be 
monitor precisely with the presence of fluorescence tag. The selection process can then be 
terminated when the overall library binding affinity toward the target reaches a plateau. A similar 
technique has been incorporated in single microbead SELEX described by Tok and Fischer. In 
their work, only 2 cycles of SELEX were performed to identify multiple ssDNA MREs specific 
for botulinum neurotoxin with low-micro to nanomolar Kd values [30]. The usage of 
fluorescence tag in the library is further investigated by Veedu and co-workers by performing a 
one-step selection against alpha-bugarotoxin [31]. 
Microfluidic chips are also being investigated to facilitate the SELEX process (M-
SELEX). Microfluidic chips are capable of manipulating a very small amount of immobilized 
target on magnetic beads, thus achieving a more efficient separation of bound MREs [32]. Soh 
and co-workers were able to identify ssDNA MREs specific for Botulinum neurotoxin type A 
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with low nanomolar binding affinity after only one round of selection [32, 33]. Recently, MREs 
with nanomolar binding affinity specific for whole influenza A/ H1N1 virus were selected using 
M-SELEX [34]. 
Complex targets such as live mammalian and bacteria whole cells have become popular 
targets for selection. These types of selection are called cell-SELEX or whole cell-SELEX. Early 
works mostly focused on identifying MREs specific for tumor cells [35-38]. The general 
methodology of cell-SELEX is very similar to traditional SELEX, but fluorescence-activated cell 
sorting (FACS) can be utilized to achieve a very high level of separation of MRE bound and 
unbound cell targets. Multiple pathogenic bacteria gennera, such as Salmonella, Pseudomonas, 
Staphylococcus, Listeria and Escherichia have been chosen as selection target. The selection and 
biosening application of ssDNA MREs targeting bacteria, viruses, and associated biomolecules 
are discussed in the following section.   
1.2.3 Single-stranded DNA MREs Targeting Bacteria 
Single-stranded DNA MREs targeting bacteria can be classified into two general 
categories, 1) targeting whole cells with known or unknown molecular targets, and 2) targeting 
pre-defined bacteria cell surface targets or bacteria spores (Table 1.1). 
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Table 1.1: Summary table of ssDNA MREs targeting bacteria and bacteria structural 
components. 
Target SELEX 
Method 
Kd Detection Method LOD Reference 
E. coli K88 Cell-SELEX 15 ± 4 nM 
 
Fluorescence 1100 
CFU/mL 
 
[39] 
E. coli 
 
Cell-SELEX 12.4  to 
25.2 nM 
 
- - [40] 
E. coli NSM59 
 
Cell- SELEX 
 
110 nM 
 
- - [41] 
E.coli K88 
fimbriae protein 
 
Plate 
immobilized 
25 ± 4 nM 
 
- - [42] 
 
E. coli 8739 outer 
membrane protein 
Magnetic 
Beads 
- FRET 30 CFU/ 
mL 
[43] 
E. coli O111:B4 
Lipopolysaccharid
e 
 
Magnetic 
Beads 
- - - [44] 
Salmonella 
Typhimurium 
Cell-SELEX 1.73 ± 0.54 
µM 
Magnetic capture-qPCR 
 
100-1000 
CFU 
 
[45] 
Salmonella 
Typhimurium 
Cell-SELEX 6.33 ± 0.58 
nM 
Fluorescence 25 
CFU/mL 
[46] 
Salmonella 
Typhimurium 
Cell-SELEX - - - [47] 
Salmonella 
Typhimurium 
outer membrane 
protein 
Nitrocellulos
e membrane 
- Magnetic capture-qPCR 
(spike and recovery) 
 
< 10 
CFU/g 
[48] 
Salmonellae 
typhimurium/ 
enteritidis 
Cell-SELEX nanomolar 
to 
micromola
r range 
- - [49] 
Salmonellae 
enteritidis/  
Cell-SELEX 7 nM, 25 
nM 
- - [50] 
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typhimurium  
Salmonella 
Paratyphi A 
Cell-SELEX 47 ± 3 nM Chemoluminescence 
 
1000 
CFU/mL 
[51] 
Salmonella O8 Cell-SELEX 32.04 nM - - [52] 
Vibrio alginolyticus 
 
Cell-SELEX 
 
27.5 ± 9.2 
nM 
PCR 
 
100 
CFU/mL 
[53] 
Vibrio 
parahemolyticus 
 
Cell-SELEX 
 
16.88 ± 
1.92 nM 
- - [54] 
Listeria 
monocytogenes 
Cell-SELEX 
 
Mid 
nanomolar 
range 
- - [55] 
Listeria 
monocytogenes 
Cell-SELEX 35.7 ± 8.02 
uM 
Magnetic capture-qPCR < 60 
CFU/500 
µL 
[56] 
Listeria 
monocytogenes 
Cell-SELEX 
 
60.01 nM 
 
Fluorescence - [57] 
Listeria 
monocytogenes 
Cell-SELEX 48.74 ± 
3.11 nM 
Fluorescence 75 
CFU/mL 
[58] 
Listeria 
monocytogenes 
Internalin A 
Filter plate - Fiber-optic 1000 
CFU/mL 
[59] 
Shigella 
dysenteriae 
Cell-SELEX 23.47 ± 
2.48 nM 
 
Fluorescence 50 
CFU/mL 
[60] 
Streptococcus 
mutans 
 
Cell-SELEX 33 nM 
 
Colorimetric (Flow 
through) 
105-108 
CFU/mL 
[61] 
Streptococcus 
pyogenes 
 
Cell-SELEX 9 , 10 nM - - [62] 
Staphylococcus 
aureus 
 
Cell-SELEX 
 
35, 129 
nM 
 
Optical Light scattering 1 CFU/mL [63] 
Staphylococcus 
aureus 
Cell-SELEX 
 
nanomolar 
range 
- - [64] 
Proteus mirabilis Cell-SELEX 
 
7.7 nM, 
4.1 nM 
 
- - [65] 
Pseudomonas 
aeruginosa 
 
Cell-SELEX 
 
Low 
nanomolar 
range 
Fluorescence - [66] 
Mycobacterium 
tuberculosis 
 
Cell-SELEX 
 
 
Ka 105 – 
106 M 
 
- - [67] 
Francisella 
tularensis 
Cell SELEX 
 
- ALISA 1700 
bacteria/m
[68] 
13 
 
subspecies (subsp) 
japonica bacterial 
antigen 
 
L 
Bacillus anthracis 
spores/ anthrose 
sugar 
Magnetic 
beads 
-  30,000 
spores/ml 
[69] 
Bacillus anthracis 
spores 
Magnetic 
beads 
- Magnetic bead-
electrochemiluminescen
ce   
10- 6 x 106 
spores 
[70] 
Bacillus 
thuringiensis 
spores 
Magnetic 
Beads 
 
- Fluorescence 1000 
CFU/mL 
[71] 
Campylobacter 
jejuni 
Cell SELEX 
 
292.8 ± 
53.1 nM 
- - [72] 
Campylobacter 
jejuni (surface 
protein) 
Magnetic 
Beads 
 
- Fluorescence (Magnetic 
bead/ Quantum dot) 
10-250 
CFU in 
food 
matrix, 2.5 
CFU in 
buffer 
[73] 
Campylobacter 
jejuni (killed) 
CE-SELEX - Capillary 
Electrophoresis 
6.4 x106 
cells/mL 
[74] 
Peptidoglycan 
 
Filter 
 
0.415 ± 
0.047 μM /  
1.261 ± 
0.280 μM 
- - [75] 
 
Lipopolysaccharid
e (endotoxin) 
NECEEM 
non-SELEX 
low to high 
nanomolar 
range 
Electrochemical 0.01 - 1 
ng/mL 
[76] 
 
Multiple virulent strains of the gram-negative bacteria, Escherichia coli, have been 
chosen as targets for the selection of specific ssDNA MREs due to their enterotoxigenic effects 
and the potential of contaminating food and water [77]. Peng et al. enriched a ssDNA MRE 
library specific for E.coli K88 whole bacteria [39]. They also developed a sandwich detection 
system, in which biotinylated antibodies targeting the K88 strain were immobilized on magnetic 
beads as the capturing element and the 5’ FITC labeled ssDNA library from Round 13 selection 
served as the reporter in a fluorescent assay. A lower limit of detection (LOD) of 1100 CFU/mL 
was achieved in pure culture. Artificial contaminated fecal samples were also tested with a LOD 
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of 2200 CFU per gram. However, no individual ssDNA MREs were able to achieve the same 
degree of binding affinity as the whole library and a ssDNA MRE with high affinity and 
specificity against K88 fimbriae protein was selected after eleven rounds [42]. A fluorescence 
binding assay was used to obtain the affinity of selected MRE candidates. The reported 
equilibrium dissociation constant (Kd) for the best candidate MRE was 25 ± 4 nM. Kim et al. 
performed ten rounds of selection against a fecal strain of E. coli along with multiple negative 
selections against other species of bacteria. They identified four candidate sequences with high 
affinity for the target strain. All four candidates were highly selective against negative target 
bacteria. However, they all showed cross binding activity with other strains of E.coli. This 
suggested that the selected candidates potentially bound to common antigens expressed in 
multiple strains of E. coli [40]. Savory et al. identified a ssDNA MRE with high specificity and 
affinity (Kd = 110 nM) for an uropathogenic strain of E. coli. Quantitative PCR was used to 
monitor the SELEX process in order to minimize the number of rounds of SELEX required. 
After five rounds of SELEX, a selected ssDNA MRE containing a guanine-quadruplex sequence 
motif showed low cross binding activities toward other strains of E. coli [41]. In addition to 
selecting whole E. coli bacteria as targets, outer membrane protein from E. coli 8739 (Crook’s 
strain), and lipopolysaccharide from O111:B4 strains were also chosen as targets for selection. A 
fluorescence resonance energy transfer (FRET) assay was developed to detect E. coli 8379 with 
a LOD of 30 CFU/mL [43]. The ssDNA MRE targeting lipopolysaccharide showed antibacterial 
effects on both O111:B4 and K12 strains [44]. However, Kd values were not reported in either 
study. 
Several ssDNA MREs have been selected against species of foodborne bacteria including  
Salmonella, Listeria, and Vibrio. Dwivedi et al. identified a ssDNA MRE specific for whole cell 
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Salmonella enterica serovar Typhimurium with a reported Kd of 1.73 ± 0.54 µM after eight 
rounds of selection [45]. Two rounds of negative selection against a mixture of non-target 
bacteria were also performed to enhance the selectivity of the library. A detection application 
was developed using immobilized biotinylated MREs on streptavidin coated magnetic beads as 
the capturing elements, and was coupled with quantitative PCR. The reported LOD of this assay 
was between 100 to 1000 CFU in a 290 µL sample volume. Duan et al. performed a similar 
selection on the same organism with nine rounds of target selection, and two rounds of negative 
selection against mixtures of non-target bacteria [46]. The best candidate ssDNA MRE had a Kd 
value of 6.33 ± 0.58 nM and high specificity based upon flow cytometry analysis. A fluorescence 
bioassay achieved a LOD of 25 CFU/mL. Another similar study performed by Moon et al. 
showed relatively high affinities and specificities of selected candidate sequences after ten 
rounds of target and six rounds of negative selections. However, no Kd values were reported in 
the study [47]. Outer membrane proteins of Salmonella enterica serovar Typhimurium were 
chosen as selection target by Joshi et al. In that study seven rounds of selection were performed 
with three rounds of negative selection against E. coli outer membrane proteins and 
lipopolysaccharides. A magnetic bead based quantitative real-time PCR assay was developed 
using immobilized ssDNA MRE as the capturing element. Food and environmental samples 
were tested to demonstrate the translational usage of the assay. A LOD of less than 10 CFU per 
gram of artificially contaminated bovine feces was reported. Additionally, 10 to 100 of CFU 
were detected in 9 mL of artificially contaminated whole carcass chicken rinse sample solution 
in  a pull-down assay [48]. Two recent studies identified ssDNA MREs specific for two serovars 
of Salmonella, Typhimurium and Enteritidis [49, 50]. Park et al. truncated out the random region 
(29 to 30-mer) of selected candidates and identified three ssDNA MREs with Kd values in 
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micromolar range toward their respective serovars after ten rounds of mixed target and counter 
target selection. Poly-D-lysine was conjugated to the selected MREs, and achieved an 
approximately 20 to 100-fold enhancement in their binding affinities [49]. Kalovskaya et al. also 
performed a similar selection on the two serovars of Salmonella [50]. After twelve rounds of 
selection, two ssDNA MREs with Kd values ranges in nanomolar were identified (Enteritidis: Kd 
= 7nM; Typhimurium: Kd = 25 nM). Both selected MREs were able to demonstrate a 
bacteriastatic effect in their respective bacterial cultures. An antibiotic-resistant serovar of 
Salmonella enterica, Paratyphi A was chosen as target by Yang et al. A total of thirteen positive 
rounds and four negative rounds of selection were performed to identify a MRE with high 
affinity (Kd = 47 ± 3 nM) and specificity toward Paratyphi A. A LOD of 1000 CFU/mL was 
achieved using chemoluminescence assay based on self-assembled single-walled carbon 
nanotubes and DNAzymes-labeled MRE as detection elements [51]. A MRE with high 
specificity toward Salmonella O8 was identified by Liu et al. after eleven rounds of positive and 
two rounds of negative selection. The selected MRE had a reported Kd value of 32.04 nM. A 
preliminary fluorescent in situ labeling assay was developed with the MRE. However, no LOD 
was reported [52]. 
Consumption of uncooked or undercooked seafood contaminated by Vibrio bacteria can 
lead to food poisoning [78]. Two different species, Vibrio parahemolyticus and Vibrio 
alginolyticus were chosen as selection targets. Nine rounds of cell-SELEX using flow cytometry 
were carried out to identify a ssDNA MRE with high affinity and specificity for Vibrio 
parahemolyticus (Kd = 16.88 ± 1.92 nM) [53, 54]. Tang et al. performed fifteen rounds of cell-
SELEX on inactivated Vibrio alginolyticus. Negative selection was performed every third 
positive target round to improve the library specificity. The study did not characterize affinities 
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and specificities of candidate ssDNA MREs from the last round of selection. Instead, the whole 
library was characterized to have a Kd value of 27.5 ± 9.2 nM and was highly specific toward the 
target. The enriched library was able to detect 100 CFU/mL of the bacteria based on a PCR 
amplification assay [53]. 
Listeria monocytogenes is a foodborne gram-positive bacterium that can cause serious 
illnesses and even death. FDA and European Union both have zero tolerance of L. 
monocytogenes in ready-to-eat food products. Suh et al. conducted two studies to identify 
ssDNA MREs specific for L. monocytogenes [55, 56]. In their earlier study, a MRE with a 
micromolar Kd value was identified after six rounds of positive and two rounds of negative 
selections. The MRE showed low cross binding to negative target bacteria, but had similar 
binding affinity for other members of the Listeria genus. A magnetic bead based capture assay 
coupled with quantitative PCR was developed. The assay was able to detect less than 60 CFU in 
500 µL of binding buffer containing a mixture of non-Listeria bacteria [56]. In their later study, 
the affinities of selected candidate MREs were improved with reported values of Kd in the 
nanomolar range and were specific for the target bacteria at different growth phases [55]. Duan 
et al. performed similar whole cell in vitro selection on L. monocytogenes. The selected MRE 
had high affinity (Kd = 48.74 ± 3.11 nM) and was highly specific toward the target. A 
fluorescent cross binding assay showed significantly lower binding activities toward negative 
bacteria targets and as well as other bacteria species in the Listeria genus. A sandwich 
fluorescent bioassay was developed and demonstrated a LOD of 75 CFU/mL [58]. Most recently, 
Liu et al. performed eight rounds of selection to identify ssDNA MREs specific for L. 
monoceytogenes. The best candidate MRE reported to have a Kd value of 60.01 nM and had high 
specificity. A fluorescent based detection assay was developed to enable the observation of 
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binding between the MRE and target bacteria using fluorescent microscope, but the LOD was 
not reported [57]. 
Ohk et al. selected a ssDNA MRE specific for internalin A of L. monocytogenes. 
Internalin A is a major invasion protein expressed on the cell surface of L. monocytogenes [79]. 
A highly specific sandwich style fiber-optic biosensor was developed by using the selected MRE 
and antibody. A reported LOD of 1000 CFU/mL was achieved. The sensor also successfully 
detected the bacteria in artificially contaminated ready-to-eat meat products. However, affinity 
data was not reported in the study [59]. 
Shigella dysenteriae is a gram negative bacterium that causes severe epidemic diarrhea in 
many countries [80]. Duan et al. used cell-SELEX methodology to identify ssDNA MRE 
specific for S. dysenteriae [46, 54, 58, 60]. The best candidate MRE had a reported Kd value of 
23.47 ± 2.48 nM and low cross binding activities toward negative bacteria targets. A fluorescent 
based detection assay demonstrated a LOD of 50 CFU/mL [60] 
Campylobacter jejuni is a highly infectious gram negative bacterium that is one of the 
leading causes of acute diarrheal sickness worldwide [81]. Bruno et al. performed an in vitro 
selection by extracting surface proteins of C. jejuni and immobilizing them on magnetic beads. 
No values of Kd were reported in the study. However, a fluorescent assay based on magnetic 
beads and quantum dot was developed to detect the bacteria in different food matrices. The assay 
showed low cross binding activities with other species of bacteria, but was not able to distinguish 
between bacteria in the Campylobacter genus. The reported LODs were 2.5 CFU and 10 to 250 
CFU in buffer solution and in different food matrices respectively [73]. CE-SELEX was 
employed by Stratis-Cullum et al. to identify MREs specific for C. jejuni. Killed bacteria were 
used as target in their study. A qualitative capillary electrophoresis immunoassay was developed 
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with a LOD of 6.3x106 cells/mL [74]. Dwivede et al. performed cell-SELEX on live C. jejuni. A 
total of ten positive rounds and two negative rounds were carried out to identify ssDNA MREs 
with high affinity and specificity toward the target bacteria (Kd = 292.8 ± 53.1 nM) [72]. 
Bacteria that are associated with common infectious diseases, such as Streptococcus, 
Staphylococcus and Pseudomonas, are also popular targets for in vitro selection. Identification of 
MREs targeting infectious bacteria could potentially be used to facilitate diagnosis and thus 
decreasing the time between culture collections to specific antibiotic treatment.  
Savory et al. performed cell-SELEX on Proteus mirabilis, a common cause of catheter 
associated urinary tract infections in long-term catheterized patients. MREs specific for two 
different strains of P. mirabilis with low nanomolar range Kd values were identified after 6 
rounds of in vitro selection. Additionally, an in silico maturation (ISM) process was performed to 
increase the specificity of the selected MRE. It was reported that a 36% higher specificity was 
achieved after the ISM process [65]. This same technique was again employed to select MRE 
specific for Streptococcus mutants, the main causative pathogen of dental caries. The affinity of 
the identified MRE was improved up to 16-fold and the specificity was increased 12-fold after 
ISM. A gold colloids based colorimetric flow through assay was developed and demonstrated the 
detection S. mutants in the ranges of 105-108 CFU/mL [61].  
Streptococcus pyogenes (Group A Streptococcus) is often the causative pathogen of a 
wide range of infectious diseases, such as streptococcal pharyngitis, and streptococcal toxic 
shock syndromes [82]. Different M-types of live S. pyogenes were chosen for selection by 
Hamula et al. After 20 rounds of target selection, the two best candidate MREs yielded high 
affinity for Group A Streptococcus (Kd = 9 -10 nM). It was noteworthy that the candidate MREs 
showed good specificities, even though the authors did not perform any negative selections [62].  
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Strapylococcus aureus is a gram-positive bacteria associated with numerous of infections 
in human [83]. Cao et al. selected a panel of ssDNA MREs specific for S. aureus after several 
rounds of target and counter target selection. The reported Kd values of individual candidate 
MREs were in the nanomolar range with high specificity. The study showed that the combination 
of the panel of MREs yielded a better sensitivity in recognizing S. aureus than any single MRE 
[64]. Change et al. selected two ssDNA MREs with high affinities and specific toward S. aureus 
(Kd = 35 and 129 nM). The reported values of Kd improved to 3.03 and 9.9 nM respectively 
after thiol-modification and conjugation to gold nanoparticles. Subsequently, the MRE 
conjugated gold nanoparticles were utilized to capture target bacteria, and a resonance light-
scattering signal demonstrated the detection of single S. aureus cell in 1.5 hours [63]. 
Pseudomonas aeruginosa is a gram-negative bacterium that is commonly associated with 
nosocomial infections [84, 85]. Wang et al. performed fifteen rounds of positive and two rounds 
of counter target selection to identify ssDNA MREs with Kd values in the low nanaomolar range. 
The selected MRE showed negligible binding to counter bacteria cell targets. A fluorescence in 
situ hybridization (FISH) assay was developed to show rapid detection of P. aeruginosa. 
However, the detection ranges were not reported [66]. 
Mycobacterium tuberculosis is the etiologic pathogen for tuberculosis [86]. Chen et al. 
reported a ssDNA MRE with an apparent association constant (Ka) between 105 – 106 M and was 
highly specific. The authors reported an antibacterial effect of the selected MRE with both in 
vitro and in vivo models [67]. 
Highly infectious bacteria and bacteria spores have been considered as potential 
biological warfare agents, and it is important to detect these biological threats rapidly [87]. 
Bruno et al. 1999 performed an in vitro selection of ssDNA MREs targeting Bacillus anthracis 
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spores, the causative agent of anthrax. Autoclaved anthrax spores were used in the selection. A 
MRE-magnetic bead electrochemiluminescence sandwich assay was developed with a reported 
detection range of 10-106 spores [70]. Ikanovic et al. performed a selection of ssDNA MREs 
specific for Bacillus thuringiensis spores, a closely related species to B. anthracis. In this study, 
the methodology was adopted from Bruno et al. 1999. A fluorescent assay based on cadmium 
selenide quantum dots was developed with a reported detection limit at about 1000 CFU/mL [71]. 
Bruno et al. 2012 revisited the selection of Bacillus spores. In this later study, anthrose sugar on 
anthrax spores was chosen as target for selection. A MRE beacon based on fluorescent signals 
was developed and generated strong signal at spore concentrations greater than 30,000 
spores/mL. The authors also compared the MRE sequences pattern to previous studies and 
identified similarities in sequences composed of T/G rich bases. It was also reported that MREs 
specific for whole spores did not generate fluorescent signals in the presence of anthrose sugar, 
suggesting that the selected spore specific MREs possibly bound to a different eptiope and 
warranting further research [69]. 
Francisella tularensisis is an encapsulated, gram-negative coccobacillus that is highly 
infectious. Reports show as few as 25 organisms in aerosol can cause diseases [88]. Vivekananda 
et al. performed ten rounds of selection on Francisella tularensisis subspecies japonica bacterial 
antigen. A cocktail of 25 ssDNA MREs was reported to have high specificity toward the target 
bacteria. A MRE modified enzyme-linked immunosorbent assay was developed, and 
demonstrated binding to the target and other subspecies of F. tularensisis but not to other species 
of bacteria and chicken lysozyme or chicken albumin. In addition, the assay was able to achieve 
better sensitivity then traditional ELISA using anti-tularemia antiserum and anti-tularemia 
polycolonal antibodies. The reported LOD was 1700 bacteria/mL [68]. 
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Peptidoglycan is a macromolecule universally expressed on bacteria outer cell wall [89]. 
Ferreira et al. identified two ssDNA MREs with sub to low micromolar Kd values that can bind 
specifically to both gram-positive and gram-negative bacteria. Neither MRE bounded to human 
fibroblasts or Candida albicans, and could potentially be used as generic detection elements for 
bacteria [75]. 
Lipopolysaccharide (LPS or endotoxin) is expressed in the outer membrane of gram-
negative bacteria, and can illicit strong immune response upon entering into mammalian cells. 
[90, 91] Kim et al. used nonequilibrium capillary electrophoresis of equilibrium mixtures 
(NECEEM) based non-SELEX to identify multiple ssDNA MREs with high affinities toward 
lipopolysaccharide in only three rounds of selection. Selected MREs also demonstrated very low 
cross binding activities to bovine serum albumin, and other intracellular molecules, such as DNA, 
RNA, glucose and sucrose in an electrochemical assay. This assay resulted in a target detection 
ranges of 0.01 to 1 ng/mL [76] 
1.2.4 Single-stranded DNA MREs Targeting Viruses 
There is a wealth of literature describing ssDNA MREs targeting various virus life cycle 
regulator proteins with the purpose of therapeutic application. In contrast, there is a lesser 
amount of research on ssDNA MREs for virus biosensing application (Table 1.2). 
 
Table 1.2: Summary table of ssDNA MREs targeting viruses and virus protein for 
biosensing applications. 
Target SELEX 
Method 
Kd Detection 
Method 
LOD Reference 
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Human 
Noroviruses 
Antibody-bead 
conjugates 
High nanomolar 
range 
RT-qPCR 10 RNA 
copies 
[92] 
Norovirus 
 
Nitrocellulose 
membrane 
Low picomolar 
range 
Electrochemical 180 virus 
particles 
 
[93] 
Norovirus II.4 
capsid protein 
VP1 
Filter 
 
- - - [94] 
Influenza A 
H1N1 
Microfluidic 
SELEX 
55.14 ± 22.40 
nM 
Bead/ Fluorescent 6.4 x 10-3 
HAU 
[34] 
Avian 
influenza 
H5N1 
Nitrocellulose 
membrane 
4.65 nM Dot Blot 1.28 HAU [95] 
Influenza A 
hemagglutinin 
protein 
TALON 
affinity resin 
Low nanomolar 
range 
Sandwich ELAA - [96] 
SARS-CoV N 
protein 
Ni-NTA beads 4.93 ± 0.3 nM 
 
Western Blot - [10] 
Bovine viral 
diarrhea virus 
GO-SELEX 5 x 104 
TCID50/ml 
SPR AuNP 
sandwich 
800 
copies/mL 
[24] 
HCV envelope 
surface 
glycoprotein 
E2 
Cell surface 
SELEX 
1.05 ± 1 nM - - [97] 
Dengue Virus 
Type-2 
envelope 
protein 
domain III 
Ni-NTA 
magnetic beads 
154 ± 40 nM - - [98] 
HIV reverse 
transcriptase 
CE-SELEX 180 ± 70 pM - - [99] 
 
 For the focus of this review, those MREs with therapeutic applications are listed in the 
following table without further detail discussions (Table 1.3).  
 
Table 1.3: Summary table of ssDNA MREs targeting viruses and virus proteins for 
therapeutic applications. 
Virus Target SELEX Method Kd Reference 
HIV Reverse 
transcriptase 
Nitrocellulose Filters - [100] 
HIV Reverse 
transcriptase 
Sephadex columns 660 pM [101] 
HIV Reverse Nitrocellulose Filters 1 nM [102] 
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transcriptase 
HIV Reverse 
transcriptase 
Primer-free SELEX 82 nM [103] 
HIV Integrase Nitrocellulose Filters - [104] 
HIV Integrase - - [105] 
HIV Trans-
activation-
responsive RNA 
element (TAR)  
Magnetic beads 20 nM [106] 
HIV Trans-
activation-
responsive RNA 
element (TAR)  
Magnetic beads 50 nM [107] 
HCV NS5B RNA 
polymerase 
Nitrocellulose Filters 132 nM [108] 
HBV Core Protein - High affinity determined 
by dot blot 
[109] 
SARS 
coronavirus 
Helicase Magnetic beads 5 nM [110] 
Influenza A 
virus 
Hemagglutinin 
from H3N2 
Ni-NTA beads - [111] 
Influenza A 
virus 
Hemagglutinin 
from H5N1 
Ni-NTA beads High affinity determined 
by ELISA 
[112] 
Influenza A 
virus 
Hemagglutinin 
from H3N2 
Ni-NTA magnetic beads 7 nM [113] 
Influenza A 
virus 
Hemagglutinin 
from H9N2 
Nitrocellulose Filters High affinity determined 
by ELISA 
[114] 
Influenza A 
virus 
Non-structural 
protein 1 
Glutathione agarose 
beads 
18.91 ± 3.95 nM [115] 
Rabies Virus Rabies virus 
infected BHK-
21 cells 
Cell SELEX 28 nM [116] 
HPV HPV 
transformed 
HeLa cells 
Cell SELEX 1 nM [117] 
Vaccinia 
Virus 
Whole virus 
particle 
One-step MonoLEX High affinity determined 
by dot blot, SPR, etc 
[118] 
 
In recent years, there has been an increase in the interest in the application of ssDNA 
MREs for virus detection. Human noroviruses are the leading cause of acute gastroenteritis 
worldwide. Current detection methods for the virus are time consuming and labor intensive [119]. 
Giamberardino et al. performed nine rounds of in vitro selection on murine norovirus. The best 
candidate MRE was reported to have affinity in the low picomolar range. It displayed cross 
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binding activity with human norovirus, but not to a structurally similar virus, feline calicivirus. 
An electrochemical sensor using a gold nanoparticle modified screen-printed carbon electrode 
was developed with a reported LOD of 180 virus particles [93]. Escudero-Abarca et al. 
performed selection on multiple strains of human noroviruses, including Snow Mountain virus, 
and Norwalk virus. Candidate MREs showed high binding affinities that were comparable to 
commercially available antibodies. The best MRE was also able to show binding to specific virus 
strains in human fecal samples. A reported LOD of 10 virus RNA copies was achieved in 
artificially contaminated lettuce by using immobilized biotinylated MRE on streptavidin 
magnetic beads coupled with real-time quantitative PCR [92]. The capsid protein VP1 of 
Norovirus genotype II.4 was chosen to be the target for selection by Beier et al. After twelve 
rounds of selection, surface plasmon resonance analysis was used to show the high specificity of 
the selected MRE. Computer simulation was used to characterize the binding interaction between 
VP1 and candidate MREs. However the authors did not report the Kd  value in the study [94].  
Influenza virus is the causative agent for many upper respiratory diseases and can 
potentially cause pandemics with high mobility and mortality [120]. Lai et al. used M-SELEX to 
identify ssDNA MRE target influenza A H1N1 with high affinity (Kd = 55.14 ± 22.40 nM). A 
magnetic bead based florescent assay achieved a reported LOD of 6.4 x 10-3 HAU. When the 
bead capturing method was coupled with RT-PCR, the fluorescent signal remained detectable in 
virus spiked clinically relevant matrices, including throat swab samples, sputum samples, and 
serum samples [34]. Wang et al. performed an in vitro selection specific for influenza virus 
H5N1. Purified hemagglutinin (HA) protein was used as target for the first four rounds, and then 
inactivated whole H5N1 viruses were used from round five to thirteen. The best candidate MRE 
displayed high affinity (Kd = 4.65 nM) with only minimal cross binding activities on other avian 
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influenza virus strains. A dot blot assay was developed with a LOD of 1.28 HAU, which was 
comparable to anti-H5 antibody. The dot blot assay also demonstrated the detection of the target 
virus in spiked chicken and duck swab samples [95]. Shiratori et al. chose recombinant influenza 
A HA protein as target for selection. After ten rounds of target selection, candidate sequences 
showed high binding affinities with reported Kd values in the low nanomolar range. A sandwich 
enzyme linked aptamer assay (ELAA) was developed and showed similar binding responses on 
three strains of influenza A, H5N1, H1N1 and H3N2. However, the LOD was not determined 
[96]. 
A novel coronavirus caused a severe acute respiratory syndrome (SARS) outbreak in 
2002 to 2003 [121]. Cho et al. identified ssDNA MREs specific for the SARS coronavirus 
nucleocapsid protein. After twelve rounds of positive selection, the best candidate MRE had a 
reported Kd value of 4.93 ± 0.3 nM. MRE modified Western blot showed a comparable detection 
level to nucleocapsid antibody based assay. However, the authors did not show cross binding 
reactivity of the selected MREs toward other viral proteins [10]. 
GO-SELEX was utilized to identify ssDNA MREs specific for bovine viral diarrhea virus. 
After five rounds of positive and negative selections, three best candidate MREs had reported Kd 
values of 4.08 x 104, 4.22 x 104 and 5.2 x 104 TCID50/mL respectively by SPR kinetics analysis. 
All candidate MREs showed very high specificity toward the target. A sandwich SPR detection 
assay was developed wherein a biotinylated MRE was immobilized on streptavidin coated gold 
chip as the capturing MRE, and a second different MRE with thiol modification was conjugated 
to gold nanoparticle as the reporting MRE. A LOD of 800 copies of virus/mL was reported with 
this assay [24]. 
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Hepatitis C virus (HCV) envelope surface glycoprotein E2 was chosen as target for 
selection by Chen et al. E2 protein was expressed on a murine colon carcinoma cell line, CT26 
cells, and used as target for positive selection. The native CT26 cells were used as counter target. 
After thirteen rounds of selection, the best candidate MRE showed high affinity and specificity 
toward E2-positive cells. An ELISA virus capture assay was developed by using biotinylated 
MRE as reporter and demonstrated the detection of HCV in clinical human serum samples. In 
addition, the MRE, termed ZE2 also displayed therapeutic effect by inhibiting E2 protein binding 
to CD81 and blocking HCV infection of human hepatocytes in vitro [97]. 
Dengue virus is a member of family Flaviviridae, genus flavivirus. It is a mosquito-borne 
RNA virus that can cause gangue fever, dengue hemorrhagic fever, and dengue shock syndrome 
[122]. Gandham et al. used recombinant dengue virus type-2 envelope protein domain III as 
target of interest to perform an in vitro selection of thiophosphate ester modified ssDNA MREs. 
After five rounds of target selection, the best MRE had a reported Kd value of 154 ± 40 nM, but 
no cross binding experiments were performed [98]. 
CE-SELEX was performed by Mosing et al. to identify ssDNA MREs specific for HIV 
reverse transcriptase. After only four rounds of selection, the best candidate MRE had an ultra-
high affinity with a reported Kd value in the picomolar range. Interestingly, there were no 
identifiable consensus sequence families in the round four ssDNA library. The authors claimed 
that the selected MRE had the highest affinity for the target of interest when compared to MREs 
selected by other methods, and suggested multiple ultra-high affinity MREs might exist in the 
enriched library [99]. 
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1.2.5 Single-stranded DNA MREs Targeting Toxins 
1.2.5.1 Biological Toxins/ Virulence Factors 
Secretory proteins, virulent factors, exotoxins, or small molecule toxins from bacteria, 
fungus and other organisms are important biomarkers in medical diagnosis, environmental 
monitoring and as well as in food safety surveillance. The following section discusses recent 
studies in the identification and biosening application of ssDNA MREs specific for biological 
toxins (Table 1.4). 
Table 1.4: Summary table of ssDNA MRE targeting biological toxins and virulence factors. 
Target SELEX 
Method 
Kd Detection Method LOD Referenc
e 
Enterotoxin B Magnetic 
Beads 
- Electrochemiluminescenc
e 
10 pg [123] 
Enterotoxin B Magnetic 
Beads 
- - - [11] 
Enterotoxin C1 
 
Magnetic 
Beads 
65.14 ± 
11.64 nM 
Fluorescence 6 ng/mL [124] 
Cholera toxin Magnetic 
Beads 
- ELAA/ 
Electrochemiluminescenc
e 
10 ng 
40 ng 
[123] 
C. diff Toxin A/ 
Toxin B/ Binary 
Toxin 
Magnetic 
Beads/ 
SOMAmerTM 
Sub to low 
nanomolar 
range 
Various 
 
1 pmol/L 
 
[125] 
C. diff Binary 
Toxin 
Sandwich 
SELEX/ 
SOMAmerTM 
0.02 - 2.7 
nM 
 
Sandwich assays 
 
Low 
picomolar 
 
[126] 
 
C. diff  Toxin B Magnetic 
Beads 
47.3 ± 13.7 
nM 
Modified ELISA 50 nM [127] 
CFP-10.ESAT-6 
heterodimer 
Nitrocellulos
e 
Low 
nanomolar 
range 
 
Colorimetric (ELONA) 
 
100% 
sensitivity
, 68.75% 
specificity 
[9] 
CFP-10.ESAT-6 
heterodimer 
Microwell 375 nM / 
160 nM 
Colorimetric (ELONA) 
 
89.6 – 
100% 
sensitivity
[128] 
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Plate  , 94.1% 
specificity 
MPT64 
TB protein 
Microwell 
Plate 
- Sandwich assays - [129] 
Protective Antigen CE-SELEX 112 nM Electrochemical (SWNT) 1 nM [130] 
Protective antigen Membrane 
filtration 
nanomolar 
range 
ELISA - [131] 
Botulinum 
neurotoxin type A 
heavy chain 
peptide/ toxoid 
Single 
micobead 
 
Nano to 
micromola
r range 
 
- - [30] 
Botulinum 
neurotoxin type A 
light chain 
 
Microfluidic-
SELEX 
Low 
nanomolar 
range 
- - [32] 
Botulinum 
neurotoxin type A 
light chain 
Magnetic 
Beads 
- Fluorescence 1 ng/mL [132] 
Microcystin Sepharose gel Ka: 103 M-1 SPR - [133] 
Cylinrospermospi
n 
Sepharose 
Beads 
88.78 nM Electrochemical 100 pM [134] 
Saxitoxin Magnetic 
Beads 
- - - [135] 
Okadaic acid Magnetic 
Beads 
77 nM Electrochemical 70 pg/mL [12] 
Ochratoxin A Agarose resin 200 nM Fluorescence Polarization 5 nM [136, 137] 
Ochratoxin A Magnetic 
Beads 
96-293 nM ELAA 1 ng/mL [138] 
Ochratoxin A Sepharose 
Beads 
High 
nanomolar 
range 
Fluorescence 9 nM [139] 
Fumonisin B1 Magnetic 
beads 
100 nM - - [13] 
Zearalenone Magnetic 
Beads 
41 ± 5 nM Fluorescence 0.785 nM [140] 
T-2 toxin GO-SELEX 20.8 ± 3.1 
nM 
Fluorescence 0.4 µM [141] 
Aflatoxin B1 Magnetic 
Beads 
11.39 ± 
1.27 nM 
Fluorescence 35 ng/L [142] 
Aflatoxin B1/ M1 Magnetic 
Beads 
96-221 nM 
35-1515 
nM 
Colorimetric/ AuNPs 250 - 500 
nM 
(Aflatoxin 
M1) 
[143] 
Alpha 
Bungarotoxin 
 
1 step 
SELEX 
 
7.58 µM 
 
- - [31] 
Alpha Toxin Magnetic 
Beads 
93.7 ± 7 
nM 
Modified ELISA 200 nM [144] 
Alpha Toxin Filter - - - [145] 
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Staphylococcus aureus can secrete a group of thermostable enterotoxins that have been 
shown to contaminate food. Reports suggest that these toxins are a common cause of foodborne 
illnesses [146]. There are many types and subtypes of staphylococcus enterotoxins. Bruno et al. 
first selected ssDNA MREs that bind to enterotoxin B by using magnetic bead immobilized 
target. An electrochemiluminescence assay was developed to demonstrate a detection limit of 
less than 10 pg of enterotoxin B. However, no kinetic data or crossing-binding profiles were 
presented in the study [123]. DeGrasse identified a ssDNA MRE specific for enterotoxin B after 
fourteen rounds of mixed target and negative targets selection. A MRE based precipitation assay 
was used to analyze the selectivity of candidate MREs in cell-free culture supernatant from 
multiple strains of S. aureus.  The high selectivity of candidate MREs was confirmed by 
capturing only the target toxin in the precipitation assay. However, no quantitative binding data 
was presented in the study [11]. Enterotoxin subtype C1 was chosen as target for selection by 
Huang et al. After twelve rounds of selection, the best candidate MRE demonstrated high affinity 
for enterotoxin C1 (Kd = 65.14 ± 11.64 nM). Cross binding experiments showed the selected 
MRE had high specificity and low cross binding activities on staphylococcus enterotoxin A, 
enterotoxin B and other protein molecules. A graphene oxide based fluorescence detection assay 
was developed and achieved a reported LOD of 6 ng/mL in artificially contaminated buffer-
diluted milk samples [124]. 
Bruno et al. 2002 selected a ssDNA MRE against cholera toxin. An enzyme linked 
colorimetric assay showed a detection limit of less than 10 ng of cholera toxin, and a 
electrochemiluminescent assay show a detection limit of less than 40 ng. However, affinity, 
crossing binding data, and MRE sequences were not presented in the study [123]. 
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Toxigenic strains of Clostridium difficile can produce toxin A and toxin B, which are the 
contributing factor of C. difficile induced diarrhea. Rapid diagnosis of the condition is crucial in 
facilitating patient recovery and disease control [147]. Some strains of C. difficile also secret a 
binary toxin that can inhibit actin polymerization [148]. Ochsner et al. selected several slow off-
rate modified ssDNA MREs (SOMAmer™) specific for toxins A, B and binary toxin. Several 
DNA libraries with modifications, such as  5-benzylaminocarbonyl-dU (BndU), 5-
naphthylmethylaminocarbonyl-dU (NapdU), 5-tryptaminocarbonyldU (TrpdU), 5-phenylethyl-1-
aminocarbonyl (PEdU), 5-tyrosylaminocarbonyl-dU (TyrdU), or 5-(2-naphthylmethyl) 
aminocarbonyl (2NapdU) were used in selections. Truncated recombinant toxins were used as 
targets. Equilibrium dissociation constants of selected SOMAmersTM were in pico to nanomolar 
range. The affinities for native toxins were slightly lower, but were remain in the low nanomolar 
range for majority of the candidate sequences. Pull-down capture, dot blots and antibody 
sandwich assays were developed with a reported LOD of 300 pg/mL. Selected SOMAmersTM 
were able to detect all three toxins in cell-free culture supernatants of toxigenic C. difficile [125]. 
Ochsner et al. performed another in vitro selection on C. difficile binary toxin with sandwich 
SELEX. The advantage of sandwich SELEX is to select SOMAmerTM pairs that target different 
epitopes of the target protein. The reported Kd values of selected SOMAmers ranged from 0.02 
to 2.8 nM. A SOMAmer sandwich assay was developed with a reported LOD in the low 
picomolar range. The authors claimed that these studies showed the high potential for the 
development of sensitive and specific diagnostic kits [126].  
Hong et al. performed a selection on C. diff toxin B and developed a proof-of-concept 
ssDNA MRE modified ELISA for sensitive target detection in human fecal matter. This work 
will be discussed in detail in Chapter 3 [127]. 
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Tuberculosis (TB) remains to be a challenging disease in developing countries. Recent 
discovery of multi-drug resistant strains of Mycobacterium tuberculosis has further increased 
public concerns, however, current diagnostic techniques for TB are either time consuming or 
insensitive [149-151]. Rotherham et al. performed a selection on CFP-10.ESAT6 heterodimer, a 
specific biomarker for TB infections.  After six rounds of selection, SPR binding studies showed 
candidate ssDNA MREs had affinities in the nanomolar range. One of the candidate MRE was 
tested in an enzyme linked oligonucleotide assay (ELONA). The authors reported the assay had 
100% sensitivity and 68.75% specificity in clinical sputum samples using Youden’s index. 
However, the time needed for assay completion and crossing binding activities to other antigens 
were major limitations of the assay [9]. Tang et al. performed a selection on the same CFP-
10.ESAT6 heterodimer. After seventeen rounds of selection, Kd values of candidate MREs were 
in the low nanomolar range. Two ssDNA MREs (CE24, CE 15) were used in an ELONA assay. 
The reported sensitivity and specificity of CE24 MRE based ELONA were 100% and 94.1% 
respectively. CE15 MRE based ELONA had a lower sensitivity of 89.6%, but the specificity was 
the same. Assays were tested with both pulmonary and extrapulmonary serum samples from TB 
patients [128]. 
MPT64 is a secreted protein of M. tuberculosis and can be used as biomarker for active 
TB infections [152]. Qin et al. performed twelve rounds of selection on MPT64. Affinities of 
truncated candidate ssDNA MREs, containing only a 35-base central random region, were 
qualitatively observed using streptavidin-horse radish peroxidase (HRP) binding to protein-
bound biotin-tagged MREs. A colorimetric sandwich assay using two different MREs was 
developed to detect the presence of MPT64 in culture filtrates. The sandwich assay achieved 
sensitivity and specificity of 86.3% and 88.5% respectively [129]. 
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Protective antigen (PA) is a secreted virulence factor of Bacillus anthracis that binds to 
anthrax toxin receptors on mammalian cells and subsequently causes cell dysfunction and death 
[153]. Cella et al. utilized CE-SELEX to identify a ssDNA MRE targeting PA with high affinity 
and specificity. After six rounds of CE-SELEX, the best candidate had a reported Kd value of 
112 nM. An electrochemical biosensor was developed by immobilizing 5’ amino modified MRE 
on 1-pyrenebutanoic acid succinimidyl ester (PASE) modified single wall carbon nanotubes 
(SWNT). The sensor showed low cross binding activity toward human and bovine serum 
albumin at 100 nM concentration. The sensor surface could be regenerated using 1 µL of 6 M 
guanidium hydrochloride for 15 minutes followed by a wash with 10 mM phosphate buffer. A 
reported LOD of 1 nM was achieved [130]. Choi et al. performed an in vitro selection on PA. 
After eight rounds of selection, four candidate sequences had high affinities for PA (Kd in low 
nanomolar range), and two of the four candidates had low cross binding activities toward bovine 
serum albumin and bovine serum [131]. 
Botulinum neurotoxins (BoNT) are produced by Clostridium botulinum. In additional to 
its medical uses, it can also cause serious foodborne illnesses and may potentially be used as a 
biological weapon [154]. Tok et al. used a novel single microbead SELEX to perform selection 
of ssDNA MREs specific to aldehyde-inactivated BoNT type A toxin (BoNT/A-toxoid) and 
BoNT type A heavy chain peptide (BoNT/A Hc-peptiod). Targets were immobilized onto Ni-
NTA agarose or amine-functionalized polystyrene TentaGel beads. A single target-immobilized 
microbead was incubated with the ssDNA library and retrieved for PCR amplification of bound 
ssDNA molecules. After only two rounds of selection, five candidate sequences specific for 
BoNT/A Hc-peptiod had Kd values ranging from 1.09 µM to 4.20 µM. Three candidate 
sequences specific for BoNT/A-toxoid had Kd values ranging from 3 nM to 51 nM. The authors 
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reported that all MREs specific to BoNT/A Hc-peptiod were able to competitively inhibit the 
binding between the toxin peptide and anti-BoNT antibody, and potentially be used as a 
therapeutic agent [30]. 
Lou et al. utilized a novel microfluidic device to facilitate the partitioning of a small 
volume of target coated magnetic beads (M-SELEX). The library achieved a very high overall 
affinity (Kd = 33 ± 8 nM) against BoNT/A light chain after only one round of selection. Four 
candidate sequences had a range of Kd values between 34 to 86 nM. The authors claimed that 
their M-SELEX could be readily adapted to any bead immobilized targets or whole cell target 
[33]. Bruno et al. immobilized BoNT/A light chain on magnetic beads and performed ten rounds 
of selection. The best candidate MRE was fluorescently tagged and used as a reporter for target 
detection. The reported LOD of 1 ng/mL was achieved in buffer. However, the MRE reporter 
also bound to structurally similar targets, BoNT type B, type E holotoxins and heavy or light 
chain components, in a soil dilution. The author compared their MRE sequence to previous 
ssDNA MRE specific for BoNT and found consensus short sequence segments. This suggested 
that the binding between BoNTs and MREs may be conserved within these consensus segments 
[132].  
Microcystin is a hepatotoxin produced by cyanobacteria. Three different analogs of 
microcystin were used in the study performed by Nakamura et al. Microrocystin LR, containing 
a leucine substituent was immobilized and used for twelve rounds of target selection. However, 
surface plasmon resonance binding data indicated a higher binding level between the selected 
MRE and microcystin YR, an analog containing a tyrosine substituent. There was also 
significant binding to microcystin RR, an analog containing an arginine substituent. The reported 
binding affinity (Ka) was low, at approximately 103 M-1. This early work did not demonstrate the 
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high affinity and specificity properties of MREs, however, it did show the possibility of using 
MREs as a binding molecule in a label-free detection system [133]. 
Cylindrospermopsin (CYN) is another water soluble and heat stable alkaloid secreted by 
a large group of fresh water cyanobacteria. It has a variety of toxic effects in human bodies ipon 
exposure to cylindrospermopsin usually through drinking water or food [155]. Elshafey et al. 
recently selected a ssDNA MRE with high affinity and specificity toward CYN, with a reported 
Kd value of 88.78 nM. Circular dichroism measurements showed the MRE had a conformational 
change upon binding to CYN. This property was exploited in a label-free impedimetirc biosensor. 
The reported LOD of the sensor was 100 pM with a linear range of 80 nM. It also showed 
negligible responses toward coexistent cyanobacterial toxins of microcystin-LR and Anatoxin-a. 
CYN was recoverable in a spike test with tap water [134].  
Saxitoxin is a small neurotoxin produced by few dinoflagellates and certain 
cyanobacteria that affect marine organisms [156]. Handy et al. were the first to select a ssDNA 
MRE against target saxitoxin. In their study, saxitoxin was conjugated to keyhole limpet 
hemocyanin (KLH) via a spacer compound, 2,2’-(ethylenedioxy)bis(ethylamine), or Jeffamine, 
then the protein-toxin conjugate immobilized on magnetic beads. Ten rounds of selection were 
performed, and negative selection against KLH-bead was carried out from round four to the 
round ten, in order to decrease non-specific binding to KLH and beads. One candidate sequence 
was analyzed by SPR and demonstrated a concentration-dependent and selective binding to 
saxitoxins. However, the Kd value of the selected MRE was not presented in the study [135]. 
Okadaic acid (OA) is a phycotoxin produced by Dinophysis and Prorocentrum algae. It 
can accumulate in shellfish due to its lipophlic and heat-stable nature. Human consumption of 
OA can lead to a variety of gastrointestinal symptoms [157].  Eissa et al. identified a ssDNA 
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MRE with high affinity and specificity toward OA after eighteen rounds of mixed target and 
negative target selection. The candidate MRE with the highest affinity (Kd = 77nM) was chosen 
for circular dichoism analysis. A conformational change in the MRE was observed upon binding 
of OA. A label-free electrochemical impedimetric biosensor was developed with this MRE and 
achieved a LOD of 70 pg/mL. It demonstrated no cross binding activities toward structurally 
similar toxins, including dinophysis toxins-1 and 2 and microcystin-LR [12].  
Ochratoxin A (OTA) is a mycotoxin produced by members of the Aspergillus and 
Penicillium genera. It is a nephrotoxin and has potential carcinogenic effects in humans. It has 
been shown as a contaminant in many food products, such as grains and wine [158]. However, 
the current detection method for OTA is both expensive and time consuming [159]. Cruz-
Aguado et al. identified a ssDNA MRE specific for OTA after thirteen rounds of selection. The 
best candidate MRE reported had a Kd value of 200 nM. It did not bind non-specifically to 
warfarin, N-acetyl-L-phenylalanine, or ochratoxin B in a fluorescent based cross-binding assay 
[136].  Subsequently, the authors developed a detection system based on a fluorescence 
polarization displacement assay. The author reported the assay was sensitive to OTA, but not to 
warfarin and N-acetyl-L-phenylalanine, with a LOD of 5 nM. However, the detection assay did 
not test ocharatoxin B (OTB) binding activity or sensitivity in food sample [137]. Barthelmebs et 
al. also selected ssDNA MRE specific for OTA. Several candidate MREs were identified after 
fourteen rounds of selection. After binding and cross binding analysis, the best candidate had a 
Kd value of 96 nM with minimal binding to OTB and phenylalanine. It was incorporated into an 
ELISA and ELAA assays for the detection of OTA spiked in pretreated wine samples. Different  
ELAA and ELISA assays were compared, and a direct competitive ELAA had the lowest 
detection limit of 1 ng/mL with the shortest analysis time of 125 minutes [138]. McKeague et al. 
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performed fifteen rounds of in vitro selection to identify ssDNA MREs specific for OTA. Two 
candidate MREs had reported Kd values of 110 ± 50 nM (designated B08) and 290 ± 150 nM 
(designated A08). A08 ssDNA MRE was utilized in a label-free fluorescence detection assay, 
and achieved a LOD of 9 nM. It also had low cross binding activity on OTB and warfarin. The 
authors reported a truncated version of A09 also had similar specificity and binding affinity 
profiles [139].  
Fumonisins are heat-stable mycotoxins present in most corn and are produced by fungi,  
Fusarium verticillioides and Fusarium proliferatum. Fumonisin B1 (FB1) is a nephrotoxin and 
potential carcinogen in humans. As the toxin cannot be inactivated by cooking in high 
temperature, it is crucial to monitor its level during food production [160]. McKeague et al. 
performed eight rounds of selection to identify a ssDNA MRE with high binding affinity toward 
FB1. Unmodified magnetic beads (immobilization substrate), L-homocysteine, L-cysteine, and 
L-methionineL-glutamic acid were used as negative targets in the selection. Six candidate MREs 
were identified, and the best candidate MRE had a reported Kd of 100 nM. However, the authors 
did not test the specificity of the selected MRE on other mycotoxins [13]. 
Zearalenone (ZEN; F-2 toxin) is a nonsteroidal estogenic mycotoxin produced by many 
fungus species in the Fusarium genus. It has been shown to be present in many grains worldwide, 
such as oats, wheat, rice and their derived food products [161]. Chen et al. performed fourteen 
rounds of selection, the best candidate MRE had a reported Kd of 41 ± 5 nM and high specificity. 
Crossing binding assays showed insignificant binding to other mycotoxins, β-zearalenol, 
aflatoxin B1, aflatoxin B2, fumonisin B1 and fumonisin B2. Circular dichroism measurement 
showed a conformational change of the MRE after binding of zearalenone. A detection assay 
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using MRE immobilized magnetic beads and the blue-green florescence property of zearalenone 
was developed. A LOD of 0.785 nM was achieved in pretreated beer samples [140].  
T-2 toxin (T-2) is a trichothecene mycotoxins produced by many species in the Fusarium 
genus and is harmful to humans. It is a very stable small molecule biological toxin that is 
resistant to high temperature and is present in variety of grains, such as oats, barley, wheat and 
more. Currently, it can only be detected by labor intensive and costly instruments, and is thus 
difficult to monitor its level in food [162] . Chen et al. recently utilized ten rounds of GO-
SELEX to identify a ssDNA MRE specific for T-2 with high affinity and specificity. Fluorescent 
binding and cross-binding assay showed that the Kd value of the best candidate MRE was in the 
nanomolar range, with insignificant cross binding activities on FB1, ZEN, OTA and aflatoxin B1.  
There was a conformational change upon MRE-T-2 binding. The authors also developed a 
fluorescent assay to detect spiked T-2 level in beer. A LOD of 0.4 µM was achieved [141]. 
Aflatoxins are highly toxic natural compounds produced by many species of filamentous 
fungi and can contaminate agricultural products. The LD50 can be as low as 0.5 mg/kg, and acute 
toxicity is even higher than many chemical toxins, such as cyanide or arsenic [163, 164]. Ma et 
al. performed an in vitro selection on a subtype of aflatoxins, aflatoxins B1 (AFB1). After ten 
rounds of target and negative target selection, the best candidate MRE had a reported Kd value of 
11.39 ± 1.27 nM and with minimal cross binding activities on aflatoxins B2, G1, G2, OTA and 
FB1. A fluorescent assay similar to the authors’ previous study on ZEN and T-2 specific MRE 
was developed to detect spiked levels of AFB1 in methanol-extracted peanut oil.  The assay 
achieved a LOD of 35 ng/L [142]. Malhotra et al. perform two selections (SELEX1 and SELEX2) 
using slightly different methodologies to identify ssDNA MREs specific for both AFB1 and 
aflatoxins M1 (AFM1). In SELEX1, lambda exonuclease was used to generate ssDNA from 
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amplified dsDNA. AFM1 coated magnetic beads were used as a positive target from round 1 to 
round 10, and AFB1 coated magnetic beads were used as positive target at round 11 (last round) 
only. Free targets were used to competitively elute ssDNA that bound to toxin coated beads in 
round 10 and round 11. In SELEX2, each round started from pre-incubation with counter targets 
(uncoated beads, AFB1 beads) followed by incubation with AFM1 beads. Snap cooling was used 
to obtain ssDNA from dsDNA. In SELEX2, only eight rounds were carried out. Multiple 
candidate MREs were analyzed and their Kd values were in the nano to low microloar range. 
One MRE with the best affinity (Kd = 35.6 ± 2.9 nM), designated AFAS3, was used in 
developing a colorimetric assay based on MRE immobilized gold nanoparticles. This assay had a 
detection range of 250 to 500 nM of AFM1, and only minor interaction with AFB1. However, 
there were no reported cross binding data on other mycotoxins [143].  
Two studies identified ssDNA MREs specific for biological toxins with therapeutic 
intentions. Alpha-Bungarotoxin is a toxic substance in krait snake venom and can bind 
irreversibly to acetylcholine receptors and eventually lead to death in victims [165, 166]. 
Lauridsen et al. performed a rapid one-step SELEX and identified a ssDNA MRE with relatively 
high binding affinity toward Alpha-Bungarotoxin (Kd = 7.58 µM). The authors claimed that 
rapid selection technique could potentially be used with a chemically modified nucleic acid 
library, and generate MREs suitable for diagnostic and therapeutic purposes [31].  
Vivekananda et al. selected a ssDNA MRE specific for alpha toxin of Staphylococcus 
aureus. Several candidate sequences showed cell rescuing effects when co-administrated with 
alpha toxin in multiple in vitro neutralization assays. The authors claimed that it was possible to 
generate MREs against alpha toxin for the treatment of S. aureus infections [145].  
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Hong et al. also performed an in vitro selection on S. aureus alpha toxin and developed a 
proof-of-principle modified ELISA using ssDNA MRE for sensitive target detection in human 
serum. This work will be described in detail in Chapter 4 [144]. 
1.2.5.2 Chemical Toxins 
The detection of chemical toxins is important in both food safety and environmental 
monitoring. Environmental and food contamination by various kinds of chemical toxins have 
been reported, and even at low concentrations can still be detrimental to human health. Currently, 
the majority of small chemical toxins can only be detected by labor intensive and costly 
laboratory equipments such as, liquid and/or gas chromatography coupled with mass 
spectrometry. In order to address these current limitations, there has been an increase in the 
identification and biosensing applications of MREs with high affinity and specificity to capture 
and detect chemical toxins. However, the in vitro selection of ssDNA MREs targeting small 
molecule chemical toxins has several inherent challenges, such as difficulties in efficient 
separation between bound and unbound DNA molecules, limited chemical motifs on target 
surfaces for sufficient binding, lack of chemical functional groups for target immobilization, and 
candidate MREs that may not have sufficient specificities to distinguish molecules with very 
similar chemical structures if selection schemes are not carefully designed. For these reasons, 
there are a limited number of ssDNA MREs specific for chemical toxins currently in the 
literature (Table 1.5). 
 
Table 1.5: Summary table of ssDNA MREs targeting chemical toxins. 
Target SELEX Method Kd Detection LOD Reference 
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Method 
17β-estradiol (E2) 
 
Sepharose 
column 
 
 
0.13 µM 
 
Electrochemical 
 
0.1 nM 
 
[167] 
17β-estradiol (E2) Sepharose 
column 
 
50 nM 
 
Dynamic light 
scattering, 
resistive pulse 
sensing 
5 nM - 100 
nM 
 
[168] 
Bisphenol A Epoxy-activated 
resin 
8.3 nM Fluorescence Nanomolar 
range 
[169] 
Polychlorinated 
biphenyls  
 
FluMag–SELEX 
 
Low 
micromolar 
range 
Fluorescence 0.1 to 100 
ng/mL 
 
[170] 
Polychlorinated 
biphenyls  
 
Magnetic Beads 
 
nanomolar 
range 
 
- - [171] 
Atrazine CE-SELEX 890 nM Fluorescence 
Polarization 
- [172] 
Atrazine Magnetic Beads 0.62 ± 0.21 
nM 
Magnetic beads 
capturing coupled 
with CE 
Nanomolar 
range 
[14] 
Malathion Magnetic Beads 1.14 ± 0.7 
nM 
- - [15] 
Bromacil Magnetic Beads 9.6 ± 7.8 
nM 
- - [16] 
Tebuconazole 
Mefenacet 
Inabenfide 
GO-SELEX 10-100 nM Colorimetric 100 - 400 
nM 
[25] 
4 organophosphorus 
pesticides 
phorate, profenofos, 
isocarbophos, and 
omethoate 
Filtration 
column/ 
Immobilization 
free 
Low 
micromolar 
range 
 
- - [28] 
Acetamiprid 
 
Immobilization 
free 
4.98 µM 
 
- - [27] 
 
Kim et al. identified a 76-mer ssDNA MRE specific for 17-beta-estradiol (E2) with a Kd 
of 0.13 µM after seven rounds of selection. Specificity of the selected MRE was shown by 
square wave voltametry (SWV) measurement, with only minimal binding to structurally similar 
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organic chemicals 2-methoxynaphthalene and 1-aminoanthraquinone. The authors 
initiallyattempted SPR for the detection of E2. However, due to the small molecular weight of 
E2, there were no observable binding events by SPR. An electrochemical platform measured 
under SWV was eventually utilized to detect E2 with a LOD of 0.1 nM in buffer solutions [167]. 
Alsager et al. selected a 75-mer ssDNA MRE specific for E2 with a Kd of 50 nM after eighteen 
rounds of selection. The 5’ amino-modified MRE was covalently conjugated to carboxylated 
nanoparticles, and dynamic light scattering/ resistive pulse sensing was used to observe size 
contraction in particle size upon E2 binding. A detection range of 5 nM to 100 nM was achieved 
with this detection platform. Progesterone, testosterone, Bis (4 hydroxyphenyl) methane (BPF), 
and bisphenol-A (BPA) were also tested for the specificity of the selected MRE. The assay 
showed minimal binding to both BPA and BPF, however, the MRE was not able to distinguish 
the other two steroids [168]. 
Bisphenol A (BPA) is an estrogen mimicking chemical that has been classified as an 
endocrine-disrupting compound. It is used in the manufacture of polycarbonate plastic products, 
such as plastic bottles and containers. It has been shown to be released into food after heating, 
and can accumulate in human [173]. Jo et al. selected a ssDNA MRE specific for Bisophenol A 
with high affinity and specificity. The reported Kd value was 8.3 nM with only minimal binding 
to structurally related chemical molecules, including 6F biophenol A, bisphenol B, and 4, 4’-
bisphenol. A cy-3 labeled MRE pair was immobilized on sol-gel biochip and a sandwich 
detection assay was developed with nanomolar range sensitivity. However, the authors 
acknowledged the assay system can only detect a limited range of BPA concentrations [169].  
Polychlorinated biphenyls (PCB) are a group of chlorinated hydrocarbons that are used in 
varies of industrial settings. PCBs are highly toxic and are reported to be an environmental 
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contaminant affecting water bodies and food sources [174]. Mehta et al. identified PCB binding 
ssDNA MREs with nanomolar range affinity. In their study, two PCB compounds with hydroxyl 
functional group were immobilized on magnetic beads, and used as target for selection. After 
nine rounds of selection, three candidate sequences were chosen for characterization. Two of the 
three candidate sequences (9.1 and 9.3) showed comparable binding affinities to both 
immobilized targets. In subsequent crossing binding analysis, candidate 9.1 showed broad 
substrate binding affinity to other PCB compounds, while candidate 9.2 showed a high 
specificity for the two PCBs with hydroxyl functional groups. The study did not test specificity 
on other hydrocarbons that are structurally similar to PCB [171]. Xu et al. immobilized a primary 
amine modified PCB compound (PCB77-NH2) on epoxy-activated Sepharose agarose as the 
target for in vitro selection. After eleven rounds of selection, four candidate sequences were 
characterized to have affinity in the low micromolar range. Cross binding assays showed only 
minimal binding toward other hydrocarbons and agarose substrate. A fluorescent based detection 
assay was developed using the fluorescence quenching property of gold nanoparticle. Upon 
binding to target, the fluorescent signal was released. A detection range of 0.1-100 ng/mL was 
achieved. This assay detected other PCB compounds with different sensitivities [170].  
The current detection method for herbicides and pesticides environmental contaminants 
in the environment relies on using time consuming and labor intensive laboratory based 
equipments. MREs have been investigated as binding elements in rapid, field deployable 
detection systems. Atrazine is a widely used herbicide worldwide [175]. Sanchez utilized CE-
SELEX to identify a ssDNA MRE specific for atrazine with a Kd of 890 nM. However, the MRE 
did not show specificity in binding between atrazine and structurally closely related simazine at 
concentration below approximately 2 µM in a fluorescence polarization detection assay [172]. 
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Williams et al. also performed an in vitro selection of ssDNA MRE specific for atrazine. 
A derivative of atrazine, desethyl atrazine was first biotinylated, and then immobilized on 
streptavidin coated magnetic beads. The selection scheme was designed with increasing selection 
stringency, by incorporating negative selections on streptavidin magnetic beads, simazine, 
metabolites of atrazine and other commonly used pesticides. Competition selection was also 
performed to ensure the library bound only to free atrazine in solution, but not to desethyl 
atrazine. As a result, a ssDNA MRE with subnanamolar affinity and high specificity was 
identified after twelve rounds of selection. A magnetic bead based capture assay coupled with 
capillary electrophoresis was developed to detect atrazine in artificially contaminated river water 
samples. The assay was able to detect atrazine in the nanomolar range [14]. Similar in vitro 
selection methodology was also employed by Williams et al. to identify MREs specific for a 
commonly used organophosphate pesticide, malathion. In their second selection, the selected 
MRE had high nanomolar range affinity, and minimal binding to metabolites of malathion and 
other herbicides. However, the author noted the cross binding activity was high on bovine serum 
albumin possibility due to the large, globular characteristics of the protein [15]. William et al. 
subsequently performed another selection on an herbicide, bromacil. This study further validated 
the methodology the authors employed to identify MREs with high affinity and low cross 
binding activities on structurally similar compounds, and compounds that were likely to coexist 
in the environment. The authors noted that these properties were particularly important for 
incorporating ssDNA MREs as sensing elements in biosensors [16]. 
As noted above, not every chemical toxin can be readily immobilized for portioning 
during selection. In order to circumvent this limitation, Wang et al. utilized an immobilization 
free in vitro SELEX developed by Li and co-workers to select ssDNA MREs specific for four 
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different organophosphorus pesticides, phorate, profenofos, isocarbophos and omethoate [26, 28]. 
After twelve rounds of selection, two candidate sequences reported Kd values in the low 
micromolar range for all four targets. Cross binding assays showed good specificities for the 
selected two MREs, with only minimal observed binding to eight other different pesticides [28]. 
The same group of researchers later developed a fluorescence polarization assay using the 
selected MREs to detect phorate, profenofos, isocarbophos, and omethoate at a LOD of 19.2, 
13.4, 17.2, and 23.4 nM, respectively [176]. 
He et al. employed immobilization-free SELEX to identify a ssDNA MRE specific for 
pesticide, acetamiprid.  After eighteen rounds of selection, the best candidate MRE was reported 
to have a Kd value of 4.96 µM. Specificity of the selected MRE was tested and cross-binding 
data showed no significant change in fluorescent signals in the presence of three other pesticides, 
imidacloprid, nitenpyram, and chlorpyrifos. The authors noted that the affinity of the selected 
MRE was lower than typical antibodies [27]. 
GO-SELEX was used to identify three ssDNA MREs specific to three different pesticides: 
tebuconazole, mefenacet and inabenfide [25]. The reported values of Kd were in the range of 10 
to 100 nM. High specificity of each identified MRE was also determined by isothermal titration 
calorimetric and gold nanoparticle colorimetric assays. A simple, rapid detection method using 
gold nanoparticles was developed with LOD ranges from 100 to 400 nM.  
1.3 General Classes of Detection Methods 
In recent years, a large number of researches have taken place in applying ssDNA MREs 
for the use in biosensors. Major detection methods can be categorized into three classes: 1) 
electrical/ electrochemical, 2) optical, and 3) mass sensitive. The following section highlights the 
basic principles of the general classes of detection methods that have been utilized widely in the 
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development of ssDNA MRE based biosensors. Recent literatures describing the detection of 
pathogens, and toxins using ssDNA MREs biosensors are summarized in tables 1.6, 1.7, and 1.8. 
 
Table 1.6: Summary table of ssDNA MRE based biosensors for the detection of pathogens. 
Target Detection 
Methods 
Enhancers LOD Relevant 
sample 
Reference 
Salmonella enteritidis Fluorescence Graphene Oxide 
 
40 
CFU/mL 
 
Milk [177] 
Salmonella enteritidis Colorimetric 
Lateral flow 
Gold 
Nanoparticles 
10 
CFU/mL 
Milk 
powder 
[178] 
Salmonella 
typhimurium 
Colorimetric Silver staining 
 
7 CFU/mL 
 
Lake 
water 
[179] 
Salmonella 
typhimurium 
Electrochemical 
Impedance 
 
Graphene oxide, 
gold nanoparticles 
 
3 CFU/mL 
 
Pork [180] 
Salmonella 
typhimurium 
Electrochemical 
Impedance 
Gold nanoparticles 600 
CFU/mL 
 
- [181] 
Salmonella 
typhimurium 
Colorimetric 
Enzyme linked 
assay 
Gold nanoparticles 1000 
CFU/mL 
Milk [182] 
Vibrio 
parahaemolyticus/ 
Salmonella 
Typhimurium 
Fluorescence 
Flow cytometry 
Quantum dots 5000 
CFU/mL 
 
Shrimp [183] 
Salmonella 
Typhimurium/ 
Staphylococcus aureus 
Fluorescence 
 
- 5 CFU/mL 
8 CFU/mL 
 
- [184] 
 
Staphylococcus aureus Electrochemical 
Impedance 
Single wall carbon 
nanotubes 
800 
CFU/mL 
Pig skin [185] 
Staphylococcus aureus Electrochemical 
Impedance 
Graphene oxide 1 CFU/mL - [186] 
Staphylococcus aureus Colorimetric Horseradish 
peroxidase 
9 CFU/mL Milk [187] 
Group A Streptococcus Piezoelectric 
quartz crystal 
 
Single wall carbon 
nanotubes 
12 
CFU/mL 
 
Milk [188] 
E. coli Electrochemical/  
Fluorescence 
MRE cocktails 370 
CFU/mL 
 
- [189] 
E. coli O157:H7/ 
Salmonella 
Typhimurium 
Colorimetric - 10000 
CFU/mL 
- [190] 
E. coli O111 Electrochemical 
Redox current 
Alkaline 
phosphatase 
305 
CFU/mL 
Milk [191] 
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E. coli CECT 675 Electrochemical 
Impedance 
Single wall carbon 
nanotubes 
6 CFU/mL 
26 
CFU/mL 
Milk, 
apple 
juice 
[192] 
Pseudomonas 
aeruginosa 
 
Fluorescence 
 
- 5 CFU/mL 
 
Drinking 
water 
[193] 
Staphylococcus aureus/ 
Vibrio 
parahemolyticus/  
Salmonella 
Typhimurium 
 
Luminescence 
 
Lanthanide-doped 
near infrared to 
visible 
upconversion 
nanoparticles 
25 
CFU/mL 
10 
CFU/mL 
15 
CFU/mL 
 
Milk, 
shrimp 
[194] 
Lactobacillus 
acidophilus/ 
Staphylococcus enteric/ 
Staphylococcus aureus 
Fluorescence 
Microfluidic 
biochip 
- 11 
CFU/mL 
 61 
CFU/mL 
800 
CFU/mL 
  
- [195] 
Influenza H5N1 
 
Quartz crystal 
microbalance 
Hydrogel 0.0128 
HAU 
 
- [196] 
Vaccinia virus Electrochemical 
Impedance 
- 60 
virions/µL 
- [197] 
Influenza H5N1 Surface plasmon 
resonance 
- 0.128 
HAU 
Poultry [198] 
 
Table 7: Summary table of ssDNA MRE based biosensors for the detection of biological 
toxins. 
Target Detection Methods Enhancers LOD Relevant 
sample 
Referenc
e 
Prion protein 
 
Resonance light scattering Gold 
nanoparticles  
 
0.01 
nM 
 
Human serum [199] 
Clostridium 
difficile 
Toxin A 
Electrochemical 
Impedance 
Horseradish 
peroxidase 
1 nM - [200] 
Staphylococca
l enterotoxin B 
Electrochemical 
Impedance 
Horseradish 
peroxidase 
0.24 
ng/mL 
 
Human serum [201] 
Staphylococca
l enterotoxin B 
Surface-enhanced Raman 
scattering 
Gold 
nanoparticles  
 
224 
aM 
 
Milk, blood, 
urine 
[202] 
E. coli outer 
membranes 
proteins 
Evanescent wave fiber 
optic 
 
- 0.1 nM 
 
Environmenta
l water 
[203] 
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E. coli outer 
membranes 
proteins 
Electrochemical 
Impedance 
 
- 100 
nM 
Environmenta
l water 
[204] 
Botulinum 
neurotoxin, 
type A 
Electrochemical 
Redox current 
Horseradish 
peroxidase 
40 
pg/mL 
 
- [205] 
Aflatoxin B1 RT-qPCR 
 
- 25 
fg/mL 
 
Chinese wild 
rye hay, infant 
rice cereal 
[206] 
Aflatoxin B1 Fluorescence 
Dipstick 
- 0.3 
ng/g 
Corn [207] 
 
Aflatoxin M1 Electrochemical 
Redox current 
Magnetic 
nanoparticles 
8 ng/L Milk [208] 
Ochratoxin A Colorimetric - 20 nM - [209] 
Ochratoxin A Electrochemical  
Impedance 
 Graphene oxide, 
gold nanoparticles 
 
0.74 
pM 
Red wine [210] 
Ochratoxin A Fluorescence - 1 
ng/mL 
Beer [211] 
Ochratoxin A Electrochemical 
Redox current 
Gold 
nanoparticles 
0.75 
pM 
Red wine [212] 
Ochratoxin A 
 
Electrochemiluminescenc
e 
Loop-mediated 
isothermal 
amplification 
10 fM Red wine [213] 
Ochratoxin A Fluorescence - 2 pg/ 
mL 
 
Wheat [214] 
Ochratoxin A 
 
Localized surface 
plasmon resonance 
- 1 nM Corn powder [215] 
Ochratoxin A RT-qPCR - 1 
fg/mL 
Red wine [216] 
Ochratoxin A Fluorescence - 0.2 
ng/mL 
Red wine [217] 
Ochratoxin A Chemiluminescence Nicking 
endonuclease 
0.3 
pg/mL 
Wheat [218] 
Ochratoxin A Electrochemical 
Impedance 
- 0.25 
ng/mL 
Beer [219] 
Ochratoxin A Electrochemical 
Redox current 
- 0.1 
ng/mL 
Beer [220] 
Ochratoxin A Electrochemical 
Impedance 
- 0.12 
ng/mL 
Beer [221] 
Ochratoxin A Electrochemical 
Differential pulse 
voltametry 
Horseradish 
peroxidase, 
alkaline 
phosphatase, 
superparamagneti
c nanoparticles 
0.15 
ng/mL 
Red wine [222] 
Ochratoxin A Electrochemical 
Flow-based 
- 0.05 
µg/L 
 
Beer [223] 
Ochratoxin A Colorimetric Gold 1 Red wine [224] 
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 Lateral flow nanoparticles ng/mL
, 0.18 
ng/mL 
 
Ochratoxin A 
 
Fluorescence 
Lateral flow 
Quantum dots 1.9 
ng/mL 
Red wine [225] 
Ochratoxin A Electrochemical 
Electric current 
Horseradish 
peroxidase 
0.07 ± 
0.01 
ng/mL 
Wheat [226] 
Ochratoxin A Electrochemical 
Redox current 
Gold 
nanoparticles 
30 
pg/mL 
Red wine [227] 
Ochratoxin A Electrochemical 
Impedance 
Horseradish 
peroxidase 
0.4 
pg/mL 
Wheat [228] 
Ochratoxin A Electrochemical 
Redox current 
- 0.095 
pg/mL 
Red wine [229] 
Ochratoxin A Chemiluminescence Upconversion 
nanoparticles 
0.1 
pg/mL 
Maize [230] 
Ochratoxin A Electrochemical 
Impedance 
Silver 
nanoparticles 
0.05 
nM 
Beer [231] 
Ochratoxin A Electrochemical 
Impedance 
Loop-mediated 
isothermal 
0.3 pM Red wine [232] 
Ochratoxin A Fluorescence - 0.8 
ng/mL 
Corn [233] 
Ochratoxin A Fluorescence Single-stranded 
signal probes 
20 
pg/mL 
Wheat [234] 
Ochratoxin A Fluorescence Terbium 0.08 - 
5.42 
ng/mL 
Wheat [235] 
Ochratoxin A Electrochemical 
Impedance 
Redox probe 0.12- 
0.4 nM 
Coffee, flour, 
wine 
[236] 
Ochratoxin A Fluorescence resonance 
energy transfer 
- 2 
pg/mL 
Maize Flour [237] 
Ochratoxin A Electrochemical 
Redox current 
Exonuclease 
digestion      
1.0 
pg/mL 
Wheat starch [238] 
Ochratoxin A Electrochemical 
Electric current 
Rolling circle 
amplification 
0.2 
pg/mL 
Red wine [239] 
Ochratoxin A Fluorescence - 21.8 
nM 
Red Wine [240] 
Ochratoxin A Electrochemiluminescenc
e 
Gold 
nanoparticles 
0.007 
ng/mL 
Wheat [241] 
Ochratoxin A Colorimetric - 2.5 nM Red wine [242] 
Ochratoxin A Colorimetric - 4 nM Red wine [243] 
Ochratoxin A Fluorescence - 24.1 
nM 
Beer [244] 
Ochratoxin A Electrochemical 
Impedance 
- 0.1 
ng/mL 
- [245] 
Ochratoxin A Fluorescence - 0.01 
ng/mL 
Maize Flour [246] 
 
50 
 
Table 1.8: Summary table of ssDNA MREs based biosensors for the detection of chemical 
toxins. 
Target Detection Methods Enhancers LOD Relevant 
sample 
Reference 
Bisphenol A  
 
Fiber optic 
Fluorescence 
- 1.86 
nM 
 
Wastewater 
 
[247] 
Bisphenol A  
 
Resonance light 
scattering 
Gold 
nanoparticles 
0.012 - 
0.28 
ng/mL 
 
Supermarket 
ticket 
[248] 
Bisphenol A  Electrochemical 
Redox current 
Gold 
nanoparticles 
dotted graphene 
5 nM Milk [249] 
Bisphenol A  Colorimetric/ 
Fluorescent 
- 0.1 
ng/mL 
0.01 
pg/mL 
Water [250] 
Bisphenol A Colorimetric 
 
- 0.1 
ng/mL 
Tap water [251] 
Bisphenol A  Colorimetric 
Lateral Flow 
Gold 
nanoparticles 
76 
pg/mL 
Tap water 
 
[252] 
Bisphenol A  Resonance Rayleigh 
scattering 
Gold 
nanoparticles 
83 
pg/mL 
Tap water [253] 
Bisphenol A  Electrochemcial 
Electric current 
Single walled 
carbon 
nanotubes field 
effect transistor 
10 fM 
to 1pM 
 [254] 
Bisphenol A  Plasmonic chirality - 8 
pg/mL 
Tap water [255] 
17β-estradiol (E2) Photoelectrochemical Titanium oxide 
nanotubes 
arrays 
33 fM Medical waste 
water, lake 
water, tap 
water 
[256] 
17β-estradiol (E2) Electrochemical 
Impedance 
- 2.0 pM Human urine [257] 
17β-estradiol (E2) Fluorescence - 2.1 nM Wastewater [258] 
Acetamiprid Colorimetric - 5 nM Soil [259] 
Acetamiprid Electrochemical 
Impedance 
Gold 
nanoparticles 
1 nM Waste water, 
tomatoes 
[260] 
4 organophosphorus 
pesticides 
phorate, profenofos, 
isocarbophos, and 
omethoate 
Fluorescence 
Polarization 
 
- 19.2, 
13.4, 
17.2, 
23.4 
nM 
 
Chinese 
cabbage 
[176] 
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1.3.1 Electrical/ Electrochemical 
The principle of electrochemical detection is based on measuring changes in electrical 
properties of the sensing platform. In this method, ssDNA MRE is usually immobilized on a gold 
electrode via thiol-gold linkage. A redox label, such as methylene blue can be used to detect 
binding between MRE and the target [261]. In a “signal on” system, the redox label is away from 
the electrode surface, and the binding of target causes a conformational change in the MRE, and 
brings the redox label into close proximity with the electrode, thus causing a measurable change 
in electrical properties (Figure 1.2). A “signal off” system behaves similarly, but the binding of 
target causes the redox label move away from the electrode. This system can also be modified as 
a “label-free” system, in which the redox molecule is intercalated in a hairpin structure of a MRE 
in a target unbound state, and binding of the target causes the release of the redox molecule 
(Figure 1.2). In addition to measuring redox current, the changes in impedance upon binding of 
the target can also be measured. In this case, no labeling of MRE is required and the 
conformational changes in MRE upon target binding causes a measurable change in impedance 
that can be recorded by voltammetry [226].  
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Figure 1.2: Illustration of examples of ssDNA MRE based electrochemical biosensors. (A) 
A representation of an “on-mode” system using a redox label for current transduction. (B) A 
representation of a “label-free” system by intercalating a redox label in a hairpin structure. (C) A 
representation of an “on-mode” system by hybridization with the complementary sequence.  
 
Nanomaterials can also be incorporated into electrochemical sensor to enhance signals. 
Single-walled carbon nanotube field effect transistors (SWCNT-FET) can be used to build 
electrochemical biosensors (Figure 1.3). In this system, MREs are immobilized on SWCNTs and 
SWCNTs are sandwiched between a source and a drain electrode. When the immobilized MREs 
bind to the target, there is a measurable change in the conductance of the system [254]. Gold 
nanoparticles (AuNP) are also widely used as signal enhancers. AuNPs can be coated on 
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electrodes and greatly increase the surface area. As a result, more MREs can be immobilized on 
the electrode, and thus enhancing the system’s sensitivity. AuNPs can also be coated with a 
second MRE and reporting probes in a sandwich assay (Figure 1.3). In this case, the target first 
binds to a primary capturing MRE, followed by the binding a secondary reporting MRE along 
with a redox molecule, which can generate an enhanced signal for sensitive detection [262]. 
 
Figure 1.3: Illustration of examples of signal enhancement methods in ssDNA MRE based 
electrochemical biosensors. (A) A representation of a single-walled carbon nanotubes field 
effect transistors. (B) A representation of gold nanoparticles carrying redox labels in a sandwich 
detection style. 
1.3.2 Optical 
Optical detection methods can be classified into three major categories. 1) Fluorescence 
detection, which require specialized instruments to measure fluorescent signals. 2) Colorimetric 
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detection, which color changes can be observed by the naked eye or measured in terms of optical 
density. 3) Absorbance assay can enhance detection signals, and subsequently be measured by 
instruments as well. 
1.3.2.1 Fluorescence 
The principle of fluorescence detection is based upon the generation or quenching of 
fluorescence signals upon target binding. Various fluorescence molecules and quantum dots can 
be linked to ssDNA MREs. Conformational changes induced by target binding can alter the 
fluorescence signal generated by the fluorophore, and therefore can be measured (Figure 1.4) 
[263]. Quenching molecules can also be linked to the other end of the ssDNA MRE. In this 
system, the quencher completely blocks the fluorescence signal from the fluorophore and target 
binding can move the quencher away from the fluorophore, and have “signal on” detection 
(Figure 1.4) [264]. The same principle can also be applied for a “signal off” system. Carbon 
nanotubes and graphene can also be used as quenchers, which fluorescent labeled ssDNA MREs 
is adsorbed on the carbon quenchers via π-π stacking interactions. Fluorescence resonance 
energy transfer (FRET) can also be utilized as measurements when the distance of the two 
fluorescence molecules linked to MREs is changed upon target binding. 
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Figure 1.4: Illustration of examples of ssDNA MRE based fluorescent biosensors. (A) A 
representation of the changes in fluorescent signal upon target binding to a fluorophore labeled 
MRE. (B) A representation of an “on-mode” system by using a quencher labeled on the 
complementary sequence.  
1.3.2.2 Colorimetric 
Gold nanoparticles (AuNP) have been widely used in various colorimetric assays. AuNPs 
aggregate in salt solution and appear in purple color. When they are dispersed, they are in red 
color. This special absorbance property of AuNPs allows observation of target binding by naked 
eye. MREs in salt solution can bind to AuNPs and dispersing the AuNPs. When targets are 
introduced into the system, MRE preferably bind to the targets, and therefore causing AuNPs to 
aggregate, a red to purple color change is observed (Figure 1.5) [265]. Alternatively, ssDNA 
MREs can be used to link AuNPs that are functionalized with probe strands. In this case, the 
initial state of the MRE/AuNPs solution is aggregated purple. Upon target binding, the linked 
AuNPs are released, and a purple to red color change is observed (Figure 1.5) [266]. Furthermore, 
AuNPs can be used in a sandwich colorimetric assay, in which the secondary reporting MRE 
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linked AuNP can grow in size when the detection system is placed in a growth solution 
containing HAuCl4, and thus enhancing the detection limit [267]. 
 
Figure 1.5: Illustration of examples of ssDNA MRE based colorimetric biosensors. (A) A 
representation of a colorimetric assay using MRE dispersed gold nanoparticles. (B) A 
representation of a colorimetric assay using cross-linked gold nanoparticles aggregates via MRE 
and probe DNA. 
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1.3.2.3 Absorbance 
Nucleic acid MREs have been used in modified enzyme linked immunoassays, usually 
substituting for either the capturing or the reporter antibodies. In a direct oligonucleotide enzyme 
link assay, often the protein target is adsorbed on plate and biotinylated MREs bind to the target, 
and then followed by the addition of streptavidin-horse radish peroxidase (HRP) conjugate and 
enzyme substrate for signal development [138]. In a sandwich assay, biotinylated MREs can be 
immobilized on streptavidin plate, and then followed by the addition of the protein target, HPR 
linked antibody, and enzyme substrate [96]. This detection method however is mostly limited to 
protein targets, and the availability of specific antibodies (Figure 1.6). 
 
Figure 1.6: Illustration of examples of ssDNA MRE modified enzyme linked assays. (A) a 
representation of a direct MREs modified enzyme linked assay with MRE as the reporter. (B) A 
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representation of an indirect MREs modified enzyme linked assay with MRE as the target 
capturing element. 
 
1.3.3 Mass Sensitive 
Mass sensitive detection is a class of label-free detection system that can be sub-divided 
into four major categories: 1) Surface Plasmon Resonance (SPR), 2) Quartz Crystal 
Microbalance (QCM), 3) Surface Acoustic Wave (SAW) and 4) Micromechanical cantilever. 
None of these detection systems require additional labeling. 
Surface plasmon resonance (SPR) sensors measure a change in the refractive index and 
resonance angle when a mass change occurs upon target binding. MREs are often biotin-tagged 
and immobilized on streptavidin coated gold chip. When targets in solution pass through the 
flow cell, the binding between targets and immobilized MREs cause a change in mass on the 
sensor chip surface, and is subsequently translated into a change in the refractive index. This 
change in resonance is proportional to the amount of target bound to the immobilized MREs, and 
therefore providing a real-time detection of the target in solution (Figure 1.7) [198].  
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Figure 1.7: Illustration of ssDNA MRE based surface plasmon resonance biosensors. When 
targets bind to immobilized MREs, a change in the plasmon resonance and plasmon angle will be 
detected and translated into a real-time response unit. 
 
A Quartz crystal microbalance (QCM) is an acoustic wave resonator based on the 
piezoelectric property of quartz crystal. Nucleic acid MREs can be immobilized on gold-coated 
quartz. The binding between target and MRE increases the mass on the surface of the crystal and 
leads to a detectable decrease in the resonance frequency of the crystal (Figure 1.8) [196].  The 
detection principle of surface acoustic wave (SAW) based biosensor is similar to QCM. Nucleic 
acid MREs have been utilized to fabricate a special type of Love-wave sensor that uses shear 
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horizontal waves to enhance the surface sensitivity,  and achieve ultra-sensitive detection of the 
target [268]. 
Micromechanical cantilevers have been investigated for MRE based biosensors. The 
major advantage of this type of sensor is that it can be readily scale up and perform parallel 
analysis for multiple analytes with low background interference [269]. When the target binds to 
the MRE on the surface of the cantilever, a nanometer scale deflection in the cantilever can be 
detected optically (Figure 1.8). 
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Figure 1.8: Illustration of examples of ssDNA MRE based mass sensitive biosensors. (A) A 
representation of a detectable change in resonance frequency upon target binding to immobilized 
MRE on quartz crystal micro balance. (B) Representation of a detectable nanometer scale 
bending upon target binding to immobilized MRE on micromechanical cantilever.  
1.4 Conclusion and Future Perspectives 
Over the last two decades, there has been a continuous increase in the research of 
molecular recognition elements. Single-stranded DNA MREs have several advantages over 
antibodies, in terms of stability, reusability, and production cost. However, ssDNA MREs are not 
without limitations. The binding affinity of MREs is highly dependent on their three dimensional 
structure and is influenced by factors including the ionic condition, temperature, and pH of the 
binding condition [4]. Challenges remain in eliminating cross binding activities to other 
molecules in native environments. These limitations hinder the use of MRE for detection in 
many real world complex samples, such as biological fluids and food matrices. A carefully 
designed selection scheme can greatly improve the specificity of the identified MRE, which can 
better distinguish closely related molecules at low concentrations. Using modified bases in PCR 
amplification or performing base modifications after selection can also help improving resistance 
to nucleases in many biological fluids, such as human serum [270]. The overall attractive 
features of ssDNA MREs prompt researchers continue to investigate and optimize their 
applications in biosensing.  
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Chapter 2 
Selection of Single-Stranded DNA Molecular Recognition 
Elements Against Exotoxin A using A Novel Decoy-SELEX 
Method and Sensitive Detection of Exotoxin A in Human 
Serum 
This chapter is adapted from the work that is currently under revision for publication in PLoS 
One. 
Citation: Hong KL, Yancey K, Battistella L, Williams RM, Hickey KM, Bostick CD, Gannett 
PM and Sooter LJ. 2014. “In vitro selection of single-stranded DNA molecular recognition 
elements against Exotoxin A and sensitive detection in human serum” Under revision, PLoS One 
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2.1 Introduction 
Exotoxin A is a virulence factor secreted by gram negative bacilli bacteria, Pseudomonas 
aeruginosa [1]. P. aeruginosa has been identified as an opportunistic bacterium that is 
commonly associated with wound infections, nosocomial lung infections and respiratory diseases 
in cystic fibrosis patients [2, 3]. Due to increasing antibiotic resistance, infections caused by P. 
aeruginosa have been associated with decreased in the quality of life, increased mortality in 
patients and significant cost burden in health care systems [4, 5]. 
Upon covalent cleavage of the full length protein, the enzymatically active fragment of 
Exotoxin A enters host cells [6]. It causes ADP-ribosylation of elongation factor 2 and thus 
inhibits polypeptide assembly to ribosome and protein translation, causing death of host cells [7, 
8]. Early studies of purified Exotoxin A report  an intravenous lethal dose as low as 3 µg/kg in 
mice or a LD50 of ~10 µg/kg via intraperitoneal injection [9, 10]. Because of this highly toxic 
nature, it is essential to treat P. aeruginosa infection as early as possible.  
However, current diagnosis of P. aeruginosa infection largely relies on traditional 
methods, such as Gram-stain, bacterial culturing, biochemical methods and immunoassays [11]. 
Though those methods are sensitive and reliable, they require a significant amount time to 
confirm infection, prolonging the time between patient clinical presentations and antibiotics 
treatments. This leads to the initial use of non-specific broad spectrum antibiotics and increases 
the selection pressure for antibiotic resistant strains of the bacteria [12].  In recent years, 
molecular diagnostic techniques have been developed to increase the efficiency of diagnosing P. 
aeruginosa infection. A majority of these new techniques use polymerase chain reaction (PCR) 
to identify genes in P. aeruginosa [13-16]. Although PCR based diagnostic methods are proven 
to be sensitive, clinical samples presented may have DNA polymerase inhibitor and other 
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contaminants that increase chances of false positive, which means that a greater amount of  time 
is required to purify samples [17]. Another major limitation of PCR is that it cannot detect and 
monitor levels of virulence factors, such as membrane antigens and toxins, for example gene 
codes for Exotoxin A production is not expressed constitutively, due to different environmental 
factors [17-19]. Previous studies have demonstrated the clinical role of Exotoxin A in the 
pathogenesis of P. aeruginosa infections [20, 21]. Patients with higher amount of antibodies 
against Exotoxin A were correlated to better prognosis [22, 23]. This suggests Exotoxin A is a 
significant virulence factor of the bacteria, and is also an important P. aeruginosa infection 
biomarker. However, there is currently lack of regulatory approved Exotoxin A detection 
methods for diagnosis purpose. Therefore, there is an increasing need to develop new methods to 
rapidly measure Exotoxin A through molecular recognition and detection, and therefore 
facilitating the diagnosis of P. aeruginosa infections.  
Systematic Evolution of Ligand by Exponential Enrichment (SELEX) was first described 
by the Gold laboratory in 1990 [24]. It utilizes an in vitro selection process that identifies 
Molecular Recognitions Elements (MREs) that have very high affinities and specificities to their 
target molecules. The selection process of nucleic acid MREs usually begins with a library of 
1013 to 1015 different single-stranded DNA (ssDNA) or RNA molecules. The library is then 
subjected to repeating cycles of partitioning and enrichment for molecules that bind to positive 
target (target of interest) but not to negative targets. Eventually, one or few MREs are identified 
with high specificities and affinities to the target of interest that will be useful for its detection.  
In this study, a novel variation of SELEX termed Decoy-SELEX has been utilized for the 
identification of a single-stranded DNA MRE that binds to Exotoxin A with high affinity and 
specificity. The advantage of this variation is an increased emphasis on selecting against negative 
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targets. The first negative target, bovine serum albumin (BSA), is selected based on the similarly 
in structure and amino acid sequence to human serum albumin [25], which is an abundant protein 
in blood samples. The second negative target, Cholera toxin, served as example of common 
bacteria virulence factor [26]. The selection scheme is also designed to decrease non-specific 
binding to streptavidin and biotin, substrates used in target immobilization. Surface plasmon 
resonance has been used to characterize the affinity and specificity of the selected MRE. In 
addition, a modified enzyme-linked immunosorbent assay (ELISA) has been developed by using 
the selected MRE as the toxin capturing element in human serum, and demonstrated the potential 
use in clinical diagnosis [27-29].  
2.2 Materials and Methods 
2.2.1 Decoy-SELEX Method for selection of Exotoxin A-specific MREs 
A single-stranded DNA (ssDNA) library consisting of 1015 molecules was used to begin 
the selection of Exotoxin A specific MREs. This library, named, RMWN34, consisted of two 23 
base of constant regions for primer annealing flanked by a 34 base random region. It was 
designed by our laboratory and commercially synthesized (Eurofins MWG Operon; Huntsville, 
AL). A total of 14 rounds of Decoy-SELEX were utilized to enrich Exotoxin A specific MREs 
(Table 2.1), and eliminate MREs that bind to negative targets (Figure 2.1, 2.2). 
 
Table 2.1: Decoy-SELEX scheme for Exotoxin A MRE selection. 
Round Positive Selection (+) Negative Selection (˗) 
1 Immobilized Target (IT) 46 hrs, 50 µL Immobilization Substrate (IS) 18 hrs, 50  µL 
2 IT 24 hrs, 50 µL IS 22 hrs, 50 µL 
3 IT 18 hrs, 50 µL - 
4 IT 12 hrs, 50 µL IS 20 hrs, 50 µL 
5 IT 8 hrs, 50 µL - 
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6 IT 5.5 hrs, 50 µL BSA Immobilized Negative Target (INT) 24 
hrs, 50 µL  
7 IT 1 hrs, 50 µL - 
8 IT 1 hrs, 25 µL Cholera toxin INT 18hrs, 50 µL 
9 IT 1 hrs, 5 µL - 
10 IT 5 min, 5 µL BSA INT 24 hrs, 50 µL 
11 IT 5 sec, 5 µL IS 21hrs, 10 µL 
12 IT 5 sec, 5 µL - 
13 IT 5 sec, 5 µL; Competitive Elution 
with 2 µg free Exotoxin A, 5 sec 
IT 5 sec, 5 µL; Competitive Elution with 1 
mg/mL free BSA, 5 min 
14 IT 5 sec, Competitive Elution with 1 
µg free Exotoxin A, 5 sec 
- 
 
In vitro selection performed for identifying Exotoxin A-specific MRE. Immobilized target (IT) is 
Exotoxin A bound to magnetic beads. Immobilization substrate (IS) is streptavidin-coated 
magnetic beads blocked with biotin regent. BSA is the abbreviation for bovine serum albumin. 
Times listed are incubation times in hours (hrs), minutes (min) or seconds (sec).  
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Figure 2.1: Illustration of the Decoy-SELEX process. In vitro selection begins with incubation 
of target Exotoxin A with a library of 1015 ssDNA molecules. Binding molecules are amplified 
and subjected to incubation with multiple negative targets. Molecules that do not bind to 
negative targets are amplified and carried on to the next round of selection. 
 
 
Figure 2.2: Structures of targets used in the Decoy-SELEX and SPR cross binding assays. 
(A) Ribbon structure of the target of interest, Exotoxin A (PDB 1IKQ, 66kDa) [8]. (B) Ribbon 
structure of streptavidin (PDB 4GJS, 60kDa) used in cross bind assays [30]. (C), (D) Ribbon 
structures of bovine serum albumin (PDB 4F5S, 66.5kDa) and Cholera toxin (PDB 2A5D, 
84kDa) used in negative rounds of selection and crossing binding assays [31, 32]. (E) Chemical 
structure of biotin used in negative rounds of selection and cross binding assays. 
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Exotoxin A in lyophilized powder form (List Biological Laboratories; Campbell, CA) 
was reconstituted in pure water, surface accessible primary amino functional group on Exotoxin 
A was utilized to covalently biotinylated via Sulfo-NHS-LC-Biotinylation (Pierce; Rockford, IL) 
according to manufacturer’s protocol. Biotinylated Exotoxin A was washed with ZEBA Spin 
Desalting Column (Pierce, Rockford, IL) to remove excess unreacted biotin. Subsequently, 
biotinylated Exotoxin A was bound to streptavidin-coated magnetic beads (New England Biolabs, 
Ipswich, MA) and washed to generate immobilized target (IT) for selections.  
In Round 1(+) selection, 50 µL of IT was incubated with 1015 copies of ssDNA from the 
library in a total of 500 µL of selection buffer composed of 100 mM sodium chloride, 20 mM 
Tris-HCl, and 2 mM magnesium chloride (1× selection buffer) at room temperature for 46 hours 
on rotisserie. After the incubation, the selection mixture was subjected to magnetic separation. 
Unbound ssDNA was removed and ssDNA bound to IT was washed with 500 µL of selection 
buffer three times and resuspended in 100 µL of selection buffer. This solution containing IT 
functioned as template for PCR amplification using following reaction conditions: enriched 
ssDNA, 400 nM forward and biotinylated reverse RMW.N34 primers (Eurofins MWG Operon; 
Huntsville, AL) (forward: 5’-TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated reverse: 5’-
Biotin- GCACTCCTTAACACTGACTGGCT-3’), 250 µM deoxynucleotide triphosphates, 1× 
GoTaq Reaction Buffer (Promega; Madison, WI), 3.5 units Taq, and pure water. Thermal cycling 
conditions were as follows: first denatured at 95°C for 5 minutes, cycling at 95°C for 1 minute, 
63°C for 45 seconds, and 72°C for 1 minute; and final extension temperature at 72°C for 7 
minutes. Small-scale PCR (1, 5, 10 µL) was first performed to determine the optimal cycles for 
PCR. This was carried in 2 to 3 cycles step-wise manner in order to avoid over amplification of 
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the template and unwanted non-specific amplicons. Large-scale PCR (2 to 4 mL) was performed 
after each round of positive and negative selection. 
After PCR amplification, PCR product containing dsDNA was purified with the GFX 
PCR purification kit (GE Healthcare, Piscataway, NJ). Eluted dsDNA containing the biotinylated 
reverse strand was then incubated with streptavidin agarose resin (Pierce; Rockford, IL) for 
single strand separations [33]. This mixture was transferred into a flow-through column and 
washed with 5-volumes of 1× phosphate buffer solution. Five-volumes of 1 M sodium hydroxide 
were then added to the column to elute the forward strand of the dsDNA. Subsequently, 0.1-
volumes of 3 M sodium acetate at pH 5.2, 2.5-volumes of cold 100% ethanol and 10 µg/mL of 
glycogen were added to the eluted ssDNA for ethanol precipitation at -80°C. After the solution 
was frozen, it was then centrifuged at 13,000 × g for 1 hour. Precipitated ssDNA was 
subsequently washed with 70% ethanol and centrifuged at 13,000 × g for 15 minutes to remove 
co-precipitated salt. The ssDNA pellet was dried in a vacuum desiccator and resuspended in 50 
µL of selection buffer. A NanoDrop spectrometer (ThermoScientific; Wilmington, DE) was used 
to confirm the suspension contained at least 1013 copies of ssDNA before proceeding to next 
round of selection. 
Round 1(˗) was performed by incubating enriched ssDNA from the preceding positive 
round with immobilization substrate in a total volume of 100 µL selection buffer at room 
temperature for 18 hours on rotisserie. Immobilization substrate was prepared by incubating 
Sulfo-NHS-LC-Biotin (Pierce; Rockford, IL) with Tris-HCl and streptavidin-coated magnetic 
beads (New England Biolabs, Ipswich, MA). After magnetic separation, unbound ssDNA served 
as the template for PCR amplification as illustrated above.  Positive rounds 1 to 7 and negative 
rounds 1, 2, 4 and 11 were performed as described with decreasing incubation time in positive 
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rounds and increasing incubation time in negative rounds to increase stringency for selection of 
MREs specific for Exotoxin A.  
Starting with round 6(˗) selection, the first negative target, bovine serum albumin (BSA) 
(Rockland Immunochemical; Gilbersville, PA) was introduced to the selection. Immobilized 
negative targets (INT) were prepared identical to IT, substituting Exotoxin A with bovine serum 
albumin. INT, 50 µL, was incubated with enriched ssDNA from the preceding positive selection 
round in a total of 500 µL of selection buffer at room temperature for 24 hours. Unbound ssDNA 
was removed with magnetic separation and served as template for PCR amplification. Round 
10(˗) was performed in the same way. In round 8(˗), the second negative target, Cholera toxin 
(List Biological Laboratories; Campbell, CA), was introduced. Preparation of Cholera toxin INT 
was as described above. Selection conditions were similar to round 6(˗) with the exception of 18 
hours incubation.  This was to ensure the selected MRE was specific to Exotoxin A and not BSA 
or Cholera toxin. 
Starting with Round 8(+) selection, the volume of IT used was decreased in order to 
increase the stringency of the selection. Round 13(+) and 14(+) IT were subjected to competitive 
elution with free Exotoxin A solution. IT and the enriched ssDNA were initially incubated for 5 
seconds in total of 100 µL of selection buffer. IT with bound ssDNA was washed with 500 µL of 
selection buffer three times, and then 2 µg or 1 µg respectively, of Exotoxin A in 100 µL of 
selection buffer was added to the mixture and then incubated for 5 seconds. The supernatant 
obtained from magnetic separation was used as template for PCR amplification.  Round 13(˗) 
was performed in the same way using a free BSA competitive elution. However, ssDNA bound 
to IT was separated and served as PCR template. This was to ensure ssDNA only binds to free 
Exotoxin A and not to free negative targets. 
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2.2.2 Cloning and Sequencing of Exotoxin A-specific MREs 
DNA sequencing was performed following rounds 3(+), 6(˗), 9(+), 12(+), 13(+), and 
14(+) to analyze the ssDNA library for consensus binding sequences. The ssDNA library was 
amplified with non-biotinylated primers. It was then ligated into the pCRII vector (Invitrogen, 
Carlsbad, CA) and transformed into competent E. coli bacteria according to manufacturer’s 
protocol. Inserted plasmid was subsequently extracted and purified with the AxyPrep Plasmid 
Prep Kit (Axygen, Union City, CA). The M13R primer, complementary to a region upstream of 
the PCR insert was sequenced (Eurofins MWG Operon, Huntsville, AL) along with purified 
plasmid. 30-50 randomly selected sequences for each respective round were subjected to analysis 
for consensus sequence families.  
2.2.3 Exotoxin A-specific MRE Binding Assays with Surface Plasmon Resonance 
After analyzing round 14 for its DNA sequences, R14.33 was selected for further 
characterization. The Mfold DNA web server was used to predict the secondary structure with 
the following conditions: 25°C, 100 mM Na+, and 2 mM Mg2+  [34]. Subsequently, R14.33 was 
synthesized by Eurofins MWG Operon with a 5’ amino-C6 modification for use in surface 
plasmon resonance (SPR) binding assays. 
Glass slides (12 mm x 10 mm) were cleaned by sonication in acetone, isopropyl alcohol, 
and doubly deionized water (5 min, each) and then blown dry with nitrogen. Gold was 
evaporated on to the slides using Temescal BJD-2000 system (Edwards Vacuum; Phoenix, AZ) 
with an Inficon XTC/2 deposition controller (Inficon; East Syracuse, NY) (chamber pressures ≤ 
1.0 × 10−6 Torr). Samples were rotated (3 rpm) and monitored during deposition for metal 
thickness (6 MHz quartz piezoelectric crystals, gold-coated) (Kurt J. Lesker Co., Clairton, PA). 
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Rates of 0.3−0.5 Å/s were maintained during the deposition of a titanium adhesion layer (2 nm) 
and a gold layer (50 nm). After that, samples were cooled to room temperature before being 
removed from the chamber. 
The gold slide was then cleaned in 100% ethanol under sonication for 5 minutes, then 
placed in a solution containing 10 mM 11-mercaptoundecanoic acid (11-MUA) (Sigma; St. 
Louis, MO) and 10 mM triethylene glycol mono-11-mercaptoundecylether (PEG3) (Sigma; St. 
Louis, MO) in a 1 to 5 ratio for 24 hours under argon. After the formation of the self-assembled 
monolayer (SAM), the gold slide was rinsed with 100% ethanol, pure water, and blown dry with 
a slow stream of nitrogen. The prepared gold slide was inserted into the carrying cartridge and 
docked into a Biacore X100 (GE Healthcare; Piscataway, NJ). The running buffer for 
immobilization was composed of 100 mM sodium chloride, 20 mM potassium phosphate, and 2 
mM magnesium chloride, pH 7.56 (1× immobilization buffer). Next, 100 mM N-
hydroxysulfonyl succinimide (sulfo-NHS) (Pierce; Rockford, IL) and 400 mM 1-ethyl-3-(3-
dimethylaminopropyl) (EDC) (Pierce; Rockford, IL) was mixed (1:1) and injected into flow cell 
1 and 2 at a flow rate of 5 µL/min for ten minutes for the activation of the carboxyl group of 11-
MUA. Then, 300 µL of 1 µM 5’amino modified ssDNA in immobolization buffer (after 
denaturing at 95°C for 5min and cooling to room temperature) was injected into flow cell 2 at a 
rate of 5 µL/min. At the end of the DNA injection, unreacted carboxyl groups were inactivated 
by injection of  selection buffer twice for a total of twenty minutes, followed by a regeneration 
cycle with 45 mM glycine, 100 mM sodium hydroxide in 5% ethanol (regeneration buffer) for 30 
seconds [35, 36]. 
After immobilization, selection buffer was then used as the running buffer for binding 
assays. The binding affinity of R14.33 was determined by injecting concentrations of 0, 0.5, 1, 
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1.2, 1.4 and 2 µM of Exotoxin A in flow cells 1 and 2 at a flow rate of 5 µL/min at room 
temperature. Each cycle comprised a 180 seconds wait period, 180 seconds contact period, 180 
seconds wait period and 30 seconds regeneration period using regeneration buffer. Assays were 
performed in duplicate. Kinetic data was analyzed using the Scrubber-2 software (BioLogic 
Software; Campbell, Australia) to determine the equilibrium dissociation constant (Kd), 
assuming a one-to-one kinetics model.  
To determine the cross binding activity of R14.33 to negative targets, blank selection 
buffer and 5 µM each of Exotoxin A, BSA, biotin (Sigma; St. Louis, MO), Cholera toxin, and 
streptavidin (Amresco; Solon, OH) were injected into both flow cells with the same conditions as 
described above. Each molecule was tested in triplicate. All data was averaged and standard 
deviations were calculated as previously described [35]. One-way ANOVA and Bonferroni post-
hoc test were performed to determine statistical differences in the means for analytes.  
2.2.4 Exotoxin A-specific MRE modified ELISA assays  
A sandwich ELISA assay modified with ssDNA MRE was developed. R14.33 was 
commercially synthesized with 5’ biotinlylation for the use as the antigen capturing element 
(Eurofins MWG Operon; Huntsville, AL). Streptavidin coated 96-well plate (Pierce; Rockford, 
IL) was washed three times for 5 minutes, with 200 µL of wash buffer (1× selection buffer, 0.1% 
BSA, 0.05% Tween-20 detergent). Subsequently, 100 µL of 40 nM 5’ biotinylated ssDNA in 
selection buffer (after denaturing at 95°C for 5 min and cooling to room temperature) was added 
to sample wells and incubated for 2 hours with shaking at room temperature. Each well was 
washed three times with wash buffer to remove non-immobilized ssDNA.  A negative control for 
each replicate consisted of a blank well without immobilized ssDNA. Then, 100 µL of each 1× 
phosphate buffer solution, selection buffer, 100 nM of Exotoxin A in selection buffer, human 
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serum (Sigma; St. Louis, MO), or 100 nM of Exotoxin A in human serum were added to 
individual sample wells. The plate was incubated for 1 hour with shaking at room temperature.  
Following sample incubation, each well was washed three times with wash buffer to 
remove unbound Exotoxin A.  Next, 100 µL of 1:100 dilution of primary goat anti-Exotoxin A 
antibody (List Biological Laboratories; Campbell, CA) in wash buffer was added to each well 
and followed by 30 minutes of incubation with shaking at room temperature. Following primary 
antibody incubation, each well was washed three times. Subsequently, 100 µL of 1:500 dilution 
of secondary rabbit anti-goat antibody conjugated to horseradish peroxidase (Pierce; Rockford, 
IL) in wash buffer was added to each well and incubated for 30 minutes at room temperature 
with shaking. Lastly, each well was washed five times to remove non-specifically bound 
antibodies. Controls with no antibodies added and with only primary antibodies added were also 
performed. Assays were performed in quadruplicate. 
ABTS substrate (Pierce; Rockford, IL) was added to each well according to the 
manufacturer’s instruction. After ABTS was added, absorbance  was measured in a Synergy 2 
microplate reader with OD reading at 410 nm and 650 nm using Gen5 1.06 software (Biotek US; 
Winooski, VT) in  two-minute increments. All data was averaged and standard deviations were 
calculated. For each Exotoxin A containing sample, a two tailed t-test was performed to 
determine statistical differences respectively to their blank controls (selection buffer or human 
serum). 
2.3 Results and discussions 
2.3.1 Selection of Exotoxin A-specific MREs 
Fourteen rounds of Decoy-SELEX were performed to identify ssDNA MREs specific to 
Exotoxin A. The selection scheme was aimed to direct the ssDNA MREs to bind to free 
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Exotoxin A in solution and reduce enrichment of non-specific binding to immobilization 
substrates, BSA, and Cholera toxin. Initially, 30-50 randomly selected sequences were analyzed 
for consensus sequence family after every 3 rounds of selection (rounds 3, 6, 9, 12). Toward the 
end of the selection, in order to monitor the enrichment of family sequences more frequently, 30-
50 random sequences from both round 13 and 14 were analyzed.  In the round 14 ssDNA library, 
there was a noticeable and significant convergence of sequence families in one sequence, R14.33 
(Table 2.2), which was subsequently chosen for further characterization. The sequence had a 
Gibbs energy value of -9.93 kcal/mol which indicated it would assume a highly stable structure 
according to Mfold prediction (Figure 2.3).   
 
Table 2.2: Sequence families after Round 14 Decoy-SELEX. 
R14.02 
TGTACCGTCTGAGCGATTCGTACTACGCCACACGTGGTGAGGGATTCGATCGCTTGAAGCCAGTCAGTGTTAAGGAGTGC 
R14.20 
TGTACCGTCTGAGCGATTCGTACTGCTATTCATCACCACTCTAGAGCCACTTTTAAAAGCCAGTCAGTGTTAAGGAGTGC 
R14.22 
TGTACCGTCTGAGCGATTCGTACTGGGCGGCGAGCCACCCGGCAATTTAGTACAGGCAGCCAGTCAGTGTTAAGGAGTGC 
R14.33 
TGTACCGTCTGAGCGATTCGTACCATAGGGTGCTTTTCAAGGCCACACGTTAGTGTAAGCCAGTCAGTGTTAAGGAGTGC 
R14.36 
TGTACCGTCTGAGCGATTCGTACAAAGCATCCAGCCGGTATGTGCCAGAGTCTCTGAAGCCAGTCAGTGTTAAGGAGTGC 
R14.38 
TGTACCGTCTGAGCGATTCGTACAAATGTGAGTGGCCAGGCATCAGGTACGTCGGTAAGCCAGTCAGTGTTAAGGAGTGC 
 
 
R14.03 
TGTACCGTCTGAGCGATTCGTACGGATAGGTGCCTCTGCTTCATCATGTTGAACTTAAGCCAGTCAGTGTTAAGGAGTGC 
R14.13 
TGTACCGTCTGAGCGATTCGTACAGTTTCACCAGTCGCCTGTTAGCCGTGATATACGAGCCAGTCAGTGTTAAGGAGTGC 
R14.20 
TGTACCGTCTGAGCGATTCGTACTGCTATTCATCACCACTCTAGAGCCACTTTTAAAAGCCAGTCAGTGTTAAGGAGTGC 
R14.27 
TGTACCGTCTGAGCGATTCGTACTGTCAATATTACGTTGCTCTTAGGTTCACCATCTAGCCAGTCAGTGTTAAGGAGTGC 
R14.28 
TGTACCGTCTGAGCGATTCGTACTTGTGATTCAAATAGGCGTGTTGGTGTGAGACCTAGCCAGTCAGTGTTAAGGAGTGC 
R14.33 
TGTACCGTCTGAGCGATTCGTACCATAGGGTGCTTTTCAAGGCCACACGTTAGTGTAAGCCAGTCAGTGTTAAGGAGTGC 
 
R14.03 
TGTACCGTCTGAGCGATTCGTACGGATAGGTGCCTCTGCTTCATCATGTTGAACTTAAGCCAGTCAGTGTTAAGGAGTGC 
R14.23 
TGTACCGTCTGAGCGATTCGTACCGTGGATCATGCTTCGCGTCGGTTTATAGGTTCCAGCCAGTCAGTGTTAAGGAGTGC 
R14.33 
TGTACCGTCTGAGCGATTCGTACCATAGGGTGCTTTTCAAGGCCACACGTTAGTGTAAGCCAGTCAGTGTTAAGGAGTGC 
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R14.39 
TGTACCGTCTGAGCGATTCGTACAGAAGAGCATCGGTAACTTCCATAGGAGATGGGGAGCCAGTCAGTGTTAAGGAGTGC 
 
R14.02 
TGTACCGTCTGAGCGATTCGTACTACGCCACACGTGGTGAGGGATTCGATCGCTTGAAGCCAGTCAGTGTTAAGGAGTGC 
R14.06 
TGTACCGTCTGAGCGATTCGTACCATCCGAGGGTATTGTATGCGTATATCCTAGTCGAGCCAGTCAGTGTTAAGGAGTGC 
R14.10 
TGTACCGTCTGAGCGATTCGTACCAAGTTCCTCATGGAGGGTGCTCAGAGCTTAGACAGCCAGTCAGTGTTAAGGAGTAA 
R14.33 
TGTACCGTCTGAGCGATTCGTACCATAGGGTGCTTTTCAAGGCCACACGTTAGTGTAAGCCAGTCAGTGTTAAGGAGTGC 
R14.34 
TGTACCGTCTGAGCGATTCGTACAGGGGGATTCCTAGGGCCCGGCCCAACGCTGTTTAGCCAGTCAGTGTTAAGGAGTGC 
R14.42 
TGTACCGTCTGAGCGATTCGTACCAAGACCCTTGAATCACGGGTAGGGTCTCGTAACAGCCAGTCAGTGTTAAGGAGTGC 
 
Representative sequence families following Round 14 of Decoy-SELEX. Families are grouped 
by boxes with common sequences double-underlined and sub-families underlined. 
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Figure 2.3: Secondary structure and sequence of R14.33 ssDNA MRE. (A) ssDNA sequence 
of Exotoxin A MRE R14.33. Gray letters indicates constant regions of the MRE. (B) Mfold 
prediction of R14.33 secondary structure [34]. 
2.3.2 Affinity and Specificity of Exotoxin A-specific MRE 
Affinity of the selected MRE was determined by SPR binding assays. Assays were 
performed with Exotoxin A concentration from high nM to low µM range with at least 2 
duplicate concentrations. The equilibrium dissociation constant (Kd) was between 4.2 to 4.5 µM 
(Figure 2.4). In recent years, there have been a number of MREs have been selected against 
protein targets which utilized SPR for characterization of binding affinity. Reported equilibrium 
dissociation constants in these studies ranged from low-nanomolar to high-nanomolar range [37-
41]. It is to be noted that  these studies relied on different immobilization methods than what was 
used here, including streptavidin/ biotin linkage and thiolated DNA attachment [38-41]. Also, 
several studies utilized a sandwich detection method to amplify signals and thus enhance limit of 
detections [39, 42, 43].  
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Figure 2.4: SPR binding kinetics assays of R14.33 ssDNA MRE. Data represent Kd of R14.33 
from two binding assays evaluated via Scrubber 2 software (Software; Campbell, Australia). (A) 
Representative binding response curve of R14.33. (B) Equilibrium dissociation constants and 
standard error of two binding assays. The average Kd is 4.35 ± 2.12 µM. 
 
SPR cross binding assays were performed to test the specificity of the selected Exotoxin 
A MRE. Concentrations of all cross binding analytes were higher than those used in affinity 
assays to ensure R14.33 has no non-specific binding to negative targets. The method of 
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presentation of the current data as relative response unit of R14.33 to all analytes has been 
previously described [35, 43]. Binding responses showed a much higher affinity of R14.33 to 
Exotoxin A in solution than to all negative targets (one-way ANOVA: F2, 12 = 573.4, p < 0.001) 
(Figure 2.5), as well as to streptavidin, a significant component of the immobilization substrate. 
This is noteworthy as streptavidin was present in  all of the selection rounds. It is clear that 
competitive elutions performed in the last two positive rounds gave the ssDNA library selectivity 
for free Exotoxin A in solution over immobilized target and other negative targets, thus 
validating the Decoy-SELEX method.  
 
 
Figure 2.5: SPR cross binding assays of R14.33. Data represent specificity of R14.33 Exotoxin 
A MRE. Error bars represents standard deviations of three runs. Statistical significance levels of 
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p < 0.001 are designated by ‘*’. The observed significance levels are adjusted by Bonferroni 
post-hoc procedure. Exotoxin A has a significantly higher response when compare to blank 
control and all other analytes, indicating low cross-binding activities of R14.33. Blank represents 
1× selection buffer. Concentrations of all analytes are at 5 µM.  
 
The determined equilibrium binding constant of the selected Exotoxin A MRE is higher 
than other studies utilizing SPR binding assays. This difference is likely due to different methods 
of immobilizing the ssDNA MRE as noted above and thus leads to a lower level of 
immobilization and detection responses. The current study utilizes direct covalent conjugation of 
5’ amino modified ssDNA to the SAM on gold surface [36]. One of the major challenges of this 
method is the electrostatic repulsion between negatively charged DNA and deprotonated 
carboxyl groups on the SAM surface during immobilization under neutral to basic running buffer. 
However, covalently attached DNA provides a more stable immobilization as compared to 
streptavidin/biotin and thiolated DNA attachment under a wide range of storage conditions. This 
is a potential advantage in the real application of a ssDNA MREs based biosensor, as the 
longevity of the biological probe is a huge determining factor of its application value [44]. It is 
also important to note that previous study demonstrated a 100-fold higher Kd between SPR 
binding measurements and binding assays relying on free ssDNA in solution [45]. This is likely 
due to the difference in the availability of binding pockets on MREs that are immobilized on 
solid platform as compared to being in solution. The SPR setup in this study is also very similar 
to the potential design of a final sensor. Therefore, this is a very realistic assay and is 
translational as a sensor.  
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2.3.3 Diagnostic application of Exotoxin A-specific MRE 
 The Exotoxin A specific MRE demonstrated high specificity, and minimal cross binding 
activity to BSA. It is reasonable to believe this low binding property may be extrapolated to 
human serum albumin [38]. This allowed the investigation of using the selected MRE as a 
potential diagnostic tool. A sandwich ELISA assay modified with the ssDNA MRE as the toxin 
capturing element was developed. Reproducible and statistically significant detection of 
Exotoxin A at 100 nM in spiked human serum samples were achieved compare to negative 
controls in six independent assays (p < 0.05 to p < 0.001) (Figure 2.6).  
 
 
Figure 2.6: Modified ELISA assays of Exotoxin A. Data represent one modified sandwich 
ELISA with absorbance measured at OD 410 nm. Absorbance levels presented are subtracted 
from background levels of blank well without immobilized DNA. Error bars represents standard 
deviations of 4 sample replicates in one independent assay. (A) Statistical significance levels 
with respect to buffer background of p < 0.001 are designated by ‘*’. (B) Statistical significant 
levels with respect to human serum background of p < 0.001 are designated by ‘*’. Buffer: 1× 
selection buffer; serum: human serum. 
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It has been reported that ssDNA MRE generally has a half-life of 1 hour in human serum 
due the presence of exonuclease [46]. Therefore, toxin incubation time ranged from five minutes 
to one hour was tested during assay development. While a portion of the immobilized MRE is 
likely to be degraded in serum condition, the one-hour toxin incubation period yielded the most 
consistent result and therefore it was utilized in all experimental assays. 
Previous study has attempted to incorporate ssDNA MRE into a system for target 
detection in buffer diluted human serum [47]. Similar ssDNA MRE modified ELISA assay for 
the detection of bacteria toxins have been previously described [48, 49]. However, clinically 
relevant samples were not tested in both studies. It is known that the binding activities of nucleic 
acid MREs are highly dependent on their three dimensional structures, and are influenced by 
factors such as temperature, pH and ionic strength of the binding environment [50]. This leads to 
challenges in applying nucleic acid MREs in targets’ native complex environments, such as 
human serum [51]. This study demonstrated an improvement to these previous reported studies 
by showing the robustness of the selected Exotoxin A specific MRE in undiluted serum without 
any base modifications, and it was able to retain a level of binding activity in an environment 
that was very much different than the selection condition.  
Currently, there are limited studies in quantifying the amount of Exotoxin A in vivo. 
Previous studies showed large differences in the levels of Exotoxin A detected in murine serum 
(averaged 116.0 ng/mL) and in culture media (averaged 1.4 µg/mL) [52, 53]. One study showed 
a significant differences in Exotoxin A detected in different patient sputum samples (0.3 ng/mL 
to 126 ng/mL), and as high as 29.3 µg/mL of Exotoxin A was detected in the culture supernatant 
of sputum isolated P. aeruginosa [54]. It has also been reported that blood isolated P. aeruginosa 
produced the highest amount of Exotoxin A in culture conditions (approximately 0.3 µg/mL) 
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[55]. Overall, these results suggest that in vivo levels of Exotoxin A vary significantly and are 
not well quantified in human patients. 
Historically, an ADP-ribosylation assay has been utilized to quantify the amount of 
Exotoxin A in research studies [20, 55-58]. This assay requires the use of radioactive NAD and 
intensive experimental preparations, and therefore it may not be practical for diagnostic use. 
Although a traditional antibody-based sandwich ELISA assay (MyBioSource; San Diego, CA) is 
commercially available with a reported detection range between 0.156 ng/mL and 10 ng/mL, it 
was designed for research purpose only. Also, given the likelihood of wide ranges of Exotoxin A 
levels in vivo. The relatively narrow detection range of the commercial ELISA kit may limit its 
usage in clinical samples. It is to be noted that in our ssDNA MRE modified ELISA assays, 100 
nM or 6.6 µg/mL of Exotoxin A in human serum was detected. While this is highly reproducible, 
the differences compare to negative controls are small enough to be near the assay’s detection 
limit. Based upon the available clinical data on Exotoxin A level in patients, it is difficult to 
completely rule out the clinical usage of the current ssDNA MRE modified ELISA assay. In 
order to transition the current assay into a final product for clinical use, it will need more 
modification, optimization and possibly with industrial partnership. Nevertheless, ssDNA MRE 
modified assay does offer several advantages when compared to ELISA assays that are based 
solely on antibodies, such as thermostability, and regeneration of assay by a basic buffer wash 
[59].  
  Overall, this study has identified a ssDNA MRE with high affinity and specificity for 
Exotoxin A of P. aeruginosa. To our knowledge, this is the first ssDNA MRE targeting Exotoxin 
A. The successful use of SPR for MRE characterizations showed the potential of it being 
incorporated into a SPR-based biosensor for real time, label-free detection of Exotoxin A in 
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biological matrices [38, 39]. In addition, the ssDNA MRE modified ELISA assay offers a 
potential new way to facilitate the diagnosis of P. aeruginosa infection by rapidly quantifying 
the presence of one of the most significant virulence factors in approximately 2 hours from toxin 
incubation to detection, and with minimal sample manipulations. This method may also 
supplement direct diagnosis methods based on detecting the presence of bacterial cells, such as 
culturing and PCR. 
2.4 Conclusions 
This study utilized a novel variation of the SELEX process, Decoy-SELEX, to obtain a 
ssDNA Molecular Recognition Element specific for Exotoxin A, a virulence factor of 
Pseudomonas aeruginosa. The MRE is characterized to have high affinity and specificity to its 
target, thus validating the Decoy-SELEX methodology. Utilizing surface plasmon resonance 
measurements, the determined equilibrium dissociation constant (Kd) of the MRE is between 4.2 
µM and 4.5 µM, and is highly selective for Exotoxin A over negative targets. A ssDNA MRE 
modified sandwich enzyme-linked immunosorbent assay (ELISA) has been developed and 
achieved a sensitive detection of Exotoxin A at nanomolar concentrations in human serum. This 
study has demonstrated the proof-of-principle of using ssDNA MRE as a potential clinical 
diagnostic tool.  
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Chapter 3 
In Vitro Selection of a Single-Stranded DNA Molecular 
Recognition Element Against Clostridium difficile Toxin B 
and Sensitive Detection in Human Fecal Matter 
This chapter is adapted from the work that has been published in Journal of Nucleic Acids. 
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3.1 Introduction 
Toxin B is a virulence factor secreted by Clostridium difficile, an obligate anaerobic  
spore-forming gram positive bacillus bacterium [1]. Clostridium difficile induced diarrhea 
accounts for more than 300,000 or almost 30% of all cases of diarrhea in acute care settings [2, 
3]. It also causes prolonged hospital stays and therefore increased cost burden in the health care 
system [4]. It has been reported that the cost of C. difficile infections are between $436 million 
and $3.2 billion per year in the US [4, 5]. In addition to economic burdens, the mortality rates of 
C. difficile infections have also increased from 5.7 per million in 1999 to 23.7 per million in 
2004 [6]. 
C. difficile produces two major exotoxins: toxin A and toxin B. Toxin B has been shown 
to be 1000 times more toxic than toxin A. While both toxins are considered to be the cause of C. 
difficile colitis, all toxin-producing strains of C. difficile produce toxin B [7]. Upon colonization 
of toxic strains of C. difficile in the colon, produced toxins deactivate GTPases, such as Rho and 
Rac, disrupt cytoskeleton and signal transductions, and result in cell rounding and  loss of cell 
structures, leading to host inflammatory responses [8].  
Due to the problems associated with C. difficile infection (CDI), early and accurate 
diagnosis is important for disease management and patient survival [9]. Currently, diagnostic 
tests for CDI are stool culturing, cell cytotoxicity neutralization assay, enzyme immunoassay 
(EIA) for toxin A and B, detection of C. difficile glutamate dehydrogenase (GDH) and 
polymerase chain reaction (PCR) detection of C. difficile genes [10]. Culturing diagnosis is  very 
sensitive, but the turnaround time can be up to 3-5 days [11]. GDH testing is very sensitive, but 
is not specific and requires additional EIA for toxin A and/ or toxin B [11, 12]. There are 
multiple commercial EIA kits for toxin A/B detection on the market, but their sensitivities vary 
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and  they may not be available in all countries [13]. PCR test has a rapid turnaround with good 
sensitivity and specificity, but does not detect the presence of virulence factors and the cost 
associated with the test may limit its usage [11, 14]. A confirmed diagnosis of CDI usually 
requires positive results from two or three-step of the available tests [15, 16]. When the results of 
these tests are combined, they are sensitive and specific, but excessive cost and turnaround time 
are major drawbacks. Therefore, it is important to identify new diagnostic techniques that can 
address some of these limitations. 
One potential method of addressing problems associated with toxin B testing is through 
molecular recognition and detection. Molecular recognition elements (MREs) are defined to have 
high specificity and affinity toward user defined targets. Molecules such as single-stranded 
oligoneucleotides, small peptides, antibody fragments and full length antibodies can all 
participate in molecular recognition, and have been studied in different types of biosensors [17-
20]. MREs are identified by an in vitro selection process called, Systematic Evolution of Ligands 
by Exponential Enrichment (SELEX), which was first described by the Gold laboratory in 1990 
[21]. Nucleic acid MREs are usually selected from a large random library consisting of 1013 to 
1015 different single-stranded DNA (ssDNA) or RNA molecules. The library is enriched through 
repeated cycles of incubation with the desired target and subsequently removal of molecules that 
bind to undesired targets. At the end of the selection process, the diversity of the MRE library is 
decreased to the point that one or a few candidate MREs can be identified for affinity and 
specificity screening against the target of interest. 
In this study, we applied a stringent SELEX scheme to obtain a ssDNA MRE that binds 
to toxin B with high affinity and specificity [22-24]. The selection scheme was designed to 
eliminate MREs that bind to negative targets that are likely to co-exist in the target environment. 
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Bovine serum albumin (BSA) was chosen to be the first negative target based on its similarity to 
human serum albumin and it’s prevalence as a blocking agent in assay applications [25]. Alpha 
toxin of Staphylococcus aureus and exotoxin A of Pseudomonas aeruginosa are virulence 
factors of common nosocomial infections, which have the likelihoods to co-infect hospitalized 
patients [26-28]. Cholera toxin of Vibrio cholerae is the causative agent of cholera induced 
watery diarrhea, which symptomatically mimics CDI [29]. In addition to the selection and 
characterization of the toxin B specific ssDNA MRE, a modified enzyme-linked immunoassay 
(ELISA) has been developed which utilizes the identified ssDNA MRE. The assay was able to 
show the detection of toxin B in human fecal samples at nanomolar concentrations. This work 
shows the potential of using ssDNA MREs in diagnostic applications [30-32]. 
3.2 Materials and Methods 
3.2.1 In vitro Selection of Toxin B-specific MREs 
  The selection process began with a single-stranded DNA (ssDNA) library consisting of 
1015 different molecules designed by our laboratory as previously described (Figure 3.1) [22]. In 
brief, the library, termed RMW.N34, consists of two 23-base constant regions for polymerase 
chain reaction (PCR) amplification, flanking a 34-base random region (commercially 
synthesized by Eurofins MWG Operon; Huntsville, AL).  A total of 12 rounds of SELEX were 
performed (Table 3.1) to identify ssDNA molecules that bound specifically to toxin B and not to 
negative targets (Figure 3.2). 
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Figure 3.1: Illustration of the SELEX process. The SELEX process begins with 1015 ssDNA 
molecules and incubation with the target toxin B. Those that bind to toxin B is amplified and 
subsequently incubated with negative targets. Those that do not bind to negative targets are 
retained and amplified, thus completing one round of in vitro selection. 
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Table 3.1: Systematic Evolution of Ligands by Exponential Enrichments (SELEX) scheme 
for Toxin B-specific MRE selection. 
Round Positive Selection  Time Negative Selection Time 
1 Immobilized Target 
(IT)  
24 hrs - - 
2 IT  18 hrs BSA INT  22 hrs 
3 IT  13 hrs BSA INT  26 hrs 
4 IT  7 hrs Exotoxin A INT  22 hrs 
5 IT  3 hrs Exotoxin A INT  26 hrs 
6 IT  30 min BSA INT  24 hrs 
7 IT/ 
Competitive Elution 
with 20 µg/mL free 
toxin B 
5 min/ 
5 min 
IT/  
Competitive Elution 
with 20 µg/mL free 
BSA 
5 min/  
5 min 
8 IT/ 
Competitive Elution 
with 20 µg/mL free 
toxin B 
5 sec/ 
5 sec 
IT/ 
Competitive Elution 
with 20 µg/mL free 
alpha toxin, 1 hour 
5 sec/ 
1 hrs 
9 IT/ 
Competitive Elution 
with 10 µg/mL free 
toxin B 
5 sec/ 
5 sec 
IT/ 
Competitive Elution 
with 20 µg/mL free 
cholera toxin, 1 hour 
5 sec/ 
1 hrs 
10 IT/  
Competitive Elution 
with 5 µg/mL free 
toxin B 
5 sec/ 
5 sec 
IT/ 
Competitive Elution 
with 20 µg/mL free 
exotoxin A, 1 hour 
5 sec/ 
1 hrs 
11 IT/ 
Competitive Elution 
with 2.5 µg/mL free 
toxin B 
5 sec/ 
5 sec 
IT/ 
Competitive Elution 
with 20 µg/mL free 
BSA, 24 hrs 
5 sec/ 
24 hrs 
12 IT/ 
Competitive Elution 
with 1 µg/mL free 
toxin B 
5 sec/ 
5 sec 
-  
 
In vitro selection performed for identifying toxin B-specific MRE. Immobilized target (IT) is 
toxin B conjugated to magnetic beads. Immobilized negative target (INT) is negative targets 
conjugated to magnetic beads. BSA is the abbreviation for bovine serum albumin. Times listed 
are incubation times in hours (hrs), minutes (min) or seconds (sec).  
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Figure 3.2: Structures of targets used in the SELEX scheme and cross binding assays. (A) 
Ribbon structure of the selection target, Clostridium difficile toxin B (PDB 2BVM, 270 kDa) 
[33]. (B), (C), (D), (E) Ribbon structure of Pseudomonas aeruginosa exotoxin A (PDB 1IKQ, 66 
kDa) [34], bovine serum albumin (PDB 4F5S, 66.5 kDa) [35], Vibrio cholerae cholera toxin 
(PDB 2A5D, 84 kDa) [36], and Staphylococcus aureus alpha toxin (PDB 3ANZ, 33 kDa) [37], 
used in negative rounds of selection and cross binding assays. 
 
Lyophilized toxin B (List Biological Laboratories; Campbell, CA) was reconstituted in 
pure water and covalently immobilized to carboxylic acid-coated magnetic beads (Dynabeads M-
270 Carboxylic Acid, Life Technologies; Grand Island, NY) via an amidation reaction using N-
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hydroxysulfonyl succinimide (sulfo-NHS) (Pierce; Rockford, IL) and 1-ethyl-3-(3-
dimethylaminopropyl) (EDC) (Pierce; Rockford, IL) according to manufacturer’s protocol.  
 For positive rounds, 6 µL of immobilized target was incubated with ssDNA library in 200 
µL of selection buffer composed of 100 mM sodium chloride, 20 mM Tris-HCl, and 2mM 
magnesium chloride (1× selection buffer, SB) at room temperature with rotation (8 RPM). After 
incubation, the immobilized target and solution were separated using a magnet. Unbound ssDNA 
in solution was removed. Immobilized target/ DNA complexes were washed three times with 
200 µL of SB and resuspended in 100 µL of SB. This bound DNA served as a template for PCR 
amplification. The PCR conditions were as follows: bound ssDNA, 400 nM forward and 
biotinylated reverse RMW.N34 primers (Eurofins MWG Operon; Huntsville, AL) (forward: 5’-
TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated reverse: 5’-Biotin- 
GCACTCCTTAACACTGACTGGCT-3’), 250 µM deoxynucleotide triphosphates, 1× GoTaq 
Reaction Buffer (Promega; Madison, WI), 3.5 units Taq polymerase, and pure water. Thermal 
cycling conditions were as follows: denature at 95° C for 5 minutes, cycle at 95° C for 1 minute, 
63° C for 45 seconds, and 72° C for 1 minute; and final extension temperature at 72° C for 7 
minutes [22].A large-scale 3mL amplification was carried out after each round of positive and 
negative selection. This selection procedure for the immobilized toxin B target was performed 
for Rounds 1 – 6, each with decreasing incubation time. 
 After PCR amplification, amplified dsDNA was purified with the IBI PCR purification 
kit (IBI Scientific; Peosta, IA) according to the manufacturer’s protocol. Eluted dsDNA 
containing the biotinylated reverse strand was subjected to single strand separation and ethanol 
precipitation of the forward strand as previously described [22]. This procedure was performed 
after each positive and negative round of selection. 
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 For negative rounds, multiple negative targets were covalently immobilized to carboxylic 
acid-coated magnetic beads as described above. Immobilized negative targets were incubated 
with the enriched ssDNA library in the same conditions as positive rounds. However, after 
magnetic separation, unbounded ssDNA in solution was used as template for PCR amplification. 
This selection procedure for immobilized negative targets was performed for Rounds 2 – 6. 
 Competitive elution with free toxin B in solution was performed beginning in Round 7 
positive. The enriched ssDNA library was first incubated with immobilized toxin B as described 
above. After magnetic separation and washes, toxin B at a concentration of 20 µg/ mL in 100 µL 
of 1× SB was added to magnetic beads and incubated for 5 minutes, then subjected to magnetic 
separation. The solution containing ssDNA bound to free toxin B served as PCR template. This 
procedure was performed for Rounds 7 – 12 positive, each with decreasing time of incubation 
and target concentrations.  
 Similarly, competitive elution with negative targets in solution was performed beginning 
in Round 7 negative as outlined above. However, ssDNA molecules bound to the immobilized 
target were resuspended in 100 µL of 1× selection buffer and served as PCR template. This 
procedure was performed for Rounds 7 – 11 negative. 
3.2.2 Cloning and Sequencing of Toxin B-specific MREs 
 In order to analyze the ssDNA library for consensus binding sequences, the library was 
cloned and sequenced following Rounds 3 negative, 6 negative, 9 negative and 12 positive. 
Identical procedures were performed as previously described [22]. In brief, the library was 
amplified with non-biotinylated primers, and the fresh PCR product was ligated into the pCRII 
vector (Invitrogen; Carlsbad, CA) and cloned into competent E. coli according to the 
manufacturer’s protocol. The cloned plasmid was extracted and purified with AxyPrep Plasmid 
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Miniprep kit (Axygen; Union City, CA), and subsequently sequenced with the M13R primer by 
commercial source (Eurofins MWG Operon; Huntsville, AL). A total of 30-80 randomly selected 
clones were sequenced and analyzed. 
3.2.3 Toxin B-specific MREs Sequence Alignment and Analysis 
Sequences were first grouped into super-families by analyzing common tetranucleotide 
sequence from the variable regions of sequenced clones. The largest super-family was then 
chosen for alignment and divided into smaller subfamilies. All sequences in the subfamilies were 
analyzed for their predicted secondary structures, the predicted Gibbs free energy values of those 
structures, and percent homology. These analyzed parameters were considered in the choice of 
candidate sequences. 
3.2.4 Toxin B-specific MRE Binding Assays with Surface Plasmon Resonance 
One candidate sequence from the round 12 library was chosen for further characterization. 
The candidate sequence was designated as R12.69. The secondary structure was predicted by the 
Mfold DNA web server using the following conditions: 25° C, 100 mM Na+, and 2 mM Mg2+ 
[38]. Commercially synthesized 5’amino-C6 modified R12.69 (5’ amino-C6 indicates  a primary 
amino group attached to the 5’ end of the oligonucleotide with six carbon spacer between the two) 
(Eurofins MWG Operon; Huntsville, AL) was used for surface plasmon resonance (SPR) affinity 
assays. Both in-house produced and commercially purchased CM5 (GE Healthcare; Piscataway, 
NJ) SPR sensor chips were used for binding assays.  
 Home-made gold chips were fabricated from glass slides (12 mm x 10 mm) coated with a 
2 nm titanium adhesion layer and a 45 nm gold layer. Metals were deposited using a Temescal 
BJD-2000 system (Edwards Vacuum; Phoenix, AZ) with an Inficon XTC/2 deposition controller 
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(East Syracuse, NY). The home-made gold chips were first cleaned in 100% ethanol under 
sonication for 5 minutes, then immersed in a solution of 10 mM 11-mercaptoundecanoic acid 
(11-MUA) (Sigma; St. Louis, MO) and 10 mM triethylene glycol mono-11-
mercaptoundecylether (PEG3) (Sigma) in a 1 to 5 ratio overnight under argon for the formation 
of the self-assembled monolayer. Subsequently, gold chips were rinsed in 100% ethanol and pure 
water, blown dry with nitrogen and assembled onto carrying cartridges for SPR binding assays 
using a Biacore X100 (GE Healthcare; Piscataway, NJ). 
Both in-house produced and purchased CM5 SPR sensor chips were activated by 
injecting 100 mM N-hydroxysulfonyl succinimide (sulfo-NHS) (Pierce; Rockford, IL) and 400 
mM 1-ethyl-3-(3-dimethylaminopropyl) (EDC) (Pierce; Rockford, IL) at a 1 to 1 ratio to both 
active (flow cell 2) and reference (flow cell 1) flow cells at a flow rate of 5 µL/min for ten 
minutes. An immobilization buffer composed 100 mM sodium chloride, 20 mM potassium 
phosphate, and 2 mM magnesium chloride, pH 7.4 was used as the running buffer. Then, 300 µL 
of 100 nM 5’ amino-C6modified R12.69 in immobilization buffer was injected into the active 
flow cell at a flow rate of 5 µL/min, followed by 10 minutes injection of 1 M ethanolamine-HCl 
pH 8.5 into both active and reference flow cells in order to inactivate un-reacted sensor surface. 
Maximum levels of immobilization were obtained for affinity analyses.  
Single cycle kinetics assays were performed to determine the affinity of R12.69 to toxin 
B. The 1× selection buffer was used as running buffer during kinetics assays. Toxin B at various 
concentrations (20 nM, 40 nM, 60 nM, 100 nM and 200 nM) in 1× SB were injected into both 
flow cells at a flow rate of 30 µL/min for 120 seconds with a dissociation time of 150 seconds. 
Control and baseline adjusted sensorgram responses were analyzed with the Biacore X100 
evaluation software (GE Healthcare; Piscataway, NJ). A 1:1 kinetics model was used to 
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determine the equilibrium dissociation constant (Kd). This binding assay was performed in 
triplicate.  
3.2.5 Toxin B-specific MRE Fluorescence Cross-Binding Assays 
To determine the cross binding activities of the selected MRE, 5’FAM modified R12.69 
was purchased from Eurofins MWG Operon. The assay was performed as previously described 
with slight modifications [39]. Toxin B, exotoxin A (List Biological Laboratories; Campbell, 
CA), alpha toxin (List Biological Laboratories; Campbell, CA), cholera toxin (List Biological 
Laboratories; Campbell, CA), and BSA at 40 nM in 90 µL of 50 mM carbonate/ bicarbonate 
buffer (pH 9.6) were added into individual wells of a 96 well Nunc C8 Lockwell MaxiSorp 
microplate (Pierce; Rockford, IL). Wells containing 1× SB with 0.05% Tween-20 served as the 
negative background control. The plate was placed on a shaker and incubated at 4 ºC overnight 
for protein coating (500 RPM). Subsequently, wells were blocked with 90 µL of 1× SB with 
0.05% Tween-20 for 1 hour and washed with the same blocking buffer 3 times. Fluorescently 
labeled R12.69 was diluted to 100 nM in 90 µL of 1× SB. It was then added to each well and 
incubated at room temperature for 1 hour. Unbound R12.69 was then aspirated and followed by 
washing with 1× SB 5 times. Finally, 90 µL of 1× SB was added to each well and the 
fluorescence emission was measured by a Synergy 2 microplate reader with excitation at 490 nm 
and emission at 520 nm (Biotek US; Winooski, VT). Fluorescence measurements were 
normalized to 90 µL of 100 nM fluorescent MRE in 1× SB as described previously [22]. Protein 
target sets were performed in triplicate and control well sets in duplicate. All data was averaged 
and standard deviations were calculated. A one-tailed t-test was performed to determine the 
statistical significance in difference of the means (p ≤ 0.05). 
 
115 
 
3.2.6 Toxin B-specific MRE Modified ELISA assays 
Commercially synthesized 5’ amino-C6 modified R12.69 was used as the toxin B 
capturing element in a modified sandwich ELISA assay. First, 40 nM of 5’ amino-C6 modified 
R12.69 in immobilization buffer (100 mM sodium chloride, 20 mM potassium phosphate, and 2 
mM magnesium chloride, pH 7.56) was denatured at 95°C for 5 min and cooled to room 
temperature. Then, 100 µL of the ssDNA was added to individual wells of a maleic anhydride 
activated plate (Pierce; Rockford, IL) and incubated overnight with shaking at room temperature 
(500 RPM). Each well was then blocked with 0.1% BSA in 1× SB for 1 hour, and washed three 
times with wash buffer containing 0.1% BSA, 0.05% Tween-20 in 1× SB at room temperature to 
remove non-immobilized ssDNA.   
Normal human fecal samples (Lee Biosolutions; St Louis, MO) were reconstituted in 1× 
SB at 1 g to 20 mL ratio, then centrifuged at 5000 x g for 10 minutes to collect fecal solution. 
Toxin B was spiked into 100 µL of prepared fecal solution and 100 µL of 1× SB respectively at a 
final concentration of 50 nM and served as active testing samples. Blank wells without 
immobilized ssDNA served as the first negative control, and 100 µL of 1× phosphate buffer 
solution, 100 µL of 1× SB, and 100 µL of fecal solution in wells with immobilized ssDNA 
served as the second negative control.  All samples were added to individual well and incubated 
for 1 hour with shaking at room temperature (500 RPM).  
After sample incubation, wells were washed three times with wash buffer to remove 
unbound toxin B. Then, 100 µL of chicken anti-toxin B primary antibody (List Biological 
Laboratories; Campbell, CA) at a 1 to 400 dilution ratio in wash buffer was added to each well 
and incubated for 30 minutes at room temperature with shaking (500 PRM). The primary 
antibody was then aspirated and each well was washed three times as outlined above. A 
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secondary goat anti-chicken antibody conjugated to horseradish peroxidase (Pierce; Rockford, IL) 
at 1 to 500 dilution ratio was added and incubated for 30 minutes at room temperature with 
shaking (500 RPM). Lastly, all contents were aspirated and washed five times with wash buffer 
to remove non-specifically bound antibodies (Figure 3.3). Additional negative controls were 
wells without antibodies and wells with only primary antibody. Assays were performed in 
duplicate.  
ABTS substrate (Pierce; Rockford, IL) was added to individual well according to the 
manufacturer’s protocol. Absorbance at 410 nm and 650 nm was measured in a Synergy 2 
microplate reader using Gen5 1.06 software (Biotek US; Winooski, VT) in two minute 
increments. All data was averaged and standard deviations were calculated. A two-tailed student 
t-test was used to determined statistical differences at p < 0.05. 
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Figure 3.3: Illustration of the Toxin B-specific MRE modified ELISA assay. The ssDNA 
MRE was used as the capturing element in the modified sandwich ELISA assay and signal is 
amplified by using secondary antibody conjugated to horse radish peroxidase (HRP). 
 
3.3 Results and Discussions 
3.3.1 Identification of Toxin B-specific MRE 
Twelve rounds of SELEX were carried out to identify ssDNA MREs specific to toxin B. 
This SELEX scheme is designed to enrich ssDNA MREs that bind to toxin B in solution and 
exclude ssDNA molecules that bind to BSA, alpha toxin, exotoxin A, and cholera toxin, which 
are likely to co-exist in the target environment. Multiple negative selection rounds were 
performed to enhance the specificity of the ssDNA library. After every three complete rounds of 
selection (rounds 3, 6, 9 and 12), 30 – 80 random sequences were selected and analyzed.  
In the round 12 ssDNA library, 43 sequences were successfully obtained and analyzed. 
The largest super-family contained 17 sequences. All 17 sequences were further aligned based on 
the common tetranucleotide sequence (CTAA), and divided into five smaller subfamilies (Figure 
3.4).  
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Figure 3.4: Sequence families of the round 12 library. Only the variable region is shown in 
the aligned subfamily of the CTAA super-family. MRE sequences are aligned to the CTAA 
tetranucleotide sequence. Highlighted regions represent sequence homology shared in the 
subfamilies. ΔG represents the Gibbs free energy values. Possible structures indicate the number 
of predicted structures from the Mfold web server [38]. Percent homology is calculated from 
highlighted nucleotides divided by the length of the sequenced variable region.  
 
It is to be noted that one sequence R12.62 only contained TAA tri-nucleotide, however it 
shared large homology within the subfamily, and therefore it was also included in the analysis. 
The CTAA tetranucleotide was not found in the constant regions, and therefore the constant 
regions did not participate in the family analysis, and were omitted in the figure presentation. 
However, previous studies showed that the constant regions of the MRE sequence can be 
involved in their functional secondary structures, thus they were not ignored in the overall 
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decisions of choosing candidate sequences [40-44]. Two sequences, R12.12 and R12.27 were 
identical. However, the sequences were not chosen for further characterization based on the 
relatively higher Gibbs free energy value (ΔG) (indicating lower stability) and multiple possible 
secondary structures. Sequence R12.30, R12.66 and R12.78 had the overall lowest ΔG values, 
but their variable regions did not sufficiently participate in the formation of stem-loop structures 
according to the Mfold predictions. Only one sequence, R12.69 had one possible predicted 
structure with a relatively low ΔG value (-8.07 kcal/mol), and sufficient stem-loop structures 
formed from the variable region (Figure 3.5). Therefore, R12.69 was chosen for further 
characterization.  
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Figure 3.5: Secondary structure and sequence of R12.69 ssDNA MRE. (A) ssDNA sequence 
of toxin B MRE R12.69. The red portions indicate the constant regions for primer attachment, 
and the black portion indicates the variable region. (B) Mfold prediction of R12.69 secondary 
structure. Highlighted sequence, CTAA, represents that most common tetranucleotide sequence 
in the variable regions of the 43 sequences obtained from the round 12 library, and it is used as 
the center for sequence alignment in Figure 4 [38].  
 
3.3.2 Affinity and Specificity of Toxin B-specific MRE 
Surface plasmon resonance was used to determine the affinity of R12.69. Single cycle 
kinetics analysis was performed on both in-house produced and commercial CM5 SPR sensor 
chips. This type of assay was chosen instead of multi-cycle kinetics because there was no need to 
predetermine the regeneration condition of the sensor chip. This type of assay has also been used 
in previous studies to determine the binding affinities of nucleic acid MREs [45, 46]. Two assays 
were performed on CM5 sensor chip and one assay was performed on home-made sensor chip. 
There were negligible differences between the equilibrium dissociation constants (Kd) obtained 
from both types of sensor chips. The averaged Kd value from the three assays was determined to 
be 47.3 ± 13.7 nM (Figure 3.6).  
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Figure 3.6: Affinity measurements of R12.69 ssDNA MRE. A representative SPR affinity 
saturation curve of R12.69 with 1:1 binding fit. The averaged equilibrium dissociation constant 
and standard error of three SPR measurements is 47.3 ± 13.7 nM. 
 
It is to be noted that the MRE was immobilized covalently onto the sensor chip surfaces, 
which was different than most of the previous studies [45, 47-49]. The surface of both home-
made and CM5 sensor chips were negatively charged under a neutral to basic running buffer (IM 
buffer), and the electrical repulsion between the negatively charged DNA may lead to variable 
levels of ligand immobilization and different levels of maximum SPR response unit. However, 
analyte and ligand binding was saturated in all three independent assays, thus validating the use 
of covalent linkage for MRE immobilization in SPR analysis. The determined dissociation 
constant (Kd) was comparable to other MREs targeting bacteria toxins [39, 50, 51].  
The cross binding activity of R12.69 was determined by fluorescence plate assay. The 
ssDNA MRE preferably binds to toxin B greater than other negative targets in the selection 
scheme (Table 3.2).  
 
Table 3.2: Cross-binding reactivity of R12.69 ssDNA MRE. 
Target Average 
Fluorescence 
(RFU) 
Standard 
Deviation 
P-value Selectivity Ratio 
Toxin B 0.0176 0.0066 - - 
Cholera Toxin 0.0080 0.0041 0.0497 2.2 
Alpha Toxin 0.0033 0.0022 0.0117 5.4 
Exotoxin A 0.0037 0.0022 0.0130 4.7 
Bovine Serum 
Albumin 
0.0030 0.0018 0.0106 5.8 
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For each protein target, average fluorescence is given with standard deviation. The P-value is 
given from a t-test between toxin B and other negative targets. The selective ratio describe the 
number of times greater binding to toxin B than to other negative targets.  
 
The binding of R12.69 to toxin B is 2.2 times higher than chorea toxin (p = 0.0497), 5.4 
times higher than alpha toxin (p = 0.0117), 4.7 times higher than exotoxin A (p = 0.0130), and 
5.8 times higher than bovine serum albumin (p = 0.0106). It is to be noted that both cholera toxin 
(84 kDa) and alpha toxin (33 kDa) were introduced only once in the negative selection scheme. 
However, the selectivity over alpha toxin is more than double that of cholera toxin. It is likely 
that the ssDNA library was enriched to bind preferably to large globular protein targets (M.W. of 
toxin B = 270 kDa) during early selection rounds. Other negative targets were introduced 
multiple times in the negative selection scheme and therefore their respective cross binding 
activities were sufficiently decreased. This result validates that multiple negative targets and 
competitive elution strategy employed in our stringent SELEX method can greatly enhance the 
specificity of ssDNA MREs. 
3.3.3 Diagnostic Application of Toxin B-specific MRE 
A modified sandwich ELISA assay was developed in this study to investigate the 
translational potential of R12.69. Reproducible detection of 50 nM toxin B spiked in human fecal 
solutions were achieved compared to control in 8 minutes after HRP substrate incubation (p < 
0.05) (Figure 3.7).  
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Figure 3.7: R12.69 ssDNA MRE modified ELISA assays of Toxin B. Data from one modified 
sandwich ELISA assay with absorbance measured at OD 410 nm.  Absorbance levels presented 
are subtracted from background levels of blank wells without immobilized DNA (negative 
control). Error bars represents 2x standard deviations of 2 sample replicates. (A) Statistical 
significance levels with respect to DNA in buffer background (without toxin B) of p < 0.01 are 
designated by **. (B) Statistical significance levels with respect to fecal background (without 
toxin B) of p < 0.05 are designated by *. Buffer: 1× selection buffer; Feces: 1 g/ 20mL 1× 
selection buffer. 
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It is to be noted that fecal matter is a complex matrix, which contains multiple 
macromolecules and ions [52]. Meanwhile, the three dimensional structure of nucleic MREs is 
highly dependent on the temperature, pH and ionic strength of the binding condition and these 
structures are related to their binding abilities [53]. This modified ELISA assay demonstrated the 
robustness of R12.69 in complex biological matrices. Previous studies have identified ssDNA 
MREs specific for bacteria toxins and similar ELISA assays were developed for toxin detection 
[39, 54]. However, both ELISA detections were not tested in clinically relevant samples, which 
is necessary for translation. Recently, slow off-rate modified binding elements (SOMAmerTM by 
SomaLogic, Inc; Boulder, CO) specific for toxins B, A and binary toxin of C. difficile have been 
identified with subnanomolar affinities [55]. The authors also reported sensitive detection of 
toxin B at picomolar concentrations in multiple assays, though fecal preparations were not tested 
in all of the assays. Previous study reported that fecal toxin B levels in patients with CDI ranged 
from approximately 26 ng/ mL to 25 µg/ mL [56]. The current MRE modified ELISA assay can 
detect toxin B level at 50 nM (1.35 µg/ mL), that is within a clinically relevant concentration. 
Currently, multiple commercial toxin B ELISA diagnostic kits are available in the market 
and offer sensitive detection of toxin B at nanograms/ mL concentrations. It is to be noted that 
the current clinical usage of the unmodified ssDNA MRE identified in this study is limited due to 
its lower sensitivity. However, ssDNA MREs have several advantages over antibodies, such as 
inexpensive chemical synthesis and reusability [57]. The use of the toxin B specific MRE in the 
modified sandwich ELISA assay therefore has a cost advantage over other currently available 
diagnostic techniques, and may offer an option for rapid initial screening of CDI. This MRE may 
also be incorporated into a SPR biosensor for real-time, label-free toxin B detection in biological 
matrices [47, 49].  It is also possible to increase the stability of the MRE through chemical 
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modification to bases of DNA and may stabilize its secondary structure in complex matrices [58]. 
Overall, the use of R12.69 demonstrated a proof-of-concept in substituting antibody as the 
antigen capturing element in clinically relevant samples and may have the potential to augment 
current and emerging diagnostic techniques of C. difficile infections.  
3.4 Conclusions 
This study further validated the stringent in vitro selection variation previously developed 
by our laboratory. A ssDNA molecular recognition element specific for toxin B has been 
identified with nanomolar affinity (Kd = 47.3 nM) after twelve rounds of selection. The selected 
MRE demonstrated low cross-binding activities on negatives targets: bovine serum albumin, 
Staphylococcus aureus alpha toxin, Pseudomonas aeruginosa exotoxin A and cholera toxin of 
Vibrio cholera. A modified sandwich ELISA assay was developed utilizing the selected ssDNA 
MRE as the antigen capturing element and achieved a sensitive detection of 50 nM of toxin B in 
human fecal preparations and demonstrated a proof-of-concept of the diagnostic application of 
the ssDNA MRE. 
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Chapter 4 
In Vitro Selection of a Single-Stranded DNA Molecular 
Recognition Element Against S. aureus Alpha Toxin and 
Sensitive Detection in Human Serum 
This chapter is adapted from the work that has been published in International Journal of 
Molecular Sciences 
Citation: Hong KL, Battistella L, Salva AD, Williams RM, Sooter LJ (2015) In Vitro Selection 
of a Single-Stranded DNA Molecular Recognition Element Against S. aureus Alpha Toxin and 
Sensitive Detection in Human Serum. International Journal of Molecular Sciences. 16(2):  2794-
2809 
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4.1 Introduction 
Alpha toxin, also known as alpha-hemolysin is a virulence factor secreted by 
Staphylococcus aureus, a facultative anaerobic Gram positive cocci bacteria [1]. S. aureus can 
cause a wide variety of infections in both healthy and hospitalized individuals, such as skin/soft 
tissue infections, bacteremia, pneumonia, and endocarditis [2]. Recent increases in the 
emergence of methicillin-resistant S. aureus (MRSA) in both health care settings and 
communities have raised global concerns [3, 4]. It was estimated that there were approximately 
300,000 patients in the US hospitalized with S. aureus-induced skin/soft tissues infections in 
2007, with an average hospital stay of 4.5 days [5, 6].  
Most strains of S. aureus produce alpha toxin. It forms pores in target cell membranes, 
causing leakage of ions and cytolysis. [1]. It has been shown that alpha toxin is involved in cell 
and tissue damage at infection sites and in inflammatory responses [7]. Antibodies against alpha 
toxin have been identified in patients with S. aureus infection, indicating the systemic 
involvement of alpha toxin in humans [8]. In addition, the important role of alpha toxin in 
pathogenesis has been reported in multiple previous studies [9-11]. 
Due to the problems associated with S. aureus infection, it is important to correctly 
diagnose these infections in a timely manner. The current diagnosis of S. aureus related 
infections are mostly designed for specific types of infections: echocardiography for patients 
with suspected S. aureus endocarditis and bacteria culturing from samples collected at sites of 
infections [12-14]. These methods are slow, non-specific and require multiple tests. Recently, 
PCR and Western blot/dot ELISA have been investigated to detect the presence of alpha toxin-
coding genes and alpha toxin to facilitate the diagnosis of S. aureus related skin/soft tissue 
infections [15, 16]. These methods are sensitive, but require laboratory equipment that may not 
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be readily accessible in some hospitals. Other traditional ELISA assays have also been reported 
for alpha toxin detection [17, 18]. However, the batch-to-batch variation in antibodies may 
hinder the standardization of these assays [19]. 
Single-stranded DNA molecular recognition elements (MRE) are an alternative to 
antibodies that have the potential to address the current limitations in diagnosing S. aureus 
infections. MREs can be proteins (antibodies or antibody fragments), small peptides or nucleic 
acids (aptamers or SOMAmers). They have high affinities and specificities toward the target of 
interest. The first nucleic acid MRE was described by the Gold laboratory in 1990, and was 
isolated using the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) [20]. 
For single-stranded DNA (ssDNA) MREs, the process begins with incubating a large random 
library of different ssDNA molecules (1013 to 1015) with the target of interest. The library is then 
subject to repeated cycles of partitioning, amplification of bound library molecules, and removal 
of unbound molecules. One or a few MREs with high affinities and specificities toward the target 
of interest can be identified at the end of the in vitro selection process. 
In this study, a rigorous SELEX scheme previously developed by our laboratory was used 
to identify a ssDNA MRE that binds to alpha toxin with high affinity and specificity [21-23]. 
The stringency of this SELEX variant is due to the focus on eliminating library binding to 
negative targets that are either structurally similar or likely to coexist in the same environment 
with the target of interest. These negative targets include bovine serum albumin, toxin B of 
Clostridium difficile, exotoxin A of Pseudomonas aeruginosa and cholera toxin of Vibrio 
cholerae. In addition, the identified alpha toxin-specific MRE has been utilized in a ssDNA 
MRE modified sandwich ELISA assay for the detection of the target in human serum samples at 
nanomolar concentrations.  
133 
 
4.2 Material and Methods 
4.2.1 SELEX for Identification of Alpha Toxin-specific MREs 
The in vitro selection process started from a single-stranded DNA (ssDNA) library 
consisting of 1015 different molecules (Figure 4.1). This library was previously designed by our 
laboratory, termed RMW.N34 [21]. It consisted of two 23 base constant regions for polymerase 
chain reaction (PCR) amplification flanking by a 34 base random region (synthesized by 
Eurofins MWG Operon; Huntsville, AL). Twelve rounds of SELEX were carried out to select 
ssDNA molecules that bound to alpha toxin and those that bound to negative targets were 
eliminated in the process (Table 4.1, Figure 4.2). 
 
 
Figure 4.1: Illustration of the Systematic Evolution of Ligands by EXponential enrichment 
(SELEX) process. A random library consisting of 1015 ssDNA molecules (each with  
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a different nucleotide sequence, indicated by different shapes) were incubated with the target 
alpha toxin. Those DNA that bound to the target were amplified and then incubated with 
negative targets. Those DNA that do not bind to negative targets are amplified and subjected to 
further rounds of in vitro selection. 
 
Table 4.1: Systematic Evolution of Ligands by EXponential Enrichment (SELEX) scheme 
for ssDNA molecular recognition element (MRE) identification against alpha toxin. 
Round Positive Selection (+) PCR 
Cycles 
Negative Selection (-) PCR 
Cycles 
1 Immobilized Target (IT) 24 hrs 9 - - 
2 IT 18 hrs 15 BSA Immobilized Negative 
Target (INT) 22 hrs 
16 
3 IT 13 hrs 13 BSA INT 26 hrs 17 
4 IT 7 hrs 18 Exotoxin A INT 22 hrs 16 
5 IT 3 hrs 11 Exotoxin A INT 26 hrs 15 
6 IT 30 min 17 BSA INT 24 hrs  12 
7 IT 5 min, Competitive Elution 
with 1 mg/mL free alpha toxin, 
5 min 
17 IT 5 min, Competitive Elution 
with 1 mg/mL free BSA, 5 min 
16 
8 IT 5 sec, Competitive Elution 
with 1 mg/mL free alpha toxin, 
5 sec 
15 IT 5 sec, Competitive Elution 
with 20 µg/mL free exotoxin a, 6 
hour 
13 
9 IT 5 sec, Competitive Elution 
with 10 µg/mL free alpha toxin, 
5 sec 
12 IT 5 sec, Competitive Elution 
with 20 µg/mL free cholera 
toxin, 6 hour 
13 
10 IT 5 sec, Competitive Elution 
with 5 µg/mL free alpha toxin, 
5 sec 
12 IT 5 sec, Competitive Elution 
with 20 µg/mL free toxin B, 6 
hour 
13 
11 IT 5 sec, Competitive Elution 
with 2.5 µg/mL free alpha 
toxin, 5 sec 
19 IT 5 sec, Competitive Elution 
with 20 µg/mL free BSA, 24 hrs 
7 
12 IT 5 sec, Competitive Elution 
with 1 µg/mL free alpha toxin, 
5 sec 
10 -  
In vitro selection performed for identifying alpha ttoxin specific MRE. Immobilized target (IT) is 
alpha toxin bound to magnetic beads. Immobilized negative (INT) are negative targets bound to 
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magnetic beads. BSA is the abbreviation for bovine serum albumin. Times listed are incubation 
times in hours (hrs), minutes (min) or seconds (sec). 
 
 
Figure 4.2: Structures of targets used in the SELEX scheme and cross binding assays. 
(A) Ribbon structure of the target of interest, alpha toxin (PDB 3ANZ, 33kDa) [24]. (B), 
(C), (D), (E) Ribbon structure of exotoxin A (PDB 1IKQ, 66 kDa) [25], bovine serum 
albumin (PDB 4F5S, 66.5 kDa) [26], cholera toxin (PDB 2A5D, 84 kDa) [27], and toxin B 
(PDB2BVM, 270 kDa) [28], used in negative rounds of selection and cross binding assays. 
 
Lyophilized alpha toxin (List Biological Laboratories; Campbell, CA) was reconstituted 
in pure water and conjugated to carboxylic acid-coated magnetic beads (Dynabeads M-270 
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Carboxylic Acid, Life Technologies; Grand Island, NY) via a two-step amidation reaction using 
N-hydroxysulfonyl succinimide (sulfo-NHS) (Pierce; Rockford, IL) and 1-ethyl-3-(3-
dimethylaminopropyl) (EDC) (Pierce; Rockford, IL). The reaction was performed according to 
manufacturer’s protocol.  
For positive rounds of immobilized target selection, the ssDNA library was incubated 
with 6 µL of immobilized target in 200 µL of selection buffer (100 mM sodium chloride, 20 mM 
Tris-HCl, and 2mM magnesium chloride; 1× selection buffer, SB) at room temperature with 
rotation. After incubation, the solution was then subjected to magnetic separation. Unbound 
ssDNA in solution was removed and immobilized target with bound ssDNA was washed three 
times with 200 µL of SB and resuspended in 100 µL of SB. This suspension served as template 
for PCR amplification. The PCR conditions were as follows: bound ssDNA, 400 nM forward and 
biotinylated reverse RMW.N34 primers (Eurofins MWG Operon; Huntsville, AL) (forward 
primer sequence: 5’ -TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated  reverse primer 
sequence: 5’ -Biotin-GCACTCCTTAACACTGACTGGCT-3’), 250 µM deoxynucleotide 
triphosphates, 1× GoTaq Reaction Buffer (Promega; Madison, WI), 3.5 units Taq, and pure 
water. Thermal cycling conditions were as follows: denature at 95° C for 5 minutes, cycle at 95° 
C for 1 minute, 63° C for 45 seconds, and 72° C for 1 minute; and final extension temperature at 
72° C for 7 minutes [21-23]. Large-scale 3 mL PCR was performed after each round of positive 
and negative selection. This selection process for immobilized alpha toxin target was carried out 
for Rounds 1–6, each with shortened incubation periods.  
Amplified PCR product containing dsDNA was purified with the IBI PCR purification kit 
(IBI Scientific; Peosta, IA) according to manufacturer’s protocol. Single strand separation and 
ethanol precipitation of the forward strand DNA were performed identically to as previously 
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described [21-23]. This procedure was carried out after each round of positive and negative 
selection. 
For negative rounds of selection, BSA and Exotoxin A (List Biological Laboratories; 
Campbell, CA) were conjugated to carboxylic acid-coated magnetic beads as described above 
and served as immobilized negative targets. Selection procedures were carried out similarly to 
positive Rounds 1–6. However, unbound ssDNA in solution served as template for PCR 
amplification. This procedure was performed for negative Rounds 2–6. 
Free alpha toxin in solution was used to perform competitive elutions beginning in Round 
7 positive. The ssDNA library was first incubated with immobilized target as described for 
positive Rounds 1–6. However, free alpha toxin at a concentration of 1 mg/mL in SB was used to 
resuspend the ssDNA bound magnetic beads. The solution containing ssDNA bound to free 
alpha toxin was retrieved by magnetic separation after 5 minutes of incubation and served as 
template for PCR amplification. This procedure was carried out for positive Rounds 7–12, each 
with shorter incubation times and lower free alpha toxin concentrations. Similar competitive 
elution with free negative targets in SB was performed for negative Rounds 7–11. However, 
beads were retrieved and resuspended in 100 µL of SB and served as template for PCR 
amplification. 
4.2.2 Cloning and Sequencing of Alpha Toxin-specific MREs 
DNA sequencing was performed following Rounds 3 negative, 6 negative, 9 negative and 
12 positive to analyze the enrichment of consensus binding sequences in the ssDNA library. This 
was performed identically to as previously described [21-23]. A total of thirty to fifty randomly 
selected sequences were analyzed for each sequenced round.  
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4.2.3 Alpha Toxin-specific MRE SPR Affinity Binding Assays 
One candidate sequence designated as R12.06 from the analyzed round 12 library was 
chosen for further characterization. Mfold DNA web server was used to predict the secondary 
structure of R12.06 with parameter settings at the ionic conditions of SB and at 25 ºC [29]. 
R12.06 was commercially synthesized with a 5’ amino-C6 modification for the use of surface 
plasmon resonance (SPR) affinity binding assays (Eurofins MWG Operon; Huntsville, AL). The 
5’ end was chosen for the amino modification because in the Mfold predicted secondary 
structure the 5’ end was further away from predicted secondary structures than the 3’ end.  This 
provided distance between the immobilization surface and the MRE structure in addition to the 
C6 linker between the DNA and the amino group. A commercially-purchased CM5 SPR sensor 
chip (GE Healthcare; Piscataway, NJ) and a sensor chip fabricated in house were used in the 
assays. 
Glass slides (12 mm x 10 mm) were coated with a 2 nm titanium adhesion layer and a 45 
nm gold layer using Temescal BJD-2000 system (Edwards Vacuum; Phoenix, AZ) with an 
Inficon XTC/2 deposition controller (Infincon; East Syracuse, NY). In order to assemble the 
home-made sensor chip, the gold coated glass slide was first washed with 100% ethanol under 
sonication for 5 minutes, then immersed in a self-assembled monolayer solution of 10 mM 11-
mercaptoundecanoic acid (11-MUA) (Sigma; St. Louis, MO) and 10 mM triethylene glycol 
mono-11-mercaptoundecylether (PEG3) (Sigma; St. Louis, MO) in a 1 to 5 ratio overnight under 
argon. After overnight incubation in the solution, the gold chip was rinsed with 100% ethanol 
and pure water, blown dry with nitrogen and assembled onto a carrying cartridge. A Biacore 
X100 (GE Healthcare; Piscataway, NJ) was used for binding assays. 
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Both types of sensor chips were first activated by injecting 100 mM N-hydroxysulfonyl 
succinimide (sulfo-NHS) (Pierce; Rockford, IL) and 400 mM 1-ethyl-3-(3-
dimethylaminopropyl) (EDC) (Pierce; Rockford, IL) at a 1 to 1 ratio to control and active flow 
cells at a flow rate of 5 µL/min for ten minutes. Then, 5’amino-C6 modified R12.06 was diluted 
to 100 nM in immobilization buffer (100 mM sodium chloride, 20 mM potassium phosphate, and 
2 mM magnesium chloride, pH 7.4). This buffer was also used as the running buffer for the DNA 
immobilization step. A total of 300 µL of DNA was injected into active flow cell at a flow rate 
of 5µL/min, followed by a 10-minute inactivation step using 1 M ethanolamine-HCl pH 8.5. 
Control flow cell without immobilized DNA was also inactivated by 1M ethanolomine-HCL. 
The selection buffer was then used as running buffer for single cycle kinetic assays. 
Alpha toxin at various concentrations (500 nM, 750 nM, 1000 nM, 1500 nM, 2000 nM and 2500 
nM) in SB were injected into both control and active flow cells at a flow rate of 30 µL/min for 
180 seconds with a dissociation time of 150 seconds. Binding responses after baseline and 
control adjustments were analyzed with Biacore X100 evaluation software (GE Healthcare; 
Piscataway, NJ). A 1:1 binding model was used to determine the equilibrium dissociation 
constant (Kd).   
4.2.4 Alpha Toxin-specific MRE Fluorescence Cross Binding Assays 
Commercially synthesized FAM labeled R12.06 (Eurofins MWG Operon; Huntsville, 
AL) was used in microplate based fluorescence cross binding assays. The assay was slightly 
modified from a previous study [30]. Alpha toxin, exotoxin A, toxin B (List Biological 
Laboratories; Campbell, CA), cholera toxin (List Biological Laboratories; Campbell, CA) and 
BSA were diluted to 40 nM in 50 mM carbonate/ bicarbonate buffer (pH 9.6). A volume of 90 
µL of each diluted toxin, human serum (Sigma; St. Louis, MO) and control blocking buffer (SB 
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with 0.05% Tween-20) were added to individual wells of a 96 well Nunc C8 Lockwell MaxiSorp 
microplate (Pierce; Rockford, IL). The plate was incubated on a shaker at 4 ºC overnight. After 
protein coating, all the wells were blocked for 1 hour and washed 3 times with the blocking 
buffer at room temperature. FAM labeled R12.06 at 100 nM in 90 µL of SB was added to control 
and cross binding target coated wells and incubated for 1 hour at room temperature. 
Subsequently, unbound FAM-R12.06 was removed and each well was washed 5 times with 
selection buffer. Lastly, 90 µL of SB was added to each well and the plate was measured in a 
Synergy 2 micoplate reader with excitation at 490 nm and emission at 520 nm (Biotek US; 
Winooski, VT). Fluorescence measurements were normalized to control and an internal standard 
of 90 µL of 100 nM FAM-R12.06 in SB as previously described [21-23]. All cross binding 
targets and control well sets were in triplicate. Data was averaged and standard deviation was 
calculated. A one-tailed student t-test was used to determine the statistical significance in 
difference of the means (p < 0.05). 
4.2.5 Alpha Toxin-specific MRE Modified ELISA 
A 100 µL sample of commercially synthesized 5’ amino-C6 modified R12.06 was diluted 
to 40 nM in immobilization buffer and added to individual wells of a maleic anhydride activated 
microplate (Pierce; Rockford, IL) and incubated overnight with shaking at room temperature. 
Each well was then blocked with blocking buffer (SB, 0.1% BSA and 0.05% Tween-20) for 1 
hour and washed 3 times with SB/ 0.05% Tween-20 washing buffer at room temperature. Wells 
without DNA added served as blank control. SB, human serum, and alpha toxin diluted to 200 
nM in SB and in human serum were added into individual wells and incubated on a shaker for 1 
hour at room temperature. SB and human serum served as background control.  
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After incubation, all of the contents were aspirated and wells were washed 5 times with 
the same washing buffer. Then, 100 µL of rabbit anti-alpha toxin primary antibody serum 
(Sigma; St. Louis, MO) at 1 to 500 dilution ratios in washing buffer was added and incubated for 
30 minutes with shaking at room temperature. Primary antibody was then aspirated and wells 
were washed for 3 times. A secondary goat anti-rabbit antibody conjugated to horseradish 
peroxidase (Pierce; Rockford, IL) at 1 to 500 dilution ratios in washing buffer was added and 
incubated for 30 minutes with shaking at room temperature. Lastly, all contents were aspirated 
and washed 5 times as outlined above. ABTS substrate (Pierce; Rockford, IL) was then added to 
all wells according to manufacturer’s instruction. Absorbance at 410 nm and 650 nm was 
measured in a Synergy 2 microplate reader using Gen 5 1.06 software (Biotek US; Winooski, 
VT) in two minute increments. Negative controls were wells incubated without antibodies and 
with only primary antibody. Each set was performed in triplicate. Data was averaged and 
standard deviations were determined. A two-tailed student t-test was performed to determined 
statistical differences at p < 0.05. 
4.3 Results and Discussions 
4.3.1 Identification of Alpha Toxin-specific MRE 
Twelve rounds of in vitro selection were performed to identify a ssDNA MREs against 
alpha toxin (Table 4.1). The selection utilized a SELEX scheme previously described by our lab 
[21]. This scheme was designed to enrich the ssDNA library to bind preferentially to alpha toxin 
in solution and to decrease binding to bovine serum albumin (BSA), toxin B, exotoxin A, and 
cholera toxin. Thirty to fifty random sequences were analyzed for the enrichment of consensus 
sequence families after every third round of selection (rounds 3, 6, 9, 12) to monitor the diversity 
of the library. The sequences from round 12 were analyzed for the presence of consensus 
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sequences, but were also screened based on their predicted secondary structures and the stability 
of those structures, as predicted by a Gibbs free energy value. The random region of one 
sequence, R12.06 from the analyzed Round 12 library appeared to be highly conserved among 
several sequence families, and therefore it was chosen for further characterization (Table 4.2).  
 
Table 4.2: Sequence families after 12 rounds of SELEX. 
Designation                                                    Sequence  
R12.26   
TGTACCGTCTGAGCGATTCGTACCCTTGCCGATGCCTTTACGGTCTAGTTTGGATGTAGCCAGTCAGTGTTAAGGAGTGC 
R12.06   
TGTACCGTCTGAGCGATTCGTACGATTACTATAATTTCCTATCGTCCGACCGCCGTCAGCCAGTCAGTGTTAAGGAGTGC 
R12.01   
TGTACCGTCTGAGCGATTCGTACTCGGGCGATGATACTTAGCACGGTCTAGGTCAAAAGCCAGTCAGTGTTAAGGAGTGC 
R12.20   
TGTACCGTCTGAGCGATTCGTACTAGCGGCAGAGTAGCACTCTATAGGTCGATGTTTAGCCAGTCAGTGTTAAGGAGTGC 
 
R12.01   
TGTACCGTCTGAGCGATTCGTACTCGGGCGATGATACTTAGCACGGTCTAGGTCAAAAGCCAGTCAGTGTTAAGGAGTGC 
R12.02   
TGTACCGTCTGAGCGATTCGTACCGTGTCCTATTTTCTTCTCTGTTAACTCTCGTCAGCCAGTCAGTGTTAAGGAGTGC 
R12.06   
TGTACCGTCTGAGCGATTCGTACGATTACTATAATTTCCTATCGTCCGACCGCCGTCAGCCAGTCAGTGTTAAGGAGTGC 
R12.39   
TGTACCGTCTGAGCGATTCGTACTTTGATCTCGTGTGTCTAGTTGCGGCGGATTGTCAGCCAGTCAGTGTTAAGGAGTGC 
R12.10   
TGTACCGTCTGAGCGATTCGTACGGTCAACCTCACCGACTGCCGACCGTTTAATTCGAGCCAGTCAGTGTTAAGGAGTGC 
R12.43   
TGTACCGTCTGAGCGATTCGTACCGTCATTGCCTCGTAGTATTCTTATAGTCGGTAGAGCCAGTCAGTGTTAAGGAGTGC 
R12.44   
TGTACCGTCTGAGCGATTCGTACTCCCGAAAGCGCGTCAGCCTGGGAGGTTATGCGGAGCCAGTCAGTGTTAAGGAGTGC 
 
Representative sequence families from Round 12 ssDNA library. Families are separated by 
difference cells of the table with according to common their consensus sequences (underline)s 
and sequence homologies (double-underlined). 
 
The Mfold predicted secondary structure showed a long stem-loop structure comprised of 
the random region of the MRE and with a Gibbs free energy value of -8.85 kcal/mol (Figure 4.3). 
The entire random region of R12.06 participated in the formation of the long stem-loop 
secondary structure according to the Mfold prediction. The random region of R12.06 also shares 
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approximately 30% and 50% identity with the random regions of R12.26 and R12.02 
respectively. 
 
 
Figure 4.3: Sequence and secondary structure of R12.06 ssDNA MRE. (A) ssDNA 
sequence of alpha toxin MRE R12.06; (B) Mfold prediction of R12.06 secondary structure 
[29]. 
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4.3.2 Affinity and Specificity of Alpha Toxin-specific MRE 
Surface plasmon resonance single cycle kinetics assays were used to determine the 
affinity of R12.06 for alpha toxin. The average equilibrium dissociation constant (Kd) was 93.7 ± 
7.0 nM (Table 4.3).  
Table 4.3: SPR affinity data of R12.06 ssDNA MRE. 
 Kd (nM) χ2 (RU)2 
Assay 1 102 0.493 
Assay 2 88.7 0.691 
Assay 3 90.7 0.164 
Averaged 93.7 ± 7.0 - 
The averaged equilibrium dissociation constant is given with standard deviation from three 
assays. The χ2 described the closeness of fit between the experimental and fitted curve. RU 
represents the response unit generated by the SPR instrument. 
 
Single cycle kinetics has previously been used to determine the binding affinities of 
nucleic acid MREs [31, 32]. This assay is typically used for sensor surfaces that are difficult to 
regenerate and cannot therefore undergo classical multi-cycle kinetic analysis. Single cycle 
kinetics has also been shown to provide equally valid results as multi-cycle assays [33, 34]. 
Ligand (ssDNA MRE) immobilization strategies described in this work differ from many 
previous studies [31, 35-37]. Here, covalent linkage of 5’-amino modified ssDNA MRE was 
performed instead of the more typical biotin-streptavidin capturing. At neutral to slightly basic 
running buffer, the electrical repulsion between the negatively charged DNA and sensor chip 
surface leads to relatively lower level of ligand immobilization by covalent attachment. Both 
sensor chips produced in house and commercial CM5 sensor chips were utilized in the assays. A 
different concentration range (25nM to 500 nM) of alpha toxin was also tested and yielded a 
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comparable result (Kd = 90.7 nM), and thus confirming the validity of the determined 
equilibrium dissociation constant. The Kd of R12.06 is comparable to other previously reported 
Kd values of MREs targeting bacterial toxins [30, 38, 39]. This further validates the SELEX 
variation previously developed by our laboratory [21-23]. 
A fluorescent plate-based assay was used to determine the cross binding activity of 
R12.06. This assay was slightly modified from that which is previously described by using a 
different washing buffer [30]. The data is presented relative to binding between R12.06 and 
alpha toxin as has been previously described [21, 22]. The ssDNA MRE exhibits significant 
binding preference to alpha toxin over all negative targets (p < 0.05) (Table 4.4).  
Table 4.4: Cross-reactivity data of R12.06 ssDNA MRE. 
Target Normalized 
Average 
Fluorescence 
Standard 
Deviation 
p-Value Selective Ratio 
Alpha Toxin 0.047 0.007 - - 
Cholera Toxin 0.031 0.009 0.003 1.5 
Exotoxin A 0.031 0.002 0.004 1.5 
Toxin B 0.009 0.002 0.001 5.0 
Bovine Serum 
Albumin 
0.026 0.001 0.027 1.8 
Human Serum 0.028 0.003 0.017 1.7 
 
The binding of R12.06 to alpha toxin is 1.5 times greater than cholera toxin and exotoxin 
A (p = 0.003 and p = 0.004 respectively), 5.0 times greater than toxin B (p = 0.0005), and 1.8 
times greater than BSA (p = 0.03). It is important to note that components of human serum were 
not included in the negative selection scheme, but R12.06 still shows 1.7 times greater selectivity 
over human serum (p = 0.02). This selectivity is important for downstream application 
development. An interesting phenomenon observed in this study is that the binding selectivity 
over toxin B (270 kDa) is more than triple that of cholera toxin (84 kDa). However, both toxins 
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were only introduced once in the negative selection scheme. A similar phenomenon was also 
observed in another study from the Sooter laboratory that investigated the binding selectivity of a 
C. difficile toxin B specific ssDNA MRE over other toxins, in which the toxin B MRE is two 
times more selective of alpha toxin (33 kDa) over cholera toxin. Based upon these two 
observations, it is likely that the binding selectivity of the ssDNA library is enriched early on in 
the selection process and the target molecular weight and crystal structure may play a role in the 
selectivity of MREs. The overall low cross binding activities in all tested negative targets further 
validates the stringency of our selection process [21-23].     
 
4.3.3 Diagnostic Application of Alpha Toxins-specific MRE 
The high affinity and specificity of the alpha toxin specific ssDNA MRE allowed the 
investigation of its potential application as a diagnostic tool. A modified ELISA using R12.06 as 
the toxin-capturing element was developed (Figure 4.4).  
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Figure 4.4: Illustration of the ssDNA MRE modified ELISA assay. The ssDNA MRE 
was used as the capturing element in the sandwich ELISA assay. 
 
Reproducible and statistically significant detection of 200 nM alpha toxin spiked in 
human serum samples were achieved compared to control in multiple assays (p < 0.01 to p < 
0.001) (Figure 4.5). The significant differences were first detected 20 minutes after the addition 
of horse radish peroxidase substrates. It is important to note that the average half-life of ssDNA 
MREs in serum is about one hour due to the presence of exonucleases [40]. The R12.06 MRE 
demonstrated its robustness in serum without any base modifications. The three dimensional 
structure of nucleic acid MREs are known to be influenced by temperature, pH and ionic strength 
of the binding conditions [41]. The R12.06 MRE was able to retain a level of affinity and 
specificity in undiluted human serum, which is a complex biological matrix with serum proteins, 
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lipids and varied ionic concentrations [42]. The assay completion time from the addition of alpha 
toxin to positive result was less than 4 hours. This demonstrates the potential of R12.06 as a 
clinical diagnostic tool.  
 
 
Figure 4.5: Detection of alpha toxin in modified ELISA assay. Data represent one 
modified sandwich ELISA with absorbance measured at 410 nm. Absorbance levels are 
subtracted from background levels of blank wells without immobilized DNA. (A) 
Statistical significance levels with respect to DNA with buffer background of p < 0.001 are 
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designated by *. (B) Statistical significance levels with respect to human serum 
background of p < 0.001 are designated by *. Buffer: 1× selection buffer. Error bars are 
representative of +/- 1× standard deviations.  
 
A single-stranded DNA MRE was previously incorporated into a system for target 
detection in binding buffer-diluted human serum [43]. Similar ssDNA MRE based ELISA assays 
have also been reported in previous studies for the detection of bacterial toxin targets in binding 
buffer [30, 44]. In comparison, the assay in this study demonstrates a level of superiority by 
detecting target molecules in minimally manipulated and clinically relevant samples. Traditional 
antibody-based ELISA assays for the detection of alpha toxin have been previously reported with 
high sensitivity in bacterial culture media (LOD of 1 ng/mL) [17, 18]. In these experiments 200 
nM, or 6.6 µg/mL, alpha toxin in human serum was detected. While highly reproducible, the 
signal is small enough to be near the limit of detection for the system described. This level is 
within the range of clinical relevance, as previous work has shown levels to be as high as 83 µg/mL 
[45]. The sensitivity of the assay may be improved by making the ssDNA MRE more resistant to 
exonucleases. This stability limitation may be resolved by base modifications [46]. In contrast to 
antibodies, ssDNA MREs also have several advantages, such as thermostability, reversible 
denaturation and inexpensive chemical synthesis [47]. It is to be noted that another ssDNA MRE 
targeting alpha toxin has been reported recently [48]. The authors investigated the potential 
therapeutic application of their selected MRE, however, no binding affinity and specificity data 
were reported in the study. It is unknown if R12.06 will demonstrate neutralizing effect on alpha 
toxin. Based upon the determined high affinity and specificity of R12.06, its translational value 
may not be limited to diagnostic detection and may warrant future studies. In sum, the ability of 
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R12.06 to detect alpha toxin in undiluted human serum samples has been demonstrated, which 
has the potential to augment current and future diagnostic methods for S. aureus related 
infections. 
4.4 Conclusions 
This study utilized a robust SELEX methodology to identify a molecular recognition 
element specific for alpha toxin of Staphylococcus aureus with high affinity and specificity. The 
MRE binds with a nanomolar equilibrium dissociation constant (Kd) of 93.7 ± 7.0 nM and is 
selective for alpha toxin over all bacteria toxins used in the negative selection scheme and in 
human serum. In addition, a proof-of-concept diagnostic sandwich ELISA utilizing the MRE as 
the toxin capturing element has been developed and successfully demonstrated target detection at 
200 nM in undiluted human serum samples. The results further validate our SELEX process and 
showed the potential of applying ssDNA MREs in diagnostic applications. 
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Chapter 5 
Overall Conclusions and Future Studies 
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5.1 Summary 
In summary, the work that has been presented herein demonstrated several important 
findings in the field of ssDNA MRE isolation and application. 
Firstly, three ssDNA MREs with high affinities and specificities have been identified 
with the Decoy-SELEX method. These properties of the selected ssDNA MREs are important for 
downstream applications. This work is novel in that the first ssDNA MREs were isolated against 
Pseudomonas aeruginosa exotoxin A and Clostridium difficile toxin B. It is also novel that these 
MREs were used in biosensing applications where the toxins were detected in biologically 
relevant samples. Although a previous ssDNA MRE was isolated against Staphylococcus aureus 
alpha toxin [1], the alpha toxin-specific ssDNA MRE isolated in this work was the first to apply 
it to a sensing application.  
Secondly, the method developed for immobilizing amino modified ssDNA MREs on 
customized gold surface in Chapter 2 has an important role in the fabrication of a stable sensory 
surface. This setup is readily translatable into the final design of the recognition component of a 
biosensor.  
Thirdly, the developed modified ELISA assays are applicable in clinical diagnostic 
laboratories. Bacterial toxin targets were detected in clinically relevant samples, and at clinically 
relevant concentrations. This confirmed the selected unmodified ssDNA MREs were robust and 
specific in the targets’ native environments. There were minimal sample manipulations in the 
steps of the modified ELISA assay, which is desirable and practical for real-world situations. 
Lastly, this work established the foundations for future studies in the application of 
ssDNA MREs. These foundations and future studies are briefly described in the following 
sections. 
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5.2 Future Studies 
 The work described in Chapter 2 through 4 established the foundation in the biosensing 
application of ssDNA MRE. Although the presented detection assays are a proof-of-concept at 
the current stage, this work can be further developed into biosensors that are potentially more 
sensitive and sophisticated. The ultimate design for an ideal ssDNA MRE based biosensor will 
be in the form of a point-of-care system.  
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Appendix 
In Vitro Selection of a Single-Stranded DNA Molecular 
Recognition Element Against Pesticide Fipronil 
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A.1 Introduction 
 Fipronil is a widely used phenlpyrazole insecticide in the United States since it was first 
introduced in the late-1990s [1]. Fipronil inhibits gamma-aminobutyric acid (GABA) gated 
chloride channels and causes continuous excitation of the central nervous system [2]. Due to the 
increasing resistance to organophosphate pesticide, fipronil is often used as an alternative in 
many settings, this includes residential, commercial, and agricultural [3]. From 2000 to 2005, the 
sales of fipronil in California have increased by 10-fold [4]. Report indicates that fipronil 
currently accounts for approximately 10% of the global pesticide market [5]. Its widespread use 
has led to a rapid increase in environmental exposure to fipronil. 
 Due the popular use of fipronil, it has become a widespread environmental contaminant. 
During 2002-2011, fipronil was detected in urban streams up to 63% of the time, and about 15 to 
20% of the time in agricultural, and mixed land streams in the United States [3]. Additionally, 
measured concentrations of fipronil exceed the aquatic-life benchmark in 70% of urban streams 
and more than 20% of agricultural, and mixed land streams in the mentioned time period [3]. 
Fipronil detected in surface water had levels up to 6.4 µg/L in selected area [6]. It has been 
shown to contaminate drinking water sources in Vietnam [7]. The worldwide contamination of 
fipronil is clearly interacting with ecosystem and human. 
Recent report confirmed the presence of fipronil in urban streams, and is highly toxic to 
many steam invertebrates, with a mean 96-hour viability inhibition EC50 values as low as 32.5 
ng/L for Chironomus dilutus [8]. Additionally, fipronil is highly toxic to many fish species, with 
reported 96-hour LC50 level as low as 0.246 mg/L for rainbow trout and 0.083 mg/L for bluegill 
sunfish [1]. It also has a tremendous negative impact on non-target insect, such as honey-bee [9]. 
Although fipronil binds more selectively to insect GABA receptors than mammal GABA 
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receptors, long term toxicity study showed it increased thyroid follicular cell tumor in rats [10, 
11]. The U.S. Environmental Protection Agency has therefore classified fipronil as a possible 
human carcinogen [10]. Even though there is an overall increase in the knowledge of how 
fipronil is impacting the environment and human health, large knowledge gap still exist in terms 
of its environmental fate and resides in various media, such as soils and agricultural products 
[12]. Thus, it is important to monitor the exposure level of fipronil in the environment.   
Currently, the detection of fipronil level in environmental and biological samples are 
mostly dependent on chromatographic methods, such as gas and/ or liquid chromatography 
coupled with mass spectrometry [13-16]. These methods are sensitive, but costly, time and labor 
intensive. There have been reported uses of antibody-based enzyme-linked immunosorbent 
assays (ELISA) to detect total fipronil in human blood samples and artificially contaminated tap 
water samples [17, 18]. However, there are inherent limitations in antibody-based assays, such as 
difficult or unable to be reused, expansive in production, and may suffer from batch-to-batch 
variations [19, 20]. It is therefore necessary to develop low-cost, reusable means to detect 
fipronil rapidly. One possible way to achieve this is by identifying a single-stranded DNA 
(ssDNA) Molecular Recognition Element (MRE) that specifically bind to fipronil. 
The process, Systematic Evolution of Ligands by Exponential Enrichment (SLEEX) can 
be utilized to identify such a specific binding element [21]. This in vitro selection process 
involves repeated cycles of incubation and partitioning between the target of interest and a large 
library with up to 1015 different molecules, and amplification of molecules that bind to the target 
under increasing selection pressures.  
This work describes the use of a stringent variation of the SELEX process previously 
developed by our laboratory to select ssDNA MREs specific for fipronil. This SELEX variant 
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emphasizes on introducing multiple, lengthy negative selection rounds to direct the enriched 
library away from binding to structurally similar molecules and molecules that are likely to co-
exist in the same environment [22-24]. In this work, major metabolites of fipronil, commonly 
used herbicides and pesticides, atrazine, malathion and propanil, and a closely related pesticide, 
ethiprole have been used as negative targets to increase the specificity of the enriched library. 
Bovine serum albumin (BSA) is chosen to be one of the negative targets, as it is a common 
blocking agent, and serves as a general protein target. The selection process has been completed, 
and potential candidate ssDNA MRE sequence has been identified. Future works will be the 
determination of its binding affinity and specificity to fipronil, and the development of a 
potential detection assay for fipronil. 
A.2 Materials and Methods 
A.2.1   In vitro selection for Fipronil-specific MREs 
 Twelve rounds of SELEX were carried out to identify fipronil-specific MREs (Figure 
A.1). 
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Figure A.1: Illustration of the in vitro selection process. The in vitro selection process begins 
with up to 1015 different ssDNA molecules and incubation with the target of interest, fipronil. 
Molecules bind to fipronil are amplified and subjected to incubation with negative targets. Those 
that do not bind to negative targets are retrieved and amplified. This completes one round of in 
vitro selection cycle. 
In brief, the selection began with a ssDNA library with up to 1015 different molecules. 
This library was previously designed by our laboratory, and designated RMW.N34 [23]. The 
library consists of two 23-base constant regions for primer attachment during polymerase chain 
reaction (PCR), flanking by a 34-base random region, and it was commercially synthesized 
(Eurofins MWG Operon; Huntsville, AL). The stringent selection scheme was designed to enrich 
molecules that bind to fipronil, but not the negative targets 
A.3 Preliminary Results and Future Work 
A.3.1   Round 12 Potential Fipronil-specific candidate MRE 
 Twelve rounds of SELEX were carried out to identify ssDNA MREs specific to fipronil. 
The post round 12 library was analyzed for consensus sequence families, predicted secondary 
structures and Gibbs free energy values (ΔG) (indicating stability). These steps were performed 
similarly to the method described in Chapters 2-4. One candidate sequence, designated R12.51 
was present in multiple sequence families, with relatively stable predicted secondary structures,  
and low Gibbs free energy (-9.28 kcal/mol).  
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